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ABSTRACT
The conformations of carnitine (Cn) and acetylcarni­
tine (AcCn) have been investigated through a combination 
of methods. The solid-state structures of their zwittei—  
ionic forms have been determined by single-crystal X-ray 
analyses. The crystal structures reveal different back­
bone conformations for the two molecules. Carnitine 
exists in an extended conformation (a,g~ conformations 
for the C1-C2-C3-C4 and N1-C4-C3-03 torsion angles, 
respectively), while AcCn exhibits a folded conformation 
(g-,g~).
The solution conformations of Cn and AcCn have been 
investigated by high resolution ‘H NMR coupling data. A 
simple equation has been developed for the prediction of 
torsion angles from 3J(HCCH) coupling constants. This 
equation employs experimentally determined substituent 
constants, which can account for solvent effects. The 
conformation and populations of conformers of AcCn and Cn 
in D z0 have been estimated by use of this new Karplus’ 
relationship. The assignment of diasteriotopic protons 
of Cn and AcCn was made by analogy with the lowest energy 
conformations as determined by molecular mechanics CMM2) 
calculations parameterized with atomic charges from ab 
initio (3-21G) calculations. Populations of conformers,
x i x
arising from rotation about the C2-C3 and C3-C4 bonds 
were calculated. Both compounds adopt a highly pre­
ferred g- conformation about the N1-C4-C3-03 torsion 
angle. In contrast, the C1-C2-C3-C4 torsion angle exhib­
its substantial rotational freedom between g- and a. In 
Cn the anti conformer dominates, whereas in AcCn the 
g- conformer is most prevalent. The relative energetics 
of extended and folded conformers suggest that binding 
of either Cn or AcCn to carnitine acetyltransferase (CAT) 
occurs with the folded form.
The syntheses of seventeen conformationally rigid 
morpholinium analogues of Cn and AcCn are described. 
These compounds exhibit predictable stereo- and regio- 
chemistry because of stereospecific ring closures of 
their acyclic precursors. The single-crystal X-ray 
structures for seven of the compounds are presented. The 
synthesis, resolution, and solid-state structure of a 
sulfonate analogue of Cn (sulfocarnitine) are also 
described. These compounds have been tested as inhib­
itors of pigeon CAT and rat-liver carnitine palmitoyl­
transferase (CPT). The results support the hypothesis of 
a folded conformation for enzyme-bound Cn or AcCn. The 
inhibitors also reveal distinctly different modes of Cn 





AcCoA acetyl coenzyme A
ATP adenosine 5 '-triphosphate





COT carnitine octanoyltransferase (EC 2.3.1.-)
CPT carnitine palmitoyltransferase (EC 2.3.1.21)
DMAE 2-(N ,N-dimethylamino)ethanol











While preparing this manuscript, it was always my 
intention to properly acknowledge those individuals whose 
significant contributions to the field of carnitine 
research I had the pleasure of presenting in this dissei—  
tation. In the vast majority of instances, I have cited 
original works appearing in the primary literature. How­
ever, in a few instances, when dealing with research top­
ics that were peripheral to my own, and wh'en faced with 
an enormous quantity of literature, I have resorted to 
use of review articles. Hence, the reader is occasion­
ally directed to one of several excellent reviews on cai—  
nitine and carnitine acyltransferase enzymes, which have 
appeared since 1963. This is especially true for the 
material presented in this introduction. Therefore, I 
must begin by apologizing to those few individuals whose 
names I may have discourteously buried under yet another 
layer of the biochemical literature.
Carnitine is the biological carrier-molecule of 
fatty acids destined for transport into and oxidation by 
mitochondria.1 Carnitine is absolutely required for effi­
cient metabolism of long-chain fatty acids.2*3 In fact, 
tissues containing inadequate concentrations of carnitine 
exhibit severely impaired cellular energy metabolism.4
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Before 1973, nutritionists had always assumed that an 
individual would either synthesize adequate amounts of 
carnitine, ingest adequate amounts of dietary carnitine, 
or meet carnitine requirements from both sources.3'6 Car—  
nitine was never considered an essential nutrient for any 
segment of the healthy population or diseased individu­
als. However, recent clinical studies have identified 
human carnitine deficiency resulting from both nutri­
tional condition and disease states. For instance, spe­
cific genetic disorders can result in primary muscle and 
systemic carnitine deficiency.3-3 An adequate supply of 
dietary carnitine is probably important in early infancy 
as the capacity for carnitine biosynthesis at that time 
is limited.4-3 Extended parenteral nutrition in newborns 
as well as adults often results in low serum and tissue 
carnitine levels.3 Similar effects have been noted for 
patients on hemodialysis.4 Carnitine supplementation may 
be required in all the above mentioned cases.3
An abnormal balance between carnitine and acylcarni- 
tine tissue levels has been noted in several disease 
states. Patients hospitalized for advanced cirrhosis of 
the liver frequently have subnormal plasma carnitine con­
centrations. 3 In experimental ischemia, tissue carnitine 
decreases and may become rate-limiting. Several studies
have shown that ischemia causes an increase in fatty-
x x i i i
acyl-CoA and carnitine esters in the myocardium, which 
results in unfavorable metabolic effects.7 Carnitine 
administration has been found to delay development of 
ischemic damage.4 > 7
Carnitine and its esters are the substrates of sev­
eral enzymes involved in fatty-acid metabolism.3>8 The 
general significance of this work is in providing the 
field with specific probes for the roles of carnitine and 
acetylcarnitine in fatty-acid metabolism. This can in 
part be accomplished by design of inhibitors that are 
selective for the various carnitine-dependent enzymes. 
Such probes might be employed to inhibit one particular 
enzyme and examine the impact on the entire system. More 
specifically, the work described in this dissertation is 
part of an ongoing project aimed at understanding the 
mechanisms of catalysis by carnitine acyltransferase 
enzymes. The specific goal, topographical descriptions of 
the enzyme active sites, has been approached from two 
distinct and complementary directions: First, is to gain
insight into the accessible solution conformations of the 
substrates, carnitine and acetylcarnitine; and second, is 
to design, synthesize, and assay novel enzyme inhibitors.
Chapter 1 is a historical review of the chemistry of 
carnitine as well as proteins that bind carnitine and 
acylcarnitines. An extensive literature review of carni­
XX Iv
tine acetyltransferase (CAT) is presented. Included is a 
discussion on known inhibitors of CAT and implications as 
to possible mechanisms of catalysis based upon molecular 
recognition of these inhibitors by CAT.
Chapter 2, reprinted from Bioorganic Chemistry, is a 
report on the the solid state conformations of carnitine 
and acetylcarnitine zwitterions determined by single­
crystal X-ray analyses. These crystal structures yield 
very accurate structural data and address the issue of 
electrostatic effects on conformation in these highly 
charged molecules. This X-ray work may be viewed as the 
starting point in a logical progression toward undei—  
standing the enzyme-bound conformations of carnitine and 
acetylcarnitine. The overall approach, which is outlined 
below, depends upon both computational and experimental 
methods.
Chapter 3, reprinted from Magnetic Resonance in Chem­
istry, is a detailed report on the development of a novel 
Karplus equation utilized in determining molecular con­
formations in solution from *H NMR vicinal coupling con­
stants. This equation was developed in the interest of 
solving explicitly the solution conformations of carni­
tine and acetylcarnitine, but has general application to 
a wide variety of structures. The method described is a 
novel solution to the long-standing problem of how to
XXV
properly account for the effects of molecular environment 
on vicinal coupling constants.
Chapter 4, recently published in Journal of the 
American Chemical Society, is a description of how this 
equation is applied to solve the solution conformation of 
charged flexible molecules, particularly carnitine and 
acetylcarnitine. Extensive force field calculations on 
carnitine and acetylcarnitine are presented. These molec­
ular mechanics (MM2) calculations supply valuable insight 
into electrostatic effects on conformations, and greatly 
reduce the total number of conformational states that 
need to be considered in the NMR solutions.
Chapter 5 is an outline of the rationale behind the 
design and syntheses of conformationally rigid cyclic 
analogues of carnitine. The design of these rigid ana­
logues is based on the solution conformations of carni­
tine and acetylcarnitine, which are determined by NMR. 
The syntheses and characterization of fourteen new com­
pounds are described. The solid-state structures for six 
of these and two previously known compounds are reported 
and their conformations are compared to those of carni­
tine and acetylcarnitine.
In Chapter 6, detailed results from biological evalu­
ations of these carnitine analogues, performed in the 
laboratory of Professor Linda Brady, are presented. A
x x v i
discussion of the results obtained for this new class of 
carnitine acyltransferase inhibitors and their implica­
tions to understanding the topography of the carnitine 
acyltransferase active sites is presented.
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Chapter 1. A Review of Carnitine and Proteins 




Discovery and Function of Carnitine
The discovery of carnitine (1) in meat extracts was 
made independently by two groups of investigators eighty-




two years ago.1'2 Although a correct structure was pro­
posed as early as 1907,3 a complete structural proof was 
not clearly established for another 20 years.4'® Interest 
in the metabolic significance of carnitine heightened 
after it was identified as the previously known growth 
factor, Vitamin BT , of the meal worm (Tenebrio molitor).6 
Its ubiquitous presence throughout all the phyla and 
classes of the animal kingdom was subsequently demon­
strated.7
Generally the highest concentrations of carnitine 
have been found in heart and skeletal muscles of verte­
brates,7*8 where its major role is believed to be to be 
transport of lipids into mitochondria.9 However, unusu­
ally high concentrations have been measured in the elec­
tric organ of the eel (.Torpedo occidental is) and flight 
muscle of the fly (Musca).7 Its presence (albeit in low 
concentrations) in plants®*10 suggests an even broader 
occurrence in all eucaryotes.
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The role of carnitine in fatty acid metabolism was not 
discovered until the mid-1950s, when Fritz11 demonstrated 
that addition of carnitine to liver slices and homogen- 
ates stimulated the oxidation of long-chain fatty acids. 
That same year, Friedman and Fraenkel12 reported the 
reversible enzymatic acetylation of carnitine in the 
presence of coenzyme A (CoA), by crude pigeon-1iver 
extracts (eq 1). They correctly concluded that the ester 
bond of acetylcarnitine should be classified as a high 
energy bond comparable with the thioester bond of acetyl- 
coenzyme A (AcCoA).
AcCoA + carnitine acetylcarnitine + CoA (1)
Bremer9 showed, in 1962, that isolated rat mito­
chondria from a variety of tissues could catalyze the 
same reversible reaction (eq 1). Bremer concluded that 
acetylcarnitine (2) represents an active acetate, which 
is efficiently utilized for oxidation by mitochondria. He 
correctly surmised that because the inner mitochondrial 
membrane was impermeable to CoA and AcCoA, there existed 
an acetylcarnitine-CoA-acetyltransferase, which func­
tioned to transfer acetyl groups to carnitine. Carnitine 
(as acetylcarnitine) in turn served as a transmembrane 
acetyl carrier. Because palmitate oxidation was stimu­
lated by added carnitine, it was clear that this acyl-
t
carrying function of carnitine was not limited to the 
acetyl group.
The large group-transfer potential of acetylcarni­
tine has been verified by thermodynamic studies involving 
the acetyltransferase enzyme13-14 and by microcalorime­
try.13 Table 1 shows the free energy of hydrolysis of 
acetylcarnitine compared to other esters of biological 
significance. Acetylcarnitine is found to have an even 
higher group transfer potential than either acetylcholine 
or the terminal phosphate of ATP.
Table 1. Comparison of Free Energies of Hydrolysis 
at pH 7.0.
AG° (kcal/mol)
Ester 25 °C Ref 38 °C Ref
Acetylcarnitine -7.90® 15 -8.20 14
Acetylcholine -6.47 16 -6.99 14
Acetyl Coenzyme A -8.20» 17 -8.54 14
ATP (terminal P04) -7.30 16 -7.60 18
• This value is practically invariant with longer acyl 
chains. The same value was obtained by Fritz et al.13 
but at 35 °C.
In an early example of the stereospecific nature of 
the enzyme-catalyzed acyltransferase, Bremer9 showed that 
only one enantiomer of acetylcarnitine, from 
the D,L mixture (presumably the naturally occui—
ring L isomer), was metabolized by mitochondria.
5
The L isomer [also designated 1 or (-)] was subsequently 
proven, by synthesis from (R)-/3-hydroxy-L-glutamic acid, 
to be of the R absolute configuration 19
Carnitine Specific Proteins
The knowledge that carnitine and its esters are 
involved in fatty acid metabolism quickly opened the way 
to the identification and characterization of the protein 
systems involved. Eight proteins Cor protein systems) 
specific for carnitine and its esters have been identi­
fied. These can be subdivided into five major groupings: 
First, is a carnitine active transport system, which is 
associated exclusively with the plasma membrane. Second, 
is a carnitine-acylcarnitine translocase system located 
on the inner mitochondrial membrane. Third, is a long 
chain carnitine ester hydrolase found in liver and asso­
ciated with microsomes. Fourth, is three unique carnitine 
acyltransferases, which as previously stated are associ­
ated primarily, but not exclusively (see below), with 
mitochondria. Fifth, is two degradative enzymes, carni­
tine dehydrogenase (EC 1.1. 1 . 108)20 and carnitine decai—  
boxylase (EC 4.1.1.42).21 These last two enzymes are not 
directly involved in lipid metabolism and therefore are 
not discussed in this review. The remaining systems and 
their inhibitors are of interest for defining those fea­
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tures that, are common to and essential for molecular rec­
ognition of carnitine and acylcarnitines.
Carnitine active transport. The active transport of car—  
nitine into cells is essential for those tissues that 
lack a biosynthetic capacity. Active uptake of carni­
tine, against a concentration gradient, has been observed 
in tissues of the rat from brain2z, skeletal muscle23, 
heart,24 and epididymis28
Tanphaichitr and Broquist26 have shown that 
(R)-carnitine is ultimately derived from protein bound 
e-.A/-trimethyl-L-lysine. e-A/-Trimethyl-L-lysine is con­
verted to 7-butyrobetaine (4-trimethylammoniobutyrate) in 
three steps, catalyzed by enzymes found in abundance in 
many of the previously mentioned tissues.27 However the 
enzyme, 7-butyrobetaine hydroxylase (EC 1.14.11.1), which 
converts 7-butyrobetaine to (fl)-carnitine, has been found 
in abundance only in the liver (rats)28 or kidney 
(humans).28'29 Carnitine must therefore be transported to 
all other tissues from its site of synthesis. As 
expected, an active transport system has been found in 
rat-liver cells,30 even though these cells have the 
capacity to synthesize carnitine. The same system appears 
to mediate the transport of 7-butyrobetaine, but with 
V'max 50% that of (R)-carnitine.30
The proteins that comprise the transport system are 
not well characterized. However, in one case the isola­
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tion of a cardiac-carnitine-binding protein from rat 
cells has been reported.31 This protein shows a dissocia­
tion constant of 0.7/uM for (/?S)-carnitine and is distinct 
from all previously characterized proteins known to bind 
carnitine as substrate. The protein is found associated 
with the plasma membrane and is inhibited by the sulfhy- 
dryl-specific reagents,+ mercuric chloride, W-ethylmal- 
eimide, and iodoacetic acid. Inhibition by sulfhydryl- 
specific reagents [/V-ethylmaleimide, 5,5'-dithiobi!=;(2-ni- 
trobenzoic acid) (DTNB) and p-chloromercuribenzoic acid] 
has also been observed in the intact transport system of 
a human heart cell line (CCL 27).32
As Table 2 shows, deoxy-analogues of carnitine are 
potent inhibitors of the transport system. In rat liver, 
there appears to be a common carrier that mediates the 
uphill transport of both carnitine and 7-butyrobetaine.30 
In addition, (S)-carnitine is an alternative substrate in 
the same tissue,30 as well as in rat epididymal cells25 
(Table 2). The .transport systems of both tissues show 
very weak stereospecificity and transport (S)- and 
(fl)-carnitine equally well. However, the metabolic conse­
quences of the (S)-isomer are unimportant because it does 
not occur naturally in mammals.
tlnhibition by sulfhydryl-specific reagents is a feature 
common to nearly all of those proteins that bind carni­
tine. It is generally taken as indicative of a catalyti- 
cally essential cysteine.
Table 2. Inhibitors and Alternative Substrates of the Carnitine Active Transport System.
Inhibitor/Substrate 
---------------------------------  Ki or Activity or mode Km (ftM)
Name Structure Km (*iM) of inhibition (R)-Cn Tissue source Ref
y—Ammonio-
butyrate H3N+CCHZ)3COO- 630 Comp, with (R)-Cn 2850 Rat brain 22
3—Ammoniopropane- 
sulfonate H3N+(CH2)3so3- 1750 Comp, with (fl)-Cn 2850 Rat brain 22
7-Butyro-
betaine (CH3)3N +(CH2)3coo- 8750
500
















Rat liver 30 
Rat epididymis 25
a Soleus muscle.
b Extensor digitorum longus muscle.
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Carnitine-acylcarnitine translocase. In 1975, Pande33 
characterized a unique protein system that catalyzes the 
exchange diffusion of carnitine and acylcarnitine across 
the inner mitochondrial membrane. His characterization 
was based on several lines of evidence. The impermeabil­
ity of the inner mitochondrial membrane to CoA and its 
esters had been previously demonstrated.34 On the other 
hand, the membrane's apparent permeability to carnitine 
and its esters was well recognized.13•34•3B However, the 
mechanism for the translocation was not well understood 
and had even been mistakenly proposed to occur by means 
of an electrochemical proton gradient.36 There were sug­
gestions that in the absence of a specific translocase, 
the inner membrane would be as impermeable to carnitine 
and its esters as to CoA and its esters.37 Pande33 loaded 
mitochondria with [14C]-carnitine and found that efflux 
of radioactivity Occurred when external carnitine or 
acetylcarnitine was present. Later studies verified that 
influx of acylcarnitine occurred by a mole-foi— mole 
exchange diffusion against internal carnitine.38'39 How­
ever, the translocase was observed to catalyze an equili­
brating unidirectional transport (with a concentration 
gradient) as well, albeit at a much slower rate.40
Proven inhibitors of the translocase system include 
the sulfhydryl-specific reagents, mersalyl38•39 (3), N-
ethylmaleimide38•39 and a-cyano-4-hydroxycinnamate41 (4)
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in addition to several competitive inhibitors, shown in
Table 3. The best competitive inhibitors possess long- 
chain alkyl groups or large hydrophobic moieties such as 
pyrenebutyryl.43 This is undoubtedly the consequence of 
the extremely high affinity of the translocase for extei—  
nal long chain acylcarnitines.39 For instance, palmitoyl- 
carnitine shows an apparent Km of about 2 juM compared to 
carnitine, which exhibits a Km of about 3000 /zM when 
exchanged against [3H]-carnitine or [3H]-acetylcarni­
tine. 39 In fact, the affinity of the translocase for free 
carnitine is very high only when coupled to the inward 
transport of acylcarnitines.39
Pande and coworkers38-42 have demonstrated that a 
substrate must posess both quaternary ammonium and cai—  
boxylate (or sulfonate) moieties in order to undergo 
transport. One such substrate is 7-butyrobetaine,38 which 
shows a concentration dependence but readily exchanges 
with carnitine (Table 3). On the other hand, 
7-ammoniobutyrate (GABA),38 7-ammonio-/3-hydroxy-butyrate 
(GABOB)38’44 and 3-(palmitoyloxy)-4-ammoniobutyrate44 are 
totally ineffective competitors or substrates; thus, con-
O C H .C O O N a
"v > > C N H C H iCHCH1H qO H  
o  OCH .
3 4
Table 3. Inhibitors and Alternative Substrates of the Carnltine-acylcarnltlne Translocase 
System.
Inhibitor/Substrate
Name Structure K1 or I.otMtl)




A/-Alkyl-sulfobetaines n=8 78- Comp, with (R)-Cn Rat heart 42500** Comp, with (R)-Cn Rat liver/hrt 39
RCCH,)2N»(CH2)jS02- n=10 BO- Comp, with (R)-Cn Rat heart 42
n=12 rn- Comp, with (R)-Cn • Rat heart 42
R=CnH2n*i n=14 25- Comp, with (R)-Cn Rat heart 42
(1-Pyrenebutyryl)carnitine 0.023= Comp, with (R)-Cn Rat liver 430.6d Comp, with CR)- Rat liver 43
CCHj)aN»CH2CH-0C(0)(CH2)i 
CHiCOO-
PaImitate ester of 1-N.N- 





1435* Rat heart 44
7-Butyrobeta ine (CHj)jN*(CHZ)aCOO" 72- J 48JS * • 9







10-50= 1 = Comp.Comp.
25X»









“ Iso; concentration required to obtain 50JS inhibition of Cn [3H]-Cn exchange efflux from 
loaded mitochondria at 2 mM exogenous (R)-Cn. b Concentration giving 51X inhibition of 
Cn-palmitoyl-I3H]-Cn exchange in intact mitochondria for sulfobetaine competing with I /iM 
palmitoylcarnitine. c Ki for competition with (R)-Cn [,4C]-Cn exchange efflux. d Ki for competition with (R)-palmitoyl-Cn [**C]-Cn exchange effiux. • Ability to initiate efflux of 
[1*Cj-(/?)-Cn from loaded mitochondria [(R)-Cn=100X]. * Concentrations from 20 to I mM.
9 As for (e) but employing [3H]-(R)-Cn.
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firming the rather stringent requirement for a quaternary 
nitrogen. The-palmitate ester of A/-quaternized hydroxy- 
proline is also a substrate but is only 14% as efficient 
as (R)-carnitine at initiating efflux.44
Other rigid cyclic analogues, which include 2- and 
3-carboxypiperidiniums and 2-(trimethylammonium)cyclo- 
hexanecarboxylate, have been found to be ineffective.44 
(S)-Carnitine is 25% as active as the R isomer; thus, the 
system shows only moderate stereospecificity.38
Acylcarnitine hydrolase (EC 3.1.1.28). A specific enzyme 
that hydrolyses long-chain fatty acid esters of carnitine 
has been found in the microsomal fractions of several 
rat-liver tissues: notably kidney, pancreas, small
intestine, and brain.46*47 The liver enzyme catalyzes 
hydrolyses of carnitine esters having chain lengths of C6 
to Cx 8 j with Cio giving the highest rate. The Km for 
these acylcarnitines varies from 3 to 5 mM. This binding 
constant is quite high relative to that of other protein 
systems that bind acylcarnitines. The hydrolase enzyme is 
only slightly affected by the sulfhydryl-specific 
reagents iodoacetamide and N-ethylmaleimide, and is not 
subject to product inhibition by carnitine. Hydrolyses of 
the (S)-carnitine esters do not occur. The physiological 
function of this enzyme is still not clear. However, 
Mahadevan and Sauer46 have suggested that the hydrolase 
might serve in a protective function by preventing long-
13
chain acylcarnitine esters from reaching destructive con­
centrations.
Carnitine acyltransferases. The discovery of the acetyl- 
carrying capacity of carnitine9 led quickly to the char—  
apterization of the protein, carnitine acetyltransferase 
(CAT, EC 2.3.1.7), responsible for catalysis of the reac­
tion depicted in eq I.13*48 However, a more general acyl- 
carrying capacity of carnitine (eq 2) had been demon­
strated in heart muscle mitochondria by Fritz and Yue,49 
who established the existence of a unique long-chain 
transferase, carnitine palmitoyltransferase (CPT, EC
Acyl-CoA + carnitine acylcarnitine + CoA (2)
2.3.1.21). Their conclusions were based on the known 
specificity of the acetyltransferase, which could not 
catalyze the transfer of palmitoyl groups,13 whereas CPT 
showed the highest affinity for this chain length. An 
enzyme specific for medium-chain (C6-Cg) acylcarnitines, 
carnitine octanoyltransferase (COT, EC 2.3.1.-), was 
later postulated.50*51 Its existence in mouse- and rat- 
liver peroxisomes was subsequently established.52-56
Distribution of CAT. Carnitine acetyltransferase has been 
found to be widely distributed in a variety of rat tis­
sues, with highest concentrations occurring in heart and
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brown adipose.8 In addition, unusually high CAT activity 
is observed in tissues from testes.8 In fact, rat caudal 
epididymal spermatozoa contain the highest specific CAT 
activity of any tissue studied.57 Although the presence 
of CAT in fatty tissues and the heart, which utilizes 
fatty acids for metabolism, is understandable, its high 
concentration and the high levels of carnitine and 
acetylcarnitine in the male reproductive tract are not 
wel1 understood.5 8
Studies involving ram and bovine spermatozoa58>59 
have led to the suggestion that CAT may act to buffer 
against rapid changes in the tissue content of AcCoA. 
This concept, first proposed by Pearson and Tubbs,60 is 
based on an equilibrating ratio of CAT reactants in rat 
tissues despite large variations in steady-state concen­
trations. In this proposal, CAT mediates the formation of 
an acetylcarnitine pool in the cystolic compartment. This 
pool is directly accessible to the mitochondria via the 
carnitine-acylcarnitine translocase and hence ensures an 
acyl-energy reserve for maintenance of sperm motility.
Although CAT and carnitine are found in nervous tis­
sue, their involvement in neurotransmission has not been 
substantiated.61•62 Despite similarities in the struc­
tures of carnitine and choline, as well as their esters, 
their functions are widely different. This discrimination 
occurs because of both compartmentalization and a high
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selectivity of the carnitine and choline enzymes. Whereas 
choline acetyltransferase is associated almost entirely 
with the plasma membrane, CAT is found in mitochondria 
and shows a uniform distribution throughout the nervous 
system.61 Some evidence indicates that only the 
(S)-isomer of carnitine can effectively exhibit cholinei—  
gic, muscarinic activity.63 (/?)-Acetylcarnitine is not a 
substrate for choline esterase.6* Likewise, choline is 
not an effective substrate for CAT.65
Although CAT is primarily associated with mitochond­
ria,58'66-69 its occurrence in other organelles is note­
worthy. Carnitine acetyltransferase has been isolated 
from chemically induced peroxisomes in the livers of 
rat67 and mouse55 and in yeast cells.70 In rat-liver pei—  
oxisomes, CAT is found in the soluble matrix.52 On the 
other hand, CAT from rat-liver microsomes (derived from 
endoplasmic reticulum) appears tightly associated with 
the microsomal membrane.52 Aside from these organelles, 
the presence of CAT has been demonstrated in pea chloro- 
plasts.71
But, what is the function of CAT in organelles other 
than mitochondria? Ueda et al.70 have postulated an 
acetylcarnitine shuttle between peroxisomes and mito­
chondria. Under conditions of excess fatty acid metabo­
lism, j8-oxidation of acyl-CoAs located in peroxisomes 
would lead to formation of acetylcarnitine, which would
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be available to mitochondria. Conversely, McLaren et 
al.71 have suggested that the presence of CAT in the 
chloroplast would allow acetylcarnitine originating in 
the mitochondria to be imported into the chloroplast.
The occurrence of CAT in different tissues and cel- 
%
lular organelles raises an important question: Are these
occurrences due to the same protein, or to isoenzymes? Ir 
mitochondria, inner (located on the matrix side of the 
inner membrane) and outer (located on the cytoplasmic 
side) pools of CAT have been postulated.35 Presumably, 
both enzymes working in conjunction, mediate the transfer 
of acetyl groups between cytoplasmic and matrix CoA.72-74 
In nearly all cases studied to date, the - purified CAT 
from different tissues89 and from different organelles52 
is found to be indistinguishable. The one exception may 
be peroxisomal and. mitochondrial CAT from yeast. Here, 
the purified enzymes are easily separated by DEAE-Sepha- 
cel chromatography and may be distinct isoenzymes, which 
show similar kinetic properties.70 Edwards et al.7S have 
isolated the mitochondrial protein from various tissues 
and in all cases have found enzyme activity as soluble 
and membrane-associated forms, which could be separated. 
These forms show similar kinetic properties and are 
freely interconvertible, thus, suggesting the existence 
of only a single type of CAT.
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An in-depth discussion on inhibitors and alternative 
substrates o£ CAT is presented in a later section: Bio­
chemical Characterization of CAT.
Distribution of COT. Carnitine octanoyltransferase exhib­
its as pandemic a distribution in tissues and organelles 
as does CAT. The enzyme has been characterized in the 
livers of several mammalian species in which its activity 
is about two to four times greater than CPT but generally 
about half that of CAT.76 Several studies have shown 
that COT activity in mammalian tissues resides in mito­
chondria80* 82•53*68* 77 but like CAT, COT is also located 
in both peroxisomes83*88*68 and microsomes. 82 * 83•68
Inhibitors of COT. Recently, COT has been purified from 
both rat86 and mouse88 liver and many of its properties 
described. Both enzymes show maximal activity for C6 acyl 
moieties. The rat enzyme is inactivated by 
2-bromopalmitoyl-CoA but only in the presence of carni­
tine.86 This pattern of inhibition is similar to that 
observed with the 'soluble' CPT isolated by West78 (see 
discussion of CPT below). However, bromoacetyl-CoA, 
while being a competitive inhibitor with respect to 
AcCoA, does not irreversibly inhibit COT.56 The same com­
pound causes rapid inactivation of CAT but does not 
inhibit CPT (see also additional discussion presented 
below). Unlike other carnitine specific proteins, the
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mouse COT is not affected by the sulfhydryl-specific 
reagent DTNB.85 The mouse .enzyme shows complete reaction 
stereospecificity: (S)-Carnitine is not a substrate but
is a moderate competitive inhibitor with respect to 
(R)-carnitine. (S)-Carnitine shows a Ki of 840 /iM, 
whereas under similar conditions (fl)-carnitine gives a 
Kmt of 97 /iM.8B
Distribution of CPT. Carnitine palmitoyltransferase was 
first purified from calf-liver mitochondria by Norum.79 
This enzyme shows a maximum specificity for palmitoylcai—  
nitine (Ci6) with steadily decreasing activity down to 
C 8. The reported Km for palmitoylcarnitine in this enzyme 
preparation is 40 while that of carnitine is 250 nM.
More recently, Brady and Brady80 have reported a
method for the isolation of a highly purified CPT from 
rat liver. The reported Km for palmitoylcarnitine in 
this enzyme preparation is 14 /nM; while the higher value 
of 200 /liM observed for carnitine points out the impoi—  
tance of a hydrophobic binding site.*
+Km values in the carnitine acyltransferase enzymes in 
most cases closely approach the true dissociation con­
stants and may therefore be directly compared to Ki val­
ues.
*Km values for palmitoylcarnitine and carnitine in CPT 
from other sources and preparations range from 11-136 /uM 
and 140-450 /uM, respectively. See Hoppel and Brady81 for 
a more complete review of catalysis by CPT.
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Although reportedly confined to mitochondria,53*56 
there are indications that CPT may be present in other 
organelles. Fogle and Bieber68 have reported CPT activity 
in rat-heart microsomes almost equal to that found in 
mitochondria. Likewise, McLaren et al.7i have reported 
CPT adtivity not only in mitochondria but also in peroxi­
somes and intact chloroplasts of the pea (.Pisi urn sati­
vum). The enzyme in chloroplasts may be involved in con­
trolling the flow of acyl groups across the surrounding 
envelope. The presence of CPT in peroxisomes can be 
rationalized based on their high capacity for 
j3-oxidation. However, in another case carnitine acyl- 
trarisferase activity could not be demonstrated in peroxi­
somes from spinach leaves.53
Several groups have reported the isolation of sepa­
rate and distinct inner (CPTi) and outer (CPT0) forms of 
CPT from the inner mitochondrial membrane.34*78*82 
The outer form is easily solubilized and is inactived by 
2-bromopalmitoyl esters of CoA or carnitine, while 
the inner form is tightly associated with the membrane 
and is not inhibited by the 2-bromopalmitoyl esters, 
which are instead substrates.78 More recent results,83 
based on molecular weight and kinetic properties, have 
suggested that CPTi and CPT0 isolated from rat-1iver 
mitochondria are actually the same enzyme. Assay of the 
CPT system in situ suggests that the activity of CPTi is
20
450-fold greater than CPT0 , when both are present in the 
intact membrane. This has lead Bergstrom and Reitz83 to 
suggest that in situ factors exist that greatly alter the 
catalytic properties of CPTt compared to CPT0 .
Inhibitors of CPT. Aside from 2-bromopalmitoyl esters, 
CPT is inhibited by several other compounds or classes of 
compounds. However, in many cases inhibition has been 
determined by measurement of respiration in intact mito­
chondria. In these instances effects of inhibitors or 
their metabolites on othei- protein systems may not be 
fully excluded. Such is the case with S-2-bromo- 
myristoylthiocarnitine, which inhibits respiration in 
mitochondria from rat liver by partial inactivation of 
CPT [in a fashion analogous to inactivation of CAT by
2-bromoacetylcarnitine (see below, section entitled: Bio­
chemical Characterization of CAT)] but in addition 
appears to lead to. 2-bromoacyl-CoA formation within the 
mitochondrial matrix.84 On the other hand, oxidation of 
palmitoyl-CoA is supported by thiocarnitine, which can 
substitute for carnitine, while its thioesters are altei—  
native substrates of mitochondrial respiration.84-85
Inhibition of mitochondrial respiration occurs also 
by CoA esters of 2-substituted oxiran-2-carboxylates 
(most notably 2-tetradecyl).86•87 These compounds are 
believed to inhibit the ^-oxidation of long-chain fatty 
acids at the stage of CPT.87
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(1-Pyrenebutyryl)carnitine (PBC, see Table 3) and 
1-pyrenebutyryl-CoA (PB-CoA) represent another class of 
inhibitors of mitochondrial respiration and CPT.A3 PB-CoA 
inhibits respiration in rat-liver mitochondria noncompet- 
itively (Ki=2 yuM) and competes with palmitoyl-CoA for the 
partially purified CPT (Ki=2.1 ^M). On the other hand, 
although PBC is an inhibitor of mitochondrial respiration 
versus palmitoylcarnitine (ISo=1.4 juM), it has no effect 
on the partially purified CPT. Ciardelli et al.BB have 
prepared carba-analogues of palmitoyl-CoA that are effec­
tive inhibitors of the partially purified CPTi. A mixture 
of 2'- and 3'-phospho-isomers of S-heptadecyl-CoA has an 
apparent Ki of 3.3 /uM; while an equally low Ki (1.4 pM) 
is observed for the isomers of heptadecan-2-onyldethio- 
CoA (sulfur replaced by methylene).
Several carnitine analogues have been employed as 
inhibitors of the purified CPTi enzyme but with only mild 
success.89 (RS)-Norcarnitine [4-(A/,W-dimethylammonio)-
3-hydroxybutyrate] is an alternative substrate with a 
V'max 20% that seen with carnitine and a Km of 12000 yuM 
compared to 250 /aM for carnitine. 7-Butyrobetaine com­
petes only slightly with carnitine (Ki=200,000 /uM) . 
(.RS)-Acetylcarnitine and choline are completely 
ineffective, as are several other carnitine analogues: 
crotonylbetaine [ trans-4-(A/,/\/,A/-trimethylammonium)-2-bu- 
tenoate] , 3-(Af,yV-dimethylammonio)butyrate, (RS)-4-ammon-
2 2
io-3-hydroxybutyrate, and (/?S)-4-(dimethyl ami no )-3-hy-
droxybutyramide.
The Carnitine Acyl Transport System of Mitochondria
The last four proteins, or protein systems, (the 
translocase, CAT, COT and CPT) that were discussed are 
components of the carnitine acyl transport system of the 
inner mitochondrial membrane. Figure 1 is a diagram of 
the inner mitochondrial membrane showing the inward flow 
of fatty-acyl groups and their subsequent /3-oxidation. 
The systems responsible for efficient mobility of fatty- 
acyl groups are the carnitine-acylcarnitine .translocase, 
and the inner and outer forms of long (CPT) and short 
(CAT) chain carnitine acyltransferases. For clarity, COT 
has been omitted from the diagram but its function is 
analogous to CPT. In addition, because the reactions 
depicted are reversible, outward flow o f ’ fatty-acyl 
groups is equally well facilitated by the same systems. 
Shepherd at al.90 have suggested that transfer of palmi- 
toyl groups from palmitoyl-CoA to carnitine may actually 
be the rate-limiting step in the oxidation process, 
through and including electron transport.
A model similar to that shown in Figure 1, but lack­
ing a specific translocase system, was first proposed by 
Fritz and Yue49 and was later updated by Pande33 to
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Figure I. Diagram of the inner mitochondrial mem­
brane showing the inward flow of fatty-acyl 
groups. Because all steps are reversible, outward 
flow is equally well facilitated by the same sys­
tems.
include the translocase. In this model the translocase 
facilitates the mole-foi— mole exchange of carnitine with 
carnitine esters while the carnitine transferases cata­
lyze the reversible transfer of acyl moieties between 
carnitine and CoA. The net result is an apparent flow of 
acyl-CoAs across the membrane; a flow which would othei 
wise not be possible because of the lack of a specific
24
CoA translocase. This model raises an interesting ques­
tion: Why is a specific CoA translocase system, which
would seem to obviate the need for carnitine, lacking? 
One explanation is the previously described concept of a 
buffering pool of active fatty-acyl groups,88"60 which 
would protect against rapid changes in acyl-CoA concen­
trations.
Biochemical Characterization of CAT
The CAT enzyme has been purified from the tissues 
and/or organelles of several different animal species 
shown in Table 4. The best characterized of these are the 
pigeon-breast muscle enzyme, which is commercially avail­
able, and the rat-1iver enzyme. In general, CATs from 
different sources have similar properties and do not 
appear to have been distinctly divergent in their evolu­
tions. +
Reported molecular weights, which are shown in Table 
4, range from 51,000 to 75,000. The isolation of distinct 
subunits has been reported in at least two cases from 
rat-1 iver mitochondria;66'67 thus, suggesting an a/3 com­
position. However, Miyazawa et al.e7 have demonstrated
+When species differences exist they will be noted; oth­
erwise CAT refers generally to any of the enzymes in 
Table 4.
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Bovine Heart 61 , 0 0 0 b * 89 7.5-8.2 
(7.8)59
8. 1 59 
8. 1 75 
(5.2)®
Spermatozoa 62,000b•89 7.5-8.2 
(7.8)89
8.2 59
* Gel filtration. b SDS Gel electrophoresis.
c Sedimentation-equilibrium. d A minor band at ca. pi 5 
was observed in crude samples. ° A minor band at ca. 
pi 5 was observed.
that this dimeric form isolated from mitochondria has 
nearly identical kinetic properties with a monomeric form 
isolated from the cell homogenate. They therefore con­
clude that the method of purification of CAT from rat- 
liver mitochondria inadvertently leads to cleavage of the 
enzyme into two closely associated, but different, cata- 
lytically active subunits. (A specific protease respon­
sible for this cleavage could not be identified.) Miya- 
zawa et al.9B have since demonstrated, by in vitro 
translation experiments, that the rat-1iver enzyme is 
synthesized as a larger precursor with a molecular weight 
of 69,000, which subsequently loses a 1,500 molecular 
weight fragment on becoming a mature enzyme.
In all cases studied, CAT shows a relatively broad 
optimum pH range, generally peaking at about 7.8 (Table 
4). A slightly higher isoelectric point is observed, but 
some preparations have been noted to give a minor band at 
about pi 5. The high and low pi bands have been attrib­
uted to soluble . and membrane-associated forms respec­
tively.BZ« 75 These forms are freely interconvertible and 
have similar kinetic properties.
Table 5 shows the acyl-group specificity of the CAT 
enzyme from several sources. Only minor differences are 
observed between the forward (from acyl-CoA) and reverse 
(from acylcarnitine) reactions. In many cases C2 (acetyl) 
is not the optimum substrate of the isolated enzyme,
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which may instead prefer C3 or C 4. Activity is highly 
diminished for chain lengths greater than C 4* In most 
cases a gradual decline is observed, thus, giving a 
broader specificity. However, the yeast enzyme has excep­
tional specificity for the C2 substrate only. In all 
cases palmitoylcarnitine (Ct6) is not a substrate, nor is 
palmitoyl-CoA, which is instead a very potent inhibitor 
(see discussion below entitled: Inhibition by acyl-CoAs).
Reaction parameters. Chase91 has estimated the turnover 
number for the pigeon enzyme at pH 7.8 and 30 °C. He
finds for the forward reaction a conversion rate of 
23,000 moles of substrate (carnitine/AcCoA) transformed 
per mole of enzyme per minute. The reverse reaction shows 
a conversion rate of 29,000 moles per minute; thus, the 
overall reaction (eq 1) is readily reversible. Equilib­
rium constants of 1.7 and 1.71 have been measured.13*97 
An Arrhenius plot reveals an activation energy of 11.4 
kcal/mol for the forward reaction catalyzed by CAT from 
rat-liver mitochondria.66 The optimum reaction tempera­
ture for the rat enzyme occurs at 37 °C, yet thermally
induced inactivation becomes apparent at temperatures 
beginning only 3 °C higher.66 A crude preparation of CAT 
from human platelets is even more thermosensitive, show­
ing 60% loss of activity when kept for ten minutes at 37 
°C. 98
Kinetic mechanism. On account of the reversible nature of
Table 5. Acyl-Group Specificity of Carnitine Acetyltransferases Measured as Percent 





C2a C3 .C4 C5 C6 C7 C8 C9 CIO C12 C14 C16 Ref
Pigeon Breast muscle 100b 77 41 18 13 1 1 8 5.5 4 <. 1 0 0 96
homogenate
Pig Heart 100= 123 100 37 23 13 3 0 13
Mouse Liver 100=* d 1.21 132 47 26 24 16 1 0 0 55
peroxisomes 100a* d141 1 15 17 25 17 7 3 0 55
Yeast Peroxisomes 100= 9.4 . 12 0 0 0 0 70
Mitochondria 100= 15 .26 0 0 0 0 70
Rat Liver 100=-d 124 15 7 2 0 0 0 67
mitochondria* 100°* d 1 17 28 17 6 2 0 0 67
Liver 100=-d 1 14 30 16 5 2 0 0 67
homogenate* 100a* d 104 / 33 24 9 3 <1 0 67
Liver
peroxisomes 100= 110 82 14 3 0 0 0 0 52
microsomes 100= 112 75 17 3 0 0 0 0 52
Bovine Heart 100=* d 147 1 14 26 0 59
Spermatozoa 100=* d144 121 52 24 0 59
a The reaction velocity for acetyl (C2) is taken as 100%. b Values are based on 
V ’max for the forward reaction. c Initial velocity from forward reaction 
(acyl-CoAs). d Graphical interpolation from the reference given. ° Initial 
velocity from reverse reaction (acyl-Cns). * Enzyme from mitochondria was 
isolated in a dimeric form while the homogenate gave a single monomer (see text).
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the catalyzed reaction, product inhibition is readily 
apparent. By observing product inhibition in the pigeon 
enzyme, Chase and Tubbs97 have determined that the cata­
lyzed reaction follows a random-order equilibrium (random 
Bi-Bi) mechanism. In this mechanism, Michaelis constants 
(Km) very closely approximate true dissociation constants 
(Ks), and binding of one substrate has little or no 
effect on binding of the second (i.e., Km~Ks). Scheme I 
depicts the mechanism of action for CAT proposed by Chase 
and Tubbs.97 For clarity, free substrates are omitted
Scheme I . Proposed scheme for the random-order 
equilibrium (random Bi-Bi) mechanism of action of 
CAT from pigeon-breast muscle taken from Chase and 
Tubbs.97 Free substrates, although not shown, are 
implied in the equilibrium steps.
EAc* C n ’CoA
u E*AcCn . u / /  K' E*Cn ...
>  a  %  V  V
l E*AcCn*CoA E*C n• AcCoA E
« \ c A ^  T T ' " ^ E A C A ^z E*CoA . ’ -AcCoA
K, = K4 . K2 = K3 K; = K'4 ; K2 = Kj
from the equilibrium steps, but are implied. The kinet­
ics observed are consistent with a rate determining 
interconversion of the ternary complexes, T and T r (i.e., 
acyl group transfer is rate limiting). However, an acyl-
3 0
enzyme intermediate cannot be excluded, but if it exists 
it must arise via the ternary-enzyme complexes. The 
velocity of the random-order equilibrium system is 
described by eq 3, where K a and K b are Km values for 
substrates A and B respectively. Equation 4 applies 
under conditions of competitive inhibition, where subs­
tance I competes with substrate A.
Vmax
Ka .Kb




K fl K a [I]
1 +  ■ —  +  1 ■
[A] Kj [A]
(4)
[ K b1 + ---
IB] .
Chase and Tubbs97 observed competitive inhibition 
between </?)-carnitine and (/?)-acetylcarnitine as well as 
between CoA and AcCoA, indicating single binding sites 
for the respective pairs. They also observed competitive 
inhibition of AcCoA with (ft)-acetylcarnitine, results 
that indicate overlap of the acetyl groups and a common 
acetyl-binding site.
Huckle and Tamblyn®9 have reported somewhat diffei—  
ent kinetics for the bovine enzyme. Product inhibition
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appears mixed because binding of one subs­
trate is dependent upon the concentration of the second. 
As seen in Table 6 , Km values are less than Ks indicating 
a mutual enhancement of binding of one substrate in the 
presence of the second. In this case, Km values repre­
sent binding only in the presence of bound cosubstrate,
*
as for example with carnitine:
Km
E * AcCoA * Cn  ̂ E * AcCoA + Cn,
where E represents CAT. As usual, Ks describes binding of 
a substrate to free enzyme:
Ks
E • Cn s E + Cn.
Ki values in Table 6 are defined as follows, where the 
pertinent equilibrium for carnitine is used as an exam­
ple:
Ki
E • CoA • Cn E • CoA + Cn.
The last described form of binding is the least favorable 
for the bovine enzyme. For instance, although two acetyl- 
ated substrates can bind simultaneously, the presence of 
one interferes with binding of the second.
Table 7 shows the Michaelis constants for the puri­
fied enzyme obtained from several sources. In all cases 
CoA (or AcCoA) binds more efficiently than carnitine (or
3 2
Table 6 . Kinetic Constants of Bovine Carnitine
Acetyltransferase: Data from Huckle and Tambiyn.®*
Enzyme
source Substrate Km (/uM) Ks (mM) Ki (m M)
Spermatozoa (fl)-Cn 120 270 310
(R)-AcCn 360 520 980
AcCoA 12 27 52
CoA 9.0 13 15
Heart (fl)-Cn 120 270 250
(R)-AcCn 300 740 810
AcCoA 20 43 47
CoA 9.6 • 23 21
acetylcarnitine). This difference in binding is most 
likely the consequence of the more numerous points of 
interaction available on the much larger CoA molecule. 
The rather large disparities between Km values of CoA and 
AcCoA for the mouse and yeast enzymes are noteworthy. The 
much lower value for AcCoA may be the consequence of a 
tight acetyl-binding site, or more likely a reorganiza­
tion of the enzyme that is contingent upon a filled ace­
tyl site.
Enzyme ORD spectrum. Tipton and Chase*9 have studied the 
effect of substrates on the optical rotatory dispersion 
(ORD) spectrum of the pigeon enzyme. They find a large 
perturbation upon addition of either (R)-carnitine or 
(/?)-acetylcarnitine; but no effect from either CoA or 
AcCoA, either when alone or in the presence of carnitine
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Table 7. Comparison of Michaelis Constants for Substrates 




Organism (R)-AcCn CoA (fl)-Cn AcCoA Ref
Pigeon Breast muscle 
homogenate
350 37 120 34 96,97
Pig Heart 310 310 41 65
Mouse Liver
peroxisomes
700 180 86 15.3 55
Yeast Peroxisomes 417 304 719 42 70
Mitochondria 639 257 622 36 70
Cell free 
















Bovine Heart 300b 9.6 b 12 0b 2 0b 59
Spermatozoa 360b 9. 0b 12 0 b 12 b 59
a Value for (RS)-carnitine.
b Substrate binding to the enzyme depends upon the 
concentration of the second substrate.
or acetylcarnitine. The direction of change in the 
reduced mean residue rotation at 233 nm, [M'J23 3» sug­
gests that binding of carnitine or acetylcarnitine causes
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■the enzyme to unfold. Tipton and Chase" determined the 
true dissociation constants (Ks) for (.R) -carnitine, 
(S)-carnitine and (/2)-acetylcarnitine by measuring the 
change in [M'lzas with degree of enzyme saturation. These 
values, shown in Table 8 , closely agree with the kinetic 
constants and therefore support the random-order equilib­
rium mechanism. In addition, the data show that 
(S)-carnitine binds just as efficiently to pigeon CAT as 
does (i?)-carnitine.
As we previously stated100 this indiscriminate bind­
ing between (/?)- and (S)-carnitine by pigeon CAT indi­
cates a requirement for only a two-point attachment of 
carnitine, involving the quaternary ammonium and carboxy- 
lato functions.
>
Inhibition by (S)-isomers. Inhibition by (S)-carnitine 
and (S)-acetylcarnitine has been observed . in CAT from 
several sources. As Table 9 shows, where binding is con­
cerned, the pigeon enzyme does not discriminate between 
stereoisomers of carnitine or of acetylcarnitine; yet the 
(S)-isomers are chemically inert toward enzyme-catalyzed 
acetyl transfer. In contrast to the pigeon enzyme, the 
pig, bovine and mouse enzymes discriminate substantially 
between (S)- and (/?)-carnitine. A three-point mode of 
binding is implied in these systems. In all cases the 
(S)-isomer is a competitive inhibitor with respect to the 
(fl)-isomer.
35
Table 8 . Comparison of Kinetic and Dissociation
Constants for Carnitine Acetyltransferase from 
Pigeon-Breast Muscle.
Kinetic Dissociation3
Substrate Km or K1(mM) Ref Ks (mM) Ref
(R)-Carnitine 120 96 1 15 99
(S)-Carnitine 173c 97 106 99
(R)-Acetylcarnitine 350 96 312 99
(R)-Carnitine/CoAb 108 99
a Determined from change in ORD upon addition of 
variable quantities of substrate." 
b Carnitine in the presence of 250 /iM CoA. 
c The Ki value for (S)-Cn may deviate from Ks because of 
the absence of an enzymatic standardization procedure 
for this substance."
pH Dependence. Chase92 has studied the pH dependence of 
CAT (pigeon) over the pH range 6.0 to 9.0. The enzyme is 
inactivated in solutions having a pH beyond this range. 
He finds a constant V'max for the reverse reaction over 
the range 6.0 to 8 .8 . Hence, the pH-activity curve 
reflects only changes in the affinity of CAT for its 
substrates and not its catalytic chemical efficiency. 
Therefore, Chase concludes that no ionizing group on the 
enzyme with pK* between 6 . 1 and 8.3 participates in the 
catalytic step, but he does not exclude the possibility 
of participation by ionizable groups outside of this 
range. However, these groups would be unobservable in the 
pH study.
Table 9. Competitive Inhibition of Carnitine Acetyltransferase 




Km C/xM) for 
(R )-Substrate Enzyme source Ref
(S)—Carnitine 1 100 (fl)-Cn 120 Bovine heart or 
Spermatozoa
59
2300 (R)-Cn 310 Pig heart 65
1000 (R)-Cn 86 Mouse liver 
peroxisomes
55
173 I n sj ai 120 Pigeon breast 97
106 b 120 Pigeon breast 99
(S)—Acetylcarnitine 256 (/?)—AcCna 350 Pigeon breast 97
a The authors reported apparent uncompetitive inhibition for (S)-carnitine with 
(RS)-carnitine and CS)-acetylcarnitine with (RS)-acetylcarnitine. However, 
the results fit well to a competitive model, eq 4 .91 
b True dissociation constant measured by enzyme ORD.
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Chase believes that the following groups are 
involved in the binding of substrates: 1. A group with
pKh 6.4, active in the basic form, is unequivocally iden­
tified as the 3'-phosphate of AcCoA. The lack of this 
group in acetyl-3'-dephospho-CoA resuits in a 300-fold
reduction in binding efficiency without appreciably
*
changing V'max (Table 10). 2. An unidentified ionizable
group on the enzyme with an apparent pKa of 7.85 becomes
more basic (pKa 8.25) upon binding of AcCoA or CoA. 3. A
group on the enzyme active in the basic form, with pKa of
7.2, is required for optimum binding of carnitine or
acetylcarnitine. This is possibly the imidazole of a
histidine or an a-ammonium group.
¥
Inhibition by dications. Sulfhydryl ligating dications 
such as Zn2 + and Hg2 + are inhibitors of CAT from bovine59 
and pig65 heart, respectively (Table 11). In fact, Zn2+ 
inhibits the bovine enzyme 50% (forward reaction) at a 
concentration of only 1-2 Only slight effects are
noted for Ca2+ and Mg2+ on the same enzyme.59 Farrell et 
al.as have shown that Ca2+, Mg2+, and Mn2+ are ineffec­
tive toward inhibition of the mouse enzyme, whereas Zn2+ 
(50 /iM) inhibits the reverse reaction. Complexation with 
the sulfhydryl of CoA cannot be excluded. Unlike the
+This value is about 100-times the concentration of 
enzyme under typical assaying conditions.




















CoAS-As C CH 3)z 41
CoAS-CH 2 C (0)CH 3 152
CoAS-C(0)C15H3i 0.43c
CoAS-C(0 ) ' > ^ ^ 33 d 
'1300®
Form, of S-carboxy- 93
raethyl-CoA Cn ester


















* Suicide substrate inhibitor.
b The apparent Ks, 113 pM, indicates that binding of (R)-Cn is limiting. 
c Ks value, Palmitoyl-CoA is not a substrate; initial binding of Palmitoyl-CoA 
is indicated by the kinetics. 
d Km value; V'max < 1% of AcCoA.
® Km value; V'max 97% of AcCoA.
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avian and mammalian enzymes, yeast CAT is sensitive to 
both Ca2 + and Mg2+.70
Table 11. Sulfhydryl-Specific Inhibitors of Carnitine 
Acetyltransferase.
Name Structure Enzyme source Ref






Mouse liver 55 








* The authors report the use of p-chloromecuribenzoic 
acid, which can be converted to f-hydroxymercuriber.zoic 
acid by ligand exchange in water.
Sulfhydryl-specific reagents. Carnitine acetyltransferase 
is sensitive to a wide spectrum of organic sulfhydryl- 
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been employed with success on CAT from various sources, 
while Table 10 lists two other sulfhydryl-rea.ctive com­
pounds (methoxycarbonyl-CoA disulfide and CoA disul- 
fide-S,S-dioxide), which are CoA analogues. The former 
grouping is general reagents, while the latter is primal—  
ily active-site specific and therefore more precisely 
classified as suicide substrate inhibitors. All are 
potent inactivators of CAT, in most cases by interaction 
(or reaction) with what appears to be one essential sulf­
hydryl residue in or near the active site.101•102 Meth- 
oxycarbonyl-CoA disulfide reacts with a nucleophilic 
sulfhydryl to give methanol, carbonyl sulfide and a cova­
lent enzyme disulfide derivative (eg 5).101. Coenzyme A
%
Enz-SH + CoAS-SCC0)0CHa — ► Enz-SSCoA + CHa0H + COS (5)
disulfide-S,S-dioxide reacts to give the same enzyme 
derivative but splits off Coenzyme A sulfenic acid as 
byproduct (eq 6).102
Enz-SH + CoAS-S(Oz)-CoA — ►Enz-SSCoA + CoA-SOzH (6)
The CoA analogues react with pigeon CAT...in both 
site-specific and non-site-specific fashions; thus, 
either compound, when added in stoichiometric amounts, 
results in modification of a single sulfhydryl with con­
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comitant loss of about 80% enzyme activity. However, when 
an excess of reagent is employed, the reaction kinetics 
for inactivation are biphasic. A fast bimolecular reac­
tion with one specific active-site sulfhydryl is followed 
by a slower reaction involving other sulfhydryls of the 
protein.101*102 Extrapolation to zero activity suggests a 
total of tent modifiable sulfhydryl groups.101 Because, 
the rate of modification of the first sulfhydryl group is 
only an order of magnitude faster than that of the oth­
ers, the active-site sulfhydryl is not considered to be 
excessively nucleophilic.101 This limited reactivity is 
seen with S-dimethylarsino-CoA (Table 10), which has the 
potential to react with a free sulfhydryl according to eg 
7, but does not do so with CAT.104
Enz-SH + CoAS-As (CH3)2 — ► Enz-S-As(CH3)2 + CoA (7)
In many cases CAT is partially protected from inac­
tivation by the presence of substrate(s), which presum­
ably blocks the active site from attack by the sulfhydryl 
reagent.85*6°-101 For instance, the pigeon enzyme is pro­
tected from the action of methoxycarbonyl-CoA disulfide 
by (.RS) -acetylcarnitine and AcCoA but not by
+The complete titration of pigeon CAT with the non-site- 
specific reagent DTNB indicates eleven modifiable sulfhy­
dryl groups.101 Amino acid analysis of t h e ’ rat-1iver 
enzyme reveals only six cysteine residues.67
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(/?)-carnitine, thus, suggesting that the active-site 
sulfhydryl is very close to the acetyl binding site.10 *
In those cases for which the inhibitor leads to foi—  
mation of enzyme-inhibitor disulfide linkages (for 
instance DTNB), CAT can often be reactivated by addition 
of disulfide-exchange reagents such as dithiothreitol102 




5 (threo) or 6 (.erythro)
CoA analogues. Table 10 lists several other CoA and AcCoA 
analogues, which are active with CAT from pigeon-breast 
muscle. Bromoacetyl- and chloroacetyl-CoA are suicide 
substrates, which react with carnitine to form an enzyme- 
bound bisubstrate inhibitor. The modes of action of these 
compounds and of bromoacetylcarnitine, which reacts anal­
ogously, are discussed together below (see section enti­
tled: Suicide substrate inhibitors). Acetyl-3’-dephos- 
pho-CoA is an alternative substrate, which binds poorly 
to CAT, but once bound reacts with a V'max 97% that of 
AcCoA. Clearly the 3'-phospho-site is an important 
anchor point, but the 3 '-phosphate is not essential for 
chemical steps. In contrast, sorboyl-CoA binds as effi­
ciently to CAT as does either AcCoA (34 nM) or hexanoyl- 
CoA (33 /iM), but reacts with a V'max \% that of AcCoA. 
This is surprising since even hexanoyl-CoA, which is of 
similar chain length but saturated, shows moderate activ­
ity (Table 5). Palmitoyl-CoA is not a substrate of CAT, 
but does show extremely efficient binding (Ki=0.43 mM) , 
which is in fact about two orders of magnitude better 
than AcCoA with which it competes. Surprisingly, palmi- 
toyl-CoA competes also with (fl)-carnitine. In fact, the 
inhibition observed for long-chain acyl-CoAs in general 
is novel and more fittingly discussed separately (see the 
section that follows). Three purely competitive CoA ana­
logues, desulfo-, S-dimethylarsino- and S-acetonyl-CoA 
are also listed in Table 10. For various reasons none is 
capable of reaction: Desulfo-CoA lacks, an essential sulf- 
hydryl. S-Di'methylarsino-CoA detects only very potent 
nucleophilic enzyme residues, which CAT seems not to 
have. The methylene carbon of S-acetonyl-CoA seems 
insufficiently electrophilic for reaction with carnitine.
Effect of chain length. Inhibition by palmitoyl-CoA96 is 
not unique to the pigeon-breast muscle enzyme; nearly 
identical results have been reported for the purified 
enzyme from bovine59 and rat66 sources. Palmitoyl-CoA is 
competitive with both AcCoA (Ki=18.6 *iM) and 
(/?S)-carnitine (Ki=8.0 mM) for the rat-liver enzyme. For 
the bovine enzyme, competitive inhibition is observed for
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(fl)-carnitine (Ki=1.6 /iM) while inhibition is noncompeti­
tive with respect to AcCoA, which shows mixed inhibition 
(Ki, slope=1.4 /iM; Ki, intercepts.2 • These last val­
ues and that observed for the pigeon enzyme (Ki=0.43 /uM» 
competitive for free enzyme with either substrate) are 
below the critical micelle concentration of 4 /uM 
reported for palmitoyl-CoA in similar buffers.107 There­
fore, the observed inhibition is not the result of 
sequestration of substrates or enzyme, but is most likely 
the consequence of specific interactions with- the.enzyme.
Chase96 has studied the effect of varying acyl-CoA- 
chain length on inhibition and finds a trend toward bind­
ing of acyl-CoAs to free enzyme with longer chain
lengths. The Km for (R)-carnitine is nearly invariant 
(136±29 yiM) over the range C2 to Ci0, while the Kms for 
acyl-CoAs are invariant over the range C2 to C7 (38±6 
/siM). However, V ’max decreases 10-fold over this latter 
range. Acyl-CoAs with chain length C8 to Ci6 show
enhanced binding to free enzyme (Km values drop rapidly).
The a G° of binding changes linearly with each additional 
methylene (-CH2-) beyond C8. Each methylene contributes 
-0.31 kcal/mol to the aG° of binding. Chase96 has con­
cluded that CAT contains a hydrophobic region that intei—  
acts with the side chain of the inhibitor and somehow 
hinders the binding of carnitine. Mittal and. Kurup66 
have come to the same conclusions for the- rat-liver
enzyme.
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The mechanism of inhibition, proposed by Chase,96 
involves competition between ligands attached at the cai—  
nitine and hydrocarbon sites mediated by a conformational 
change in the enzyme protein. Binding of carnitine is 
known to result in a conformational change in the pro­
tein.99 Because palmitoylcarnitine is not an inhibitor or 
substrate,96 binding at the carnitine site must result in 
disruption of the remote hydrocarbon binding site. Like­
wise, the presence of a filled hydrocarbon site must 
either hinder access to the carnitine site or prevent 
enzyme conformational changes required for proper carni­
tine binding. Because palmitate ion only moderately 
inhibits the pigeon CAT [Ki=325 ^M, competitive with
respect to (fl)-carnitine] ,9 6 and is not an inhibitor of 
the rat-1iver enzyme,66 the presence of a filled CoA site 
must be important to the overall inhibition mechanism.
The physiological relevance of this inhibition by 
acyl-CoAs is presently unknown.
Suicide substrate inhibitors. Chase and Tubbs93*108 are 
credited with having discovered one of the earliest exam­
ples of a bisubstrate analogue,109 a single compound that 
resembles two separate substrates in the same relative 
orientation as the ternary complex. Beyers109 points out 
that these may have a higher affinity for the enzyme than 
is indicated by the product of the binding constants of 
the two substrates. The bisubstrate anallogue, S-carboxy-
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methyl-CoA-(/?)-carnitine ester (7) , is novel in that it 





involving cosubstrate. The reaction of bromoacetyl 
derivatives of either CoA or (/?)-carnitine occurs accord­
ing to Scheme II, and the analogue that results binds to 
enzyme with an estimated dissociation constant that is 
less than 0.012 /uM (the product of the individual binding 
constants).93 It is possible that adduct formation is 
accompanied by a conformational change in the enzyme-in- 
hibitor complex that enhances binding.93 Slow hydrolysis 
(half-life about 14.8 days) of the adduct occurs in pH 7 
buffer at 4 °C and leads to recovery of enzyme activity 
and formation of S-carboxymethyl-CoA.93 Chase and Tubbs93 
find that chloroacetyl-CoA reacts in the same fashion as 
the bromo-corapound; while (S)-bromoacetylcarnitine shows 
only minor activity, which might be attributed to a trace 
impurity consisting of the (/?)-isomer.
When CAT is incubated with 7 in pH 7.0 buffer, inac­
tivation occurs slowly reaching a maximum of 86% after 26 
hours. A large kinetic barrier exists to the formation 
(or dissociation) of the enzyme-inhibitor complex, which
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Scheme II. Pathway for inhibition of CAT by bro- 
moacetyl derivatives of CoA and (/?)-carnitine pro­
posed by Chase and Tubbs.93 Abbreviations: Cn,
(/?) -carnitine; BrAcCn, C/?)-bromoacetylcarnitine; 
BrAcCoA, bromoacetyl-CoA.
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may be the result of the requirement for a substantial 
conformational change in the enzyme. The formation of 
enzyme bound 7 from bromoacetyl substrates demonstrates 
that CoA and (ft)-carnitine can bind simultaneously, thus, 
directly confirming the existence of the ternary com­
plexes shown in Scheme I .
Chase and Tubbs106 have found that. when
(#)-bromoacetylcarnitine is incubated with pigeon-breast- 
muscle CAT in the absence of CoA, irreversible inhibition 
occurs. Inhibition results from alkylation of a specific 
active-site histidine according to the mechanism depicted 
in Scheme III. Slow spontaneous hydrolysis (over a period 
of hours) of the enzyme-inhibitor adduct gives inactive 
alkylated enzyme. This mechanism is verified by isola­
tion of A/-3-carboxymethylhistidine after complete acid
Scheme III. Mechanism proposed by Chase and 
Tubbs106 for inhibition of CAT by (/?)-bromoacetyl- 
carnitine in the absence of CoA.
N=\
H B r
E n z  B rA cC n
% N CH,COO
H is  /_____________ X
hydrolysis of the protein. A catalytically important 
histidine (or a blocked active site) is implied because 
alkylated enzyme is catalytically inert. This histidine
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may be the group having a ptf* of 7.2 that was identified 
in the pH activity study.92 Chase and Tubbs1°* have sug­
gested, without elaboration, a catalytic role for the 
histidine imidazole in chemically important steps. If 
the histidine serves in a catalytic function, then it 
cannot be the 7.2 residue, which is involved only in 
substrate binding.
Competitive carnitine analogues. The action of carnitine 
analogues on CAT has yielded valuable information con­
cerning the enzyme’s mode of action. Table 12 lists some 
of the compounds that have been examined, most on CAT 
from pig heart.6® The only inhibitor that binds more 
efficiently than the natural substrate is acetylaminocai—  
nitine (acetoxy of acetylcarnitine replaced by acetam- 
ido). It is in fact the best competitive inhibitor 
reported to date, binding 13-fold more tightly than 
(R)-acetylcarnitine to the pigeon enzyme and 6-fold more 
tightly to the rat enzyme.110 Acetyl transfer from ace- 
tylarainocarnitine does not occur due to the low group- 
transfer potential of amides versus esters (i.e., the 
much higher bond strength).
Deoxynorcarnitine and y-butyrobetaine are inactive 
with pig-heart CAT, because they are without the essen­
tial hydroxyl group. Their relatively high binding con­
stants [factors of 4 and 8, respectively, greater than 
the Km of C/?)-carnitine] are probably due in part to the
Table 12. Compounds Tested as Potential Inhibitors of Carnitine Acetyltransferase.
Name Structure Ki (#iH) Mode of inhibition Enz. source Ref
(R)-Bromoacetylcarnitine Suicide substrate3 Pigeon breast 93,106
(S )-Bromoacetylcarnitine Unreactive Pigeon breast 93,106
(RS)—Acetylaminocarnitine 24 Comp. with (R)-AcCn Pigeon breast 110
130 Comp. with (R)-AcCn Rat 1iver 1 10
Deoxynorcarnitine (CH3)ZN(CH2)3C00H 1200 Comp. with (RS)-Cn Pig heart 65
7-Butyrobetaine (CH3)3N +(CH2)3C00H 2300 Comp. with (RS)-Cn Pig heart 65
Choline (CH3)3N +(CHZ)20H 27000 Comp. with (RS)-Cn Pig heart 65
(RS)-Acety1-0-methylcholine 71000 Comp. with (RS)-Cn Pig heart 65
(RS )-/3-Hydroxybutyric acid b Pig heart 65
(RS)-Carnitine-
nitrile (CH3)3N+CH2CH(0H)CH2CN 71000 Comp. with (RS)-Cn Pig heart 65
(RS)-Norcarnit0 1 (CH 3)2NCH 2 CH(OH)CH z'OH b Pig heart 65
(RS)-Norcarnitine
methyl ester (CH3)zNCH2CH(OH)CH2C00CH3 b Pig heart 65
(RS,) -Norcarnit in­
amide (CH3)zNCH2CH(0H)CHzC0NH2 c1 Pig heart 65
a Consult text for a complete description. 
b Not an inhibitor up to 2000 /iM concentration. 
c Not an inhibitor up to 4000 pM concentration.
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loss of favorable interactions that exist between the 
protein and hydroxy of carnitine. A parallel argument 
might be made for (S)-carnitine, which shows a Ki for the 
pig-heart enzyme exactly equal to “y-butyrobetaine (Table 
9). Based on this argument, 7-butyrobetaine might be 
expected to strongly inhibit the pigeon enzyme, which 
does not discriminate well between (S)- and 
(/?)-carnitine, but this analogue has not been examined.
Choline and (i?S)-acetyl-j3-methylcholine are 
extremely poor inhibitors, showing Ki values about 
100-fold greater than (R)-carnitine. This weak binding 
implies a need for recognition, by CAT, of the carboxyl 
of carnitine. On the other hand, the poor inhibition 
observed for (flS)-B-hydroxybutyric acid points out the 
equally important trimethylammonium site. It is clear 
that both groups must be present for enzyme recognition.
The remaining • compounds in Table 12 are carnitine 
analogues that result from alterations in the carboxyl 
group. The absence of activity that is observed for these 
compounds has led Fritz and Schultz65 to conclude that 
the carboxyl group of carnitine takes part in the cata­
lytic mechanism (see the section that follows).
However, when they proposed this mechanism they had 
no knowledge of the random-order equilibrium mechanism 
and could therefore not properly apportion the decrease 
in activity between effects on Km (binding) and.effects
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on V ’raax (chemical catalysis). For instance, with carni- 
tinenitrile, in the case that Km and Ki represent true 
binding constants (as in the random-order equilibrium 
mechanism) greater than 99% of the decreased CAT activity 
can be accounted for by binding alone (as measured by 
ratio of K values).
*
Alternative substrates. Table 13 lists alternative subs­
trates of CAT, which are all carnitine analogues. 
(fl)-Thiocarnitine binds nearly as well as (/?)-carnitine 
but is less than 5% as active. (/?)-S-Acetylthiocarnitine 
binds about 3.5-times more efficiently than 
(ft)-acetylcarnitine and is 95% as active. This disparity 
in activity may be a consequence of the high group-trans- 
fer potential observed for acetylthiocarnitine. An equi­
librium constant of 0.22, at pH 7.0 and 30 °C, has been 
measured for eq 8. 111
(/?S)-Aminocarnitine binds about 13-fold more poorly 
to the pigeon enzyme than does (fl)-carnitine and exhibits 
only 7.5% the activity (based upon V ’max). The weak bind­
ing and low enzymatic reactivity cannot be attributed to 
protonation of the 3-amino group, because its pK& is 
quite low (6.37) compared to the buffer pH (7.6).110 
Instead, incorrect H-bonding to an active-site.base and 
misalignment of the amino group for acetyl transfer have 
been suggested.110 The equilibrium for acetylation of 
(flS)-aminocarnitine by AcCoA lies in favor of acetylami-
Table 13. Alternative Substrates of Carnitine Acetyltransferase.
Name Structure Km(pH)
% Relative 
Activity8 Enz. source Ref
(RS)-Thiocarnitine (CH3)3N+CH2CH(SR)CH2C0C- R=H 170 3.3 Pigeon breast 85, 1 1 1











1 1 1 
1 1 1








(RS)—Norcarnitine (CH3)2HN+CH2CH(0H)CH2C00- 3200 ~26d Pig heart 65
(RS)-y-Ami no-0-hydroxy-
butyrate (GABOB) H3N+CH2CH(0H)CH2C00" 40000 <18 Pig heart 65







• V'.max'-of (R)-Cn and (R)-AcCn or (RS)-Cn and (RS)-AcCn are taken as 100%. b Relative 
activity compared to V ’max of (R)-Cn. c Ki (/iM) for competition with (R)-Cn. d Initial 
velocities interpreted from double reciprocal plots. V'max is equal to that obtained 
for (RS)-Cn. Ratio of Kms gives 19% activity. ® Determined from ratio of Kms, 
(R)-Cn/(RS)-GAB0B. * A range of values occurs for increasing bulk and rigidity of 
nitrogen substil uents (consult reference for specific structures).
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AcCoA + thiocarnitine acetylthiocarnitine + CoA (8)
nocarnitine; the racemate (3.3 mM) was acetylated 50% 
[presumably all available (fl)-isomer] by AcCoA (6 mM) 
incubated in the presence of enzyme.110
The results obtained for norcarnitine and GABOB 
(Table 13) point to a trend in enzyme recognition at the 
trimethylammonium site. Although norcarnitine exhibits a 
V'max equal to that obtained for carnitine, it reacts 
with only about 26% the initial velocity because of much 
poorer binding than carnitine. Binding is even more pei—  
turbed when all methyl groups are eliminated, for example 
with GABOB.
This severe trend would be unexpected if the mecha­
nism of binding only involved charge recognition, because 
the primary amine of GABOB (or tertiary amine of norcai—  
nitine) is expected to be in the cationic form at the 
buffer pH (7.8).
When alkyl groups on nitrogen are instead increased 
in size and rigidity, a corresponding increase in Km and 
decrease in V'max occurs.112 The increase in Km can be 
explained from a steric argument alone, but the decrease 
in V'max implies a more complex mechanism, possibly 
involving slight disruption of the enzyme catalytic 
machinery. How CAT selects for both charge and alkyl-me- 
thyl groups is presently a matter for speculation.
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The last compound in Table 13, hemicholinium-3, is a 
minor substrate only. Low activity may result from steric 
constraints as well as the obvious lack of a carboxyl 
function.
Mechanisms of catalysis. Several mechanisms can be pro­
posed to account for the data that have been presented.’ 
The original mechanism of Fritz et al.13 (Figure 2a) is 
based on the apparent need for a catalytically active 
carboxyl group for the formation of a reactive enzyme- 
bound-anhydride intermediate. This mechanism is probably 
not correct. As discussed previously, most evidence indi­
cates that the need for a free carboxyl group is more a 
reflection of a binding phenomenon than of -a catalytic 
function.
A second mechanism, proposed by Gandour et al.,10'0 
involves direct O- to S-acetyl transfer through a tetra­
hedral intermediate (Figure 2b). The mechanism proposed 
is based upon the relative juxtaposition of the CoA and 
carnitine binding sites. It is known from the bisubstrate 
inhibitor of Chase and Tubbs that the thiol of CoA is 
close to the acetyl site, which in turn must be adjacent 
to the carnitine hydroxyl site. However, the kinetics do 
not exclude the possibility of a third mechanism, which 
would involve formation of a reactive acyl-enzyrne intei—  
mediate.
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Figure 2. (a) Mechanism of acetyl transfer pro­
posed by Fritz et al..13 (b) Mechanism of trans­
fer proposed by Gandour et al.,100 proton transfer 
steps not included.
Two potentially nucleophilic groups, a cysteine 
sulfhydryl and a histidine imidazole, have been posi­
tively identified as residents of the active site. Either 
is capable of participation as nucleophilic catalyst by 
formation of the acyl intermediates 8 or 9. However, 
mechanisms of this type generally exhibit either ordered 
sequential kinetics, such as with choline acetyltransfej—
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ase114, or ping-pong kinetics, such as with arylamine
II
O N N — CCHj
II \ , lE n z - S C C H j  \jfc z J
Enz
8
acetyltransferase.11° Both form intermediates like 8. In 
addition, the sulfhydryl of CAT is only moderately nuc­
leophilic based upon its reactivity with several active- 
site-directed inhibitors.93•101•102•104 The histidine is 
nucleophilic towards bromoacetylcarnitine when CoA is 
absent, but is otherwise inferior to the thiol of 
CoA.93 * 196
Another, more probable, function for the histidine 
imidazole is as a general base catalyst. Proton transfer 
steps are required in any of the three mechanisms that 
have been discussed. Loss of a proton occurs at the 
hydroxyl of carnitine and sulfhydryl of CoA. If the 
active-site imidazole serves in this proton transfer 
function, than either of two constraints must apply: 
First, in accordance with the pH dependence observed by 
Chase,92 the pK& of this group must be less than 6.1 or 
greater than 8.3; or second, proton transfers must occur 
only in non-rate-limiting steps.
Summary. Although minor species variations exist for CAT
from different sources, several generalities concerning 
the mechanistic pathway of catalysis are nonetheless 
apparent. Binding of carnitine, or acetylcarnitine, most 
likely requires recognition of both carboxylato and qua­
ternary ammonium portions of the molecule, and may 
involve recognition of charge, H-bonding capacity, end- 
to-end distance (C1...N+) and relative orientation. 
Binding of carnitine occurs by an induced-fit mechanism 
CKoshland model116) rather than a simple complementary 
lock and key mechanism (Fischer model117). Hence, carni­
tine binding induces a major conformational change in the 
enzyme that results in organization of the catalytic 
machinery. The same conformational change may also 
result in disruption of a remote hydrocarbon binding 
site. This site is responsible for inhibition by long- 
chain acyl-CoAs (C8-Ci6)* A regulatory role has not been 
described but might involve a selection mechanism for 
short chain acyl-CoAs. Binding of CoA, or AcCoA, occurs 
in a classical lock and key fashion, with or without 
bound carnitine present. The 3 '-phosphate of AcCoA is an 
important anchor point to the enzyme. The kinetic mecha­
nism fits a random-order equilibrium model where kinetic 
binding constants closely approach the true binding con­
stants, and the rate-limiting step is acyl exchange 
(i.e., interconversion of ternary enzyme-reactant and 
enzyme-product complexes). An acy1-enzyme intermediate
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cannot be excluded by kinetics alone, but it is not sup­
ported by other evidence. Therefore, the mechanism of 
exchange is most likely direct transfer with formation of 
a tetrahedral intermediate.
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Crystal Structures of Carnitine and Acetylcarnitine Zwitterions: 
A Structural Hypothesis for Mode of Action
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The solid-state structures of the zwitterionic forms of both carnitine and acetylcarnitine 
have been determined by single-crystal X-ray analysis. The crystal structure of acetyl­
carnitine reveals a different backbone conformation from that of carnitine. The conforma­
tional differences observed for camitine and acetylcarnitine are more a consequence of 
sieric than electrostatic effects. A detailed comparison is made between the zwitterionic 
structures and previously published hydrochloride salts. The effect of charge distribution on 
conformation is discussed. The zwitterionic structures do not exhibit enhanced electrostatic 
attraction between carboxylate and quaternary ammonium portions of the molecules. Fi­
nally, a hypothesis is presented for the mode of binding of camitine (or acetylcarnitine) to 
the enzyme, camitine acetyltransferase. Based on this model for binding, a speculative 
topographic description of the enzymatic mechanism is presented, c 1985 Academic Previ. inc.
INTRODUCTION
(J?)-Carnitine is a naturally occurring compound found in both plant and animal 
tissues (/). High concentrations are located in vertebrates' heart and muscle 
tissues (2), which depend heavily upon fatty acid oxidation as an energy source. 
Carnitine is a substrate of the enzyme, camitine acetyltransferase (EC 2.3.1.7), 
that catalyzes the reversible transfer of acetyl groups between camitine and acetyl 
coenzyme A (3). Acylated camitine acts as a carrier of fatty acyl groups across 
mitochondrial membranes in a vectorial transport mediated by a translocase en­
zyme (4). Camitine has proven useful in the treatment of myocardial ischemia in 
animals. It facilitates the transfer of fatty acids in damaged areas, hence increasing 
energy production and promoting survivability of the tissue (J). In view of its 
central role in fatty acid oxidation, enhancing the knowledge of camitine and its 
acyl transfer reactions is crucial for the development of its therapeutic potential. 
A knowledge of structures and conformational energies of both camitine and 
acetylcarnitine is essential to an understanding of their mechanisms of action and 
their modes of binding to the enzyme.
Some methods of structural and conformational analyses have been applied to 
camitine. These include MO calculations for gas-phase structures, NMR for solu­
tion conformation, and X-ray diffraction for determining solid-state structures. An
• To whom correspondence should be addressed.
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electrostatic attraction involving the quaternary nitrogen and carboxylate anion of 
carnitine has been proposed (6). CNDO/2 calculations have supported (7) a possi­
ble role of electrostatics in favoring one conformation. Recent 'H NMR studies 
(8, 9) have identified the most populated conformations of carnitine and acetyl- 
camitine, and these conformations are similar to those seen in their crystal struc­
tures. The crystal structures of the hydrochloride salts of both carnitine and acetyl 
carnitine have been determined previously (10-12).
Since the extent of this electrostatic effect cannot be ascertained from analyses 
of the structures of the hydrochloride salts alone, single-crystal X-ray analyses 
have been conducted on the neutral zwitterions of both carnitine and acetyl- 
camitine. These zwitterionic species more accurately typify the charge state of 
these substrates because carboxy groups are expected to be fully ionized under 
physiological conditions. The structures of these zwitterions form the basis of this 
report. In addition, a  hypothesis is presented for the mode of binding of carnitine 
(or acetylcamitine) to carnitine acetyltransferase. Based on this model for bind­
ing, a speculative topographic description of the enzymatic mechanism is given.
EXPERIMENTAL PROCEDURES
Materials
Crystals of (R)-carnitine zwitterion were prepared by vapor diffusion of diethyl 
ether into a saturated solution of carnitine (Sigma Tau) in absolute methanol. The 
presence of water was strictly avoided during handling and preparation of the 
crystals.
(±)-Acetylcamitine chloride was prepared from racemic carnitine (Aldrich) by 
‘‘method A” of Ziegler et al. (13). The zwitterion was prepared by treatment with 
silver oxide in water at room temperature. In this way hydrolysis reactions ob­
served with ion exchange resins were avoided. (:fc)-Acetylcarnitine zwitterion was 
crystallized by vapor diffusion of acetone into an isopropyl alcohol solution satu­
rated with the zwitterion. (±)-Acetylcamitine zwitterion was found to crystallize 
with one equivalent of water.
Diffraction Data
Intensity data for each compound were collected on an Enraf-Nonius CAD4 
diffractometer equipped with a graphite monochromator, using crystals sealed in 
thin-walled glass capillaries for protection from humidity. Data were measured at 
25 ± 2°C by &>-20 scans of variable speeds, designed to yield /  =  50o-(l) for all 
significant reflections. One quadrant of data was measured for each crystal.
Experimental details and unit cell information are listed in Table 1.
Data reduction included corrections for background, Lorentz, polarization and. 
in the case of (R)-camitine, absorption effects. The absorption correction was 
based on ¥  scans of reflections near x -  90°, and the minimum relative transmis­
sion coefficient was 0.9268.
CARNITINE AND ACETYLCARNIT1NE ZWITTERIONS 
TABLE I
C r y s t a l  D a t a  f o r  C a r n i t i n e  a n d  A c e t y l c a r n i t i n e  • H20
Carnitine Acetylcarnitine • HjO
Formula C,H„NO, C,H „N 04 • HjO
Formula weight 161.2 221.3
Crystal system Monoctinic Monoclinic
Space group P2,lc
a (A) 7.342(1) 12.315(3)
M  A) 6.089(1) 8.851(2)
c (A ) 9.530(2) 11.109(3)
P (deg.) 97.58(1) 95.02(2)
V (A ’) 422.4(2) 1206.2(8)
Z  (formulas/cell) 2 4
Radiation CuKa MoKa
A (A) 1.54184 0.71073
Dc (g cm- ') 1.267 1.218
H (cm-1) 8.25 0.92
Crystal size (mm’l 0.16 x 0.36 x 0.60 0.36 x 0.40 x 0.56
6 limits (deg.) 2-75 1-25
Unique data 889 2119





Extinction coefficient 3.0(3) x 10-* —
Maximum residual (eA~') 0.17 0.40
Structure Solution and Refinement
A. (R)-Carnitine. The structure was solved by direct methods, MULTAN 78 
(14), and refined by full-matrix least-squares based on F, with weights o-(F0)~2, 
using data for which /  >  3a(I). Nonhydrogen atoms were treated anisotropically, 
while hydrogen atoms were located from difference maps and refined isotropi- 
cally. The crystal suffered from slight secondary extinction, and an extinction 
parameter was refined.
B. Acetylcarnitine monohydrate. The structure elucidation proceeded virtually 
identically to that for (ft)-camitine. No extinction problem was encountered; how­
ever, a slight disorder involving the acetyl group was encountered. The molecule 
exists in the crystal in two equally populated conformations, differing by a rota­
tion of approximately 40° about the 03—C8 bond. This disorder was represented 
in the refinement model by two half-populated positions for the carbonyl oxygen 
atom, 04, and also for the methyl group, C9. These half-atoms were refined 
isotropically, and the methyl hydrogen atoms were not located.
Coordinates for (/?)-carnitine are given in Table 2; those for acetylcarnitine • 
H20  are given in Table 3; and anisotropic thermal parameters and structure fac­
tors are available from the authors. ,
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TABLE 2
C o o r d i n a t e s  f o r  ( R ) - C a r n i t i n e
Atom X y z Atom X y K.
01 1.0079(1) 0.7499(3) 0.8039(1) H3 0.930(2) 0.759(4) 1.071(1)
02 0.7455(1) 0.8512(4) 0.6824(1) H4 0.736(2) 0.485(6) 1.157(2)
03 0.7408(1) 1" 1.0450(1) H5 0.569(2) 0.650(4) 1.124(2)
N 0.7340(1) 0.7050(3) 1.3083(1) H6 0.629(3) 0.918(8) 1.445(2)
Cl 0.8353(2) 0.7681(4) 0.7877(1) H7 0.650(3) 1.009(12) 1.278(4)
C2 0.7328(2) 0.6757(3) 0.9034(1) H8 0.489(3) 0.841(7) 1.312(3)
C3 0.7929(2) 0.7769(3) 1.0488(1) H9 0.689(4) 0.554(8) 1.496(3)
C4 0.6980(2) 0.6410(3) 1.1529(1) HI0 0.560(3) 0.481(7) 1.356(3)
C5 0.6177(2) 0.8953(5) 1.3383(2) H ll 0.770(3) 0.395(8) 1.387(3)
C6 0.6845(2) 0.5108(5) 1.3920(2) HI2 0.969(2) 0.877(5) 1.311(2)
C7 0.9318(2) 0.7561(4) 1.3557(1) HI3 1.004(3) 0.637(9) 1.318(3)
HI 0.616(2) 0.694(5) 0.880(2) HI4 0.939(2) 0.775(6) 1.458(3)
H2 0.764(2) 0.512(6) 0.915(2) HI5 0.826(3) 1.077(7) 1.100(3)
“ The y coordinate of 03 was fixed to define the origin of the polar space group.
RESULTS AND DISCUSSION
Crystal Structures
Figure 1 shows the structures obtained for the zwitterions of carnitine and 
acetylcarnitine. The most distinct difference between the two structures is the
TABLE 3
C o o r d i n a t e s  f o r  A c e t v l c a r n i t i n e  M o n o h v d r a t e
Atom X y Atom X >' «.
01 0.1685(2) 0.5691(3) 0.5685(2) HI 0.333(3) 0.476(5) 0.766(4)
02 0.1869(3) 0.3358(3) 0.6352(3) H2 0.217(3) 0.505(4) 0.819(3)
03 0.3648(2) 0.7269(3) 0.8681(2) H3 0.317(2) 0.719(3) 0.707(3)
04“ 0.5028(6) 0.7466(7) 0.7509(7) H4 0.169(3) 0.787(4) 0.864(3)
0 4 '“ 0.4986(5) 0.6515(7) 0.7632(6) H5 0.122(3) 0.747(3) 0.745(3)
05W 0.9888(3) 0.7582(3) 0.5187(3) H6 0.261(3) 1.023(5) 0.892(4)
N 0.1878(2) 0.9509(3) 0.7381(2) H7 0.330(4) 1.010(5) 0.778(4)
Cl 0.2000(3) 0.4741(4) 0.6465(3) H8 0.251(4) 1.149(5) 0.781(4)
C2 0.2599(3) 0.5278(4) 0.7626(3) H9 0.068(4) 1.006(5) 0.850(4)
C3 0.2863(3) 0.6952(4) 0.7664(3) H10 0.081(3) 1.126(4) 0.736(3)
C4 0.1867(3) 0.7893(4) 0.7807(3) H ll 0.016(4) 0.955(6) 0.686(5)
C5 0.2711(4) 1.0424(4) 0.8123(4) H12 0.283(4) 0.912(5) 0.605(4)
C6 0.0769(3) 1.0154(5) 0.7529(4) H13 0.156(5) 0.890(7) 0.550(5)
C7 0.2075(4) 0.9621(4) 0.6073(3) H14 0.211(4) 1.057(5) 0.586(4)
C8 0.4697(4) 0.7245(6) 0.8522(4) H1W 0.935(3) 0.723(4) 0.481(3)
C9“ 0.5400(7) 0.7260(11) 0.9750(8) H2W 1.032(3) 0.688(4) 0.523(3)
C9'“ 0.5451(7) 0.7882(11) 0.9549(8)
• Population = 1/2.





Fic. 1. (a) Solid-state conformation of carnitine zwitterion. (b) Solid-state conformation of acetyl- 
camitine zwitterion.
position of the carboxylate group. Carnitine exists in a fully “ extended” confor­
mation (Cl—C2—C3—C4—N, a-a) whereas acetylcarnitine exists in a “ folded” 
conformation (Cl—C2—C3—C4—N, g-a) (7). A perceptible difference exists in 
the torsion angles C2—C3—C4—N and 03—C3—C4—N. The respective tor­
sion angles are 156.4° and -83.1° for acetylcarnitine, but 179.7° and -61.5° for 
carnitine. Acetylation of the hydroxy group causes a rotation of approximately 
-22° about C3—C4.
Other significant differences are seen in the bond angles, C2—C3—C4 and 
03—C3—C4. fn carnitine, C2—C3—C4 is 6.1° smaller than in acetylcarnitine, 
105.6° vs 111.7°. On the other hand, 03—C3—C4 is 5.3° larger, 113.1° vs 107.8°. 
Destro and Heyda (12) have suggested that this deformation is caused by the N 4 
■ • • O coulombic attraction. Acetylation of the hydroxy increases the 03—C3— 
C4—N torsion angle, and this is compensated for by compression of 0 3 —C3— 
C4. There is a net increase in separation between the two groups as revealed by 
the 03—N nonbonded distance—3.09 A, carnitine vs 3.20 A, acetylcarnitine.
Another difference in the structures of carnitine and acetylcarnitine is in the 
relative orientation of the carboxylate groups to the backbone atoms. Since the 
oxygens are equivalent, the numbering, 01 or 02, is arbitrary. For carnitine (see 
Fig. la) C l—02 is nearly eclipsing a C—H bond, while for acetylcarnitine (see 
Fig. lb) C l—01 is virtually eclipsing C2—C3. This may occur because of differ­
ences in hydrogen bonding. In carnitine, the hydroxyl group forms an intermolec-
ular hydrogen bond with 01, having O O separation of 2.663 A and a 174° angle
at H. The acetyl compound lacks hydrogen bond donors, and the water molecule 
serves this function. It donates hydrogen bonds to two acetylcarnitine molecules
with parameters 05W -----02, 2.765 A (angle at H = 169°) and 05W-----01, 2.792
A (angle at H = 160°).
Comparison with Previous Work
A comparison of the zwitterionic structures with the hydrochloride salts (10- 
12) is made in Table 4. Selected bond distances, bond angles, torsion angles, and 
nonbonded distances are given. Aside from slight variations in torsion angles, the
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TABLE 4
S e l e c t e d  B o n d  L e n g t h s , B o n d  A n g l e s ,  T o r s i o n  A n g l e s , a n d  N o n b o n d e d  D i s t a n c e s  i n  
C r y s t a l  S t r u c t u r e s  o f  C a r n i t i n e  a n d  A c e t y l c a r n i t i n e
Carnitine Acetylcarnitine
Atoms Zwitterion Hydrochloride* Monohydrate Hydrochloride* Hydrochloride - HjOr
Bond lengths (A)Cl— 01 1.261(1) 1.203(10) 1.245(3) 1.212(7) 1.196(3)Cl— 02 1.234(2) 1.324(10) 1.239(3) 1.328(7) 1.313(3)Cl— C2 1.323(2) 1.507(11) 1.506(4) 1.509(7) 1.496(3)C2-C3 1.527(1) 1.529(11) 1.516(4) 1.525(7) 1.518(3)C3— 03 1.411(2) 1.419(10) 1.449(3) 1.470(7) 1.451(2)C3— C4 1.328(2) 1.519(11) 1.503(4) 1.517(7) 1.504(3)C4— N 1.521(1) 1.518(10) 1.508(3) 1.531(7) 1.509(2)
Bond angles (deg.)01— Cl— 02 123.8(1) 123.3(8) 124.512) 124.3(4) 123.8(21Ol— Cl— C2 117.6(11 124.9(7) 118.8(2) 125.2(4) 124.4(2)02— Cl— C2 118.6(1) 111.8(7) 116.6(2) 110.5(4) 111.812)Cl— C2— C3 113.4(1) 111.5(6) 114.8(2) 111.7(4) 112.9(2)C2— C3— C4 105.6(1) 107.2(6) 111.7(21 109.4(4) 111.1(2)C2— C3— 03 108.7(1) 108.7(7) 109.7(2) 108.0(4) 108.1(2)03— C3— C4 113.1(1) 111.3(7) 107.8(2) 105.0(4) 106.8(2)C3— C4— N 117.3(1) 116.8(7) 117.5(2) 115.9(4) 116.4121
Torsion angles (deg.)Cl— C2— C3— C4 -171.6(2) -166.2 -74.3(3) -71.4 -77.1C2— C3— C4— N 179.7(2) 174.8 156.413) 156.3 158.901— Cl— C2— C3 58.5(2) 22.7 6.5(31 -3.1 6.0Cl— C2— C3— 03 66.7(2) 73.4 116.3(3) 174.9 166.003— C3— C4— N -61.5(21 -66.4 -83.1(3) -88.0 -83.6C3— 03— C8— C9 — _ 167.5(7) -174.3 -177.8
Nonbonded distances (A)Cl— 03 3.02 2.99
1-147(7)1-'
3.78 3.78 3.7403— N 3.09 3.07 3.20 3.22 3.17Cl— N 5.13 5.06 4.35 4.24 4.33Ol— N 5.46 5.27 3.86 3.88 3.98
* R er. I /O  I.
» R c r .  i / / i .
* R e f. ( 12).'Two values, disorder in crystal.
overall conformations of the zwitterions closely match those of the hydro­
chlorides.
The data reveal no significant differences in bond distances except for proton- 
ated versus unprotonated carboxylates. The C l—O! and C l—02 distances for the 
zwitterions are nearly identical which is indicative of the resonant form.
Differences in the 01—C l—C2 versus 02—C l—C2 bond angles are seen for 
the hydrochlorides but not the zwitterions. The other angles involving the back­
bone atoms of the zwitterions and hydrochlorides are nearly the same. In all cases 
the C3—C4—N angle is unusually large because of steric repulsion between the 
trimethylammonium group and 03.
An examination of most of the torsion angles reveals close agreement among 
the zwitterionic and hydrochloride structures. A difference in the orientation of 
the carboxyl(ato) group (involving a twist about C l—C2) in carnitine is seen
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between the hydrochloride and zwitterion. The data show that the O l—C l— 
C2—C3 torsion angle of the carnitine crystals differs by 36°. This shift in position 
appears to be due to differences in intermolecular H-bonding. This occurs be­
tween 02 and a chlorine atom of carnitine * HC1, whereas for the zwitterion an H- 
bond is formed between 01 and the hydroxyl group.
A unique difference in the position of the acetyl group of acetylcarnitine is 
observed for the zwitterion compared with the hydrochlorides. As previously 
noted, the acetyl group of acetylcarnitine • H20  exists in two distinct conforma­
tions related by rotation about the 03—C8 bond. This crystal disorder has not 
been reported with the hydrochloride salts.
Contributions from crystal packing forces cannot be excluded. However, both 
zwitterion and hydrochloride have the same backbone conformation. Since the 
same backbone conformation is observed in different crystals, the suggestion that 
this backbone conformation is independent of these forces is supported.
Intramolecular Electrostatic Attraction Question
It has been proposed (6) that the “ folded" conformation is stabilized by an 
intramolecular ionic attraction between the carboxylate and the trimethyl- 
ammonium group. This proposal has received additional support from EHT and 
CNDO/2 calculations (7) that have suggested that the low-energy conformation is 
stabilized by internal ionic forces.
This electrostatic interaction should be enhanced in the zwitterionic structures 
when compared to the hydrochlorides since carboxylate has more electron den­
sity on the oxygens than carbonyl. An examination of nonbonded distances 
01—N and C l—N should give a measure of the attraction of the carboxylate to 
the ammonium group.
In carnitine, both the zwitterion and the hydrochloride have the same confor­
mation, i.e., “ extended." This means that the electrostatic attraction is not strong 
enough to favor the “ folded" over the “ extended.” The factors which favor the 
“ extended" conformation dominate. Intramolecular hydrogen bonding between 
the carboxylate and hydroxyl would stabilize the "extended" conformation. As 
seen in Fig. la, no such intramolecular hydrogen bond exists in the solid state. 
Therefore, there is no special effect that precludes formation of the “ folded" 
conformation. If electrostatic attraction is a real effect, it is not large enough to 
overcome the factors that favor the “ extended” conformation.
In acetylcarnitine, where both the zwitterion and the two hydrochlorides exist 
in the “ folded” conformation, there is no significant shortening of the distance 
between the carboxylate and ammonium groups. The steric bulk of the acetyl 
group compared with hydroxyl biases acetylcarnitine toward the “ folded" confor­
mation. The proposed electrostatic attraction should result in further stabilization. 
Although the 01—N distance is the shortest in the zwitterion, the C l—N distance 
is the longest. Both distances are dependent on a number of conformational fac­
tors. If electrostatic attraction is a dominant factor, a more apparent shortening 
should be observed.
The conclusion reached at this point is that intramolecular electrostatic attrac­
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tion between carboxylate and the irimethylammonium group is a small effect or 
unimportant for determining the conformation of carnitine and acetylcarnitine in 
the solid state.
Explanation o f  Conformational Preference
The gauche conformation of the 03—C3—C4—N torsion angle in both struc­
tures has ample precedence. This is another example of the “ gauche effect,” i.e., 
the tendency for vicinal polar bonds to adopt a gauche conformation (75). Expla­
nations, couched in the language of MO theory, of the gauche effect abound (75, 
16). The preference for the gauche conformation in acetylcholine and its analogs 
(77) has been ascribed to be due in part to “ copjugative destabilization” of the 
anti rotamer (16b). These MO descriptions complement previous suggestions for 
this preference based on electrostatic attraction (18) and dipole-dipole interaction
An explanation for the difference in the conformation of the C l—C2—C3—C4 
torsion angle, gauche in acetylcarnitine versus anti in carnitine, most likely re­
sides in steric effects.
The anti conformation of the C l—C2—C3—C4 torsion angle in carnitine also 
has precedence. A search of the Cambridge Crystallographic Data Files (20) for 
compounds of the general formula, RCH(OH)CH2COOH, has revealed that all 17 
compounds2 have the conformation shown below. Furthermore, this conforma­
tional preference holds for a series of hydrogen malates regardless of the nature of 
the cation (21). This conformational preference is a general feature of compounds 
of this class. The gauche relationship between hydroxy and carboxyl likely arises 
from the gauche effect and not intramolecular hydrogen bonding.
The gauche conformation of the C l—C2—C3—C4 torsion angle in acetyl­
carnitine does not have much precedence. A search of the Cambridge Crystallo­
graphic Data Files for the fragment, C—OCH(R)CH2COOH, has uncovered only 
two structures besides acetylcarnitine. In both these structures, C3 and C4 are 
part of a five-membered ring which includes the oxygen attached to C3. The 
conformation in both is with C l—C2—C3—C4, anti, and C l—C2—C3—O, 
gauche. As discussed above, this is what is observed for 3-hydroxypropanoic 
acids.
This observed change in conformation about C2—C3 can be readily explained 
by steric effects. Acetylation of the hydroxyl in carnitine creates steric repulsion 
in the “ extended" conformation, both with the trimethylammonium group and the
2 Six different backbones: eight malic derivatives, five 3-aryl-3-hydroxypropanoic acids. Contact the 
authors for details of the search.
(79).
R







Fig. 2. Schematic or carnitine binding site on carnitine acctyliransfcrase. Carnitine makes a two- 
point attachment to the enzyme. The location of the CoASH binding site creates the third locus, thus 
creating the stereospecificity observed in the reaction, (a) (ft) enantiomer is bound and acetyl transfer 
can occur, (b) (S) enantiomer is bound and acetyl transfer is not possible.
carboxylate group. This potential crowding between acetoxy and carboxylate is 
relieved by rotation to the “ folded” conformation. The crowding between ace­
toxy and trimethylammonium is relieved by a rotation about C3—C4 of approxi­
mately -22°. The forces for preserving the gauche conformation for N—C4— 
C3—O are stronger than those for O—C3—C2—Cl.
In the related molecules, 4-aminobutanoic acid (GABA) and 4-amino-3- 
hydroxybutanoic acid (GABOB), the opposite occurs. GABA exists in the 
“ folded" conformation in its crystal structure (22) while GABOB is in the “ ex­
tended” (23). Craven and Weber (22) have proposed an intramolecular hydrogen 
bridging interaction in GABA as an explanation for the stability of the “ folded” 
conformation. For GABOB in the "extended” conformation, the hydroxy group 
is gauche to the ammonium group and to the carboxy group. The structure of 
GABOB suggests that the gauche effect may be more important than intra­
molecular hydrogen bridging.
Hypothesis fo r  Corformer Selective Binding in Carnitine Acetyltransferase
Carnitine acetyltransferase catalyzes the reversible transfer of an acetyl group 
between acetyl coenzyme A and (/?)-camitine (J). The enzyme is competitively 
inhibited by (S)-acetylcarnitine and (,S)-carnitine (24).
Given this stereospecificity, a likely suggestion is that carnitine makes a two- 
point attachment to the enzyme (Fig. 2). The carboxylate and the trimethyl­
ammonium group should be the parts of the carnitine framework being recog­
nized. Once anchored to the enzyme, the acetyl group can only be transferred 
when it is in proximity to the coenzyme A thiol group or the thiol group on the 
enzyme.3 In order to allow for maximum steric accessibility about the hydroxyl 
group on carnitine, the enzyme should bind the “ folded” conformation.
Murray et al. (7) have previously suggested that the conformations of carnitine 
and acylcarnitine play important roles in the activities of these various enzymes. 
They suggest that carnitine acetyltransferase requires the “ extended" conforma­
tion of carnitine for the forward reaction. They adopt the carboxy participation 
mechanism, Fig. 3a, proposed by Fritz et al. (3), and explain how the “ extended"
1 A thiol group on the enzyme is needed for activity (25). Whether or not an acylenzyme is involved
in the mechanism is not known.
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conformation is needed for intramolecular transfer of the acetyl from carboxy to 
hydroxy. Once acetylated, they suggest the carboxy is free to rotate to the favored 
“ folded” conformation. The only part of the molecule which remains firmly an­
chored to the enzyme is the quaternary ammonium group.
For the transfer of acetyl groups to and from carnitine and a thiol group, the 
following questions arise: Does the carboxy] group on carnitine participate? If 
not, then what is the most likely mechanism?
The carboxylato group probably does not participate. Studies (26) on model 
systems of intramolecular catalysis of acyl transfer by carboxylate would not 
support the formation of an anhydride intermediate. Since carnitine acetyl­
transferase catalyzes the reaction in both directions, the mechanism for the reac­
tion should be reversible. The difficulty with mechanism (a) in Fig. 3 is that 
alkoxide is a much poorer leaving group than carboxylate. This disfavors forma­
tion of the high-energy anhydride. Furthermore, the carboxylate is needed for 
binding to the enzyme surface and would not be available for assisting the acetyl 
transfer.
A mechanism for O to S  acyl transfer has been developed (27) in model reac­
tions and is given in Fig. 3b. The reaction is simply an addition-elimination 
involving formation of a tetrahedral intermediate. Factors which affect the parti­
tioning of this intermediate control the direction of the reaction.
' Assuming the addition-elimination mechanism for the reaction, the question of 
which conformation of the carnitines is bound can be addressed. Close contacts
.0
o j^ V ' ch,
+ CH j— U—S — R f ' S j H  +  GS — R
M«SN® Mes N®
to)
+ % - R  ♦  ®S— R
CH>
M tjN qM«,N„
e o o c x  ® 0 0 C ^  QJL ° JL
f ^ O H  ♦  CHS— C - S - R  S - RM,JN® CH3
(b»®ooc^
5 = ^  f ' O - I - C H j  +  ® S - R
M.jN©
F i g . 3 .  (a) Mechanism of acetyl transfer proposed by Fritz et til. (3). ( b )  Typical mechanism for O -  to 
5-acyl transfer, proton transfer steps not included.
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Fig. 4. Proposed conformation of tetrahedral intermediate in acetyi transfer between O and 5. For 
steric and electronic reasons, S  is placed opposite the irimethylammonium group.
between the carboxylate and the acetyl group disfavor the “ extended” conforma­
tion and the “ folded” conformation is observed in the crystalline state. Figure 4 
shows the proposed conformation of enzyme-bound acetylcarnitine with the tetra­
hedral intermediate formed. These contacts are even closer when examining the 
tetrahedral intermediate. The “ folded” conformation is most likely the one bound 
by the enzyme. The stereospecificity of the reaction and the lack of necessity, for 
carboxylate participation argue for a firm attachment of the carboxylate to its 
binding site.
Figure 4 further suggests a topographic arrangement in the'enzyme with respect 
to the position of the thiol group. Assuming the conformation of the acetoxy group 
in the crystalline state is similar to that in the enzyme-substrate complex, the thiol 
most likely will attach to the Reface of the acetoxy carbonyl from the carboxy side 
of carnitine. The trimethylammonium group is too bulky to allow attack from its 
side. Furthermore, development of negative charge on oxygen as the acetoxy 
group is attacked, will be stabilized by the quaternary ammonium group.
In conclusion, a hypothesis has been presented which describes the topographi­
cal and conformational arrangement of molecules involved in the transfer of acetyl 
groups to and from carnitine. This hypothesis is consistent with current informa­
tion concerning the enzymatic reaction as well as its bioorganic chemistry.
Work is in progress in these laboratories on the preparation of analogs to test 
this hypothesis.
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An Equation Utilizing Empirically Derived 
Substituent Constants lor the Prediction of 
Vicinal Coupling Constants in Substituted 
Ethanes
W n tta m  J .  C o in e d ,  S te v e n  ) .  J n n g k  a n d  R ic h a rd  D .  G a n d o u r*
Department of Chemistry, Louisiana State University, Baton Rouge, Louisiana 70803-1804, USA
A rimph equation hat been developed for the prediction of vicinal coupling constants in HCCH fragments:
A+B cos 0+Ccoi 28+eoaO [(AS,+AS,) cot (G-120)+(AS,+AS,) cos (0+120))
The equation It a cosine series in 0, the torsion angle between vicinal hydrogens. The feature which 
disrtngnMies this equation from aimflar equations it the inclusion of A$ terms, which describe the magnitude 
of each substituent’s effect. These substituent constants have been defined from experimental data. An 
orientation effect which is dependent on the torsion angle(t) between substitnent(i) and a vicinal hydrogen b 
Included. Substituent constants have been defined for 39 groups, of which 15 have been experimentally 
determined herein. The parameters for the equation have been defined from 49 torsion angles in 19 
conformstiooaHy rigid compounds. The torsion angles have been determined from x-ray crystal stmctnie data 
and molecular mechanics calculations. The multiplicity of struct aim used to determine the substituent 
constants should allow for the application of this equation to a wide variety of structures.
(2), or equivalent functions (3)6 and (4),1 by fitting 
coupling constants obtained from the spectra of con- 
formationally rigid compounds.1,6'7
3J(HCCH) = A cos1 6 + B cos 0 + C (3)
3J(HCCH) = A  cos2 0 + B cos 0 + C  sin2 0 (4)
As a result of the inherent shortcomings of the 
original Karplus equation, numerous attempts have 
been made at defining the substituent effects a priori. 
These have included MO calculations6,9 and correla­
tion with substituent electronegativity.10 Although 
MO calculations6 have had limited success in predict­
ing 3J(HCCH), the calculated coupling constants do 
reflect general trends.9 The magnitude of substituent 
effects has been quantified by Pachler10 through the 
correlation of Huggins electronegativity (E) of the 
substituents with observed coupling constants, Eqn 
(5):
3J(HCCH)
= ( a - a I A E ^ ) - ( b - b I A E . )  cos 6
+ ( c - c E a e , )  cos 20
+ ( d S ± A E .)  sin0 + ( e I± A E ^ )  sin 20 (5)
where AEI = EX—E tf. The linear'correlation between 
electronegativity and substituent effect is a good ap­
proximation but, unfortunately, breaks down for 
highly electron-withdrawing elements.10,11 
A  method which utilizes experimentally related data
CCC-0749-1581/85/0023-0335S04.50
I N T R O D U C T I O N
The need for an accurate description of vicinal coupl­
ing constants [3J(HCCH)] in substituted ethanes is 
most evident in bioorganic chemistry. To begin to 
understand recognition processes, such as enzyme- 
substrate and receptor-hormone interactions, an inti­
mate knowledge of the potential conformations and 
flexibilities of the recognized molecules is initially 
required. ’H NMR has been widely used to ascertain 
the solution conformation of molecules possessing 
physiological activity.1 Unfortunately, , the usefulness 
of fH  NMR in these conformational analyses is not 
always realized for the lack of an accurate description 
of 3J(HCCH) as a function of the HCCH torsion angle 
and the substituents on the two carbons.
The pioneering application of ‘H NMR in determin­
ing the conformation of molecules in solution came 
with the introduction by Karplus2 of the ‘cosine 
squared* relationship. There were several extensions 
of the original Karplus relationship,2 Eqn (1), and the 
more accurate trigonometric series, Eqn (2):1,3
3J(HCCH) = J0 « k2 0 + C (1)
3J(HCCH) = A + B c o s 0  + C cos20  (2)
Early abuses in the application of these equations 
were quickly pointed out by Karplus himself.3 The 
major complication was that the torsion-angle depen­
dence of /(HCCH) was shown to be significantly 
affected by substituents.4,3 Most efforts to improve the 
equation involved determining the parameters of Eqn
* Author to whom correspondence should be addressed.
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to determine substituent effects has been employed. 
The semiempirical Eqn (6), in which the substituent 
effect is determined by measurement of H), has
been proposed by Jankowski.13
3J(HCCH) =  A  cos2 e +  B l [ 1J(C,H l) + ,J(C/H))] (6)
The parameters were determined by fitting Eqn (6) to 
the data derived from a single compound. This equa­
tion's general applicability to other systems has been 
limited.15
The orientation of a substituent has an effect on 
3J(HCCH). This is clearly defined from studies on 
disubstituted ethanes14,15 and is in accord with the 
results obtained through EHT MO calculations.16,17 
Such a calculation performed on fluoroethane by 
Pachler16 has produced a difference curve (Fig. 1), 
which shows the substituent’s effect on the coupling 
constant curve for ethane.
The substituent effect is found to be a'function of 
the HCCH torsion angle, 0, and the HCCX torsion 
angles, <bnx, (see Fig. 2). This difference curve shows 
that the most important features of the substituents’ 
effects on 3 J  (HCCH) are the following:
1. No apparent effect when 0 = 30 ,90 ,210  or 270°.
2. A large decrease in 3J(HCCH) for 0 = 0 or 180°.
3. A  small increase in 3J(HCCH) for 0 = 60 or 
240°.
4. A  net decrease in 3J(HCCH) for the effect aver­
aged over all angles accessible to 0.
Pachler’s10 equation [Eqn (5)3 describes many of the 
features seen in the difference curve predicted by the 
EH T MO calculations. The equation assumes the sub­
stituent effects are additive and correlates these effects 
with electronegativity. The orientation effect is ac­
counted for in the coefficients of the sine terms, where 
X ±AE, = A E ,—AE2—A E ,+ AE,, according to the 
numbering convention of Fig. 2.
*2
Rgure 2. Newman projection showing 0 and <t> angles.
The parameters (A, B, C, a, b, c, d  and e) of Eqn 
(5) were determined empirically. Pachler10 fitted a 
large and diverse data set of conformationally rigid 
molecules with defined torsion angles to his equation, 
producing Eqn (7).
3J(HCCH)
= (7.48 -  0.74 £  A E ,) - ( 2.03- 0.17 £  A E,) cos 0 
+  ( 4 .6O - 0 .2 3 1  AE,) cos 20 
+ ( 0.O6 £  ±A E i)sin  0
+  (o .6 2 £ ± A E ,)s in 2 0  (7)
We present here a simpler equation which can re­
produce the curve for ethane and account for sub­
stituent effects. This paper describes the rationale 
behind the equation, the methodology for determining 
the substituent constants and comparisons of this new 
equation with previous ones.
M E T H O D
D e s c r ip t io n  o f  e q u a t io n
The proposed general equation [Eqn (8)] incorporates 
all o.' the previously described features. The significant 
difference is that only one parameter, AS,, is required 
for each different substituent on the ethane fragment. 
Eqn (8)
3J(HCCH) = A + B cos 0 + C  cos 20
4
+ £  AS, cos 0 cos <#>h x , (8)1-1
is constructed on the premise that the torsion-angle 
dependence of 3J(HCCH) can be described as a simple
perturbation of the ethane system. Following the lead
of Pachler,10 an assumption is made that the effects of 
multiple substituents are additive. The entire sub­
stituent effect is contained in the summation term 
which is orientation dependent. The remaining terms, 
which are identical with Eqn (2), represent the 
torsion-angle dependence of 3J(HOCH) in ethane. 
Traditionally, the trigonometric series has been trun­
cated at the cos 20 term.3 This truncation results in an 
adequate description of the curve for ethane.
The sole parameter, ASit is an empirically derived 
substituent constant. AS, for hydrogen is defined as 
zero since the ethane curve is described totally by the 
fust three terms of Eqn (8). This approach is similar 
to other sets of substituent constants derived from 
experimental data and employed in free-energy 
relationships. The origin of the substituent effect is not 
explained by AS,. Undoubtedly, as Pachler10 and 
others11 have shown, electronegativity is a major con­
tributor to the effect. However, A Si by definition 
includes all contributions to the substituent effect.
A comment should be made about the term which 
describes the angular dependence of the substituent
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effect. An examination of Fig. 1 dearly shows that this 
difference curve has the shape of a cosine-squared 
function, with the exception that it is phase-shifted 60s 
and has negative values. The simplest expression 
which satisfies the previously mentioned features of 
the difference curve is cos 0 cos 4>hx,. The cos 0 term 
ensures AJ ** 0 at 90 and 270°, while the cos <#>h x , term 
(where <f>~0± 120°) forces AJ = 0 at ca 210 and 30°.
For an sp3 hybridized carbon of perfect tetrahedral 
geometry, <£hx, can be conveniently expressed as a 
function of 0 by making the appropriate substitutions 
(Fig. 3). The cosine terms of Eqn (8) can then be 
consolidated to give a more useful expression:
3J(HCCH)
= A + B c o s 0  + C cos20n  ' a/ wj v • v w<>
+ cos 0[(ASi+ A S4) cos (0 -120 ) 
+ (AS2+ AS3) cos (0 +120)]
D e te r m in a t io n  o f  s u b s t i tu e n t  c o n s ta n ts
(9)
The values of AS, are obtained from experimental 
data on the observed coupling constants in monosub- 
stitued ethanes. Since these molecules are internally 
rotating at ambient temperatures, an average coupling 
constant is measured. The correlation of A Si to the 
measured coupling constant is accomplished by inte­
gration of Eqn (9) according to the following standard 
expression:
<J,>
= £  ’j(0 ) exp [ -  V(0)/lcT] d o /J^  "exp [ -  V(0)/kT] d0
an approach which has been used in similar applica­
tions.,6 (J,) is an average of all J(0) weighted by a 
Boltzmann distribution, where V(0) is the potential 
function of rotation.
Solving the integral requires a special treatment of 
the exponential terms and necessitates a description of 
V(0). The potential function for internal rotation in 
ethane (or a monosubstituted ethane) is described as a 
three-fold function:
V(0)= Vo(l+ cos30)/2
where V0 is the potential barrier height.18 The poten­
tial barrier is estimated to be approximately 
3 kcal mol-1 for ethane.19 Based on the magnitude of 
V0, in accordance with the Boltzmann distribution, 
most molecules will, at room temperature, occupy the 
lowest energy states, i.e. staggered conformations (0 = 
60, 180 and 300°). With this in mind, the integral
expression can be solved analytically by utilizing two 
conceptually distinct approaches.
The first approach involves discrete integration for 
states where V(0) = 0, i.e. where the molecules exist in 
the lowest energy conformational states, 0 - 6 0 ,  180 
and 300°. When V(0) = O, -V (0)/lcT = 0 and the ex­
ponential becomes 1. The integrated expression then 
reduces to
</,} = A -0 .2 5  AS, (10)
The second approach is a continuous integration 
which considers all lower energy populated states. 
These states are clustered about 0 = 60, 180 and 300°. 
In these regions V(0) has a small but finite value. An 
exponential expansion can be employed, giving
exp [ -  V (0)/kT]« 1 -  V(0)/kT+  • • •
Higher order terms can be neglected only in the 
case where V(0) is small relative to k T  (k T =
0.6 kcal mol"1 at room temperature). The approximate 
expression for the three-fold potential is substituted 
for V(0) and a rigorous solution for </,) is obtained by 
solving the integral. During the solution of the in­
tegral, the temperature and V0 dependence of both 
the numerator and demominator exactly cancel and 
the integral expression once again reduces to Eqn 
(10).
Therefore, Eqn (10), which arises regardless of the 
approach employed in the integration, is a useful 
expression for determining values of AS,. Clearly, if A 
is known, values of (J,) for monosubstituted ethanes 
give values of AS,. Fortunately, A must represent the 
average coupling constant observed in ethane itself.
The correspondence of terms in Eqn (10) with the 
firmly established Eqn ( l l ) 11,20"22 is readily apparent 
and helps to validate the method. Eqn (11) describes 
the observed coupling constant in substituted ethanes 
as a linear function of the electronegativities of the 
substituent atoms:
3j(h c c h )=Jo+ k I a e ; (id
Values for J0 have been reported ranging from 7.8 to
8.4 Hz,8'11,22"15 which sets the limits of A, the average 
coupling constant expected in ethane.
The coefficients A, B and C  can be determined by 
fitting experimental data to a rearranged form of Eqn 
( 9 ) .  Since values of AS, are unknown at this point, AS, 
must be substituted for in Eqn ( 9 ) .  Eqn (10) provides 
an expression for AS, in terms of A and (J,) (for 
convenience designated J,). Substituting
4 (A -J ,)  = AS,
in Eqn (9 )  yields
3J(HCCH)
= A + B cos 0 + C cos 2 0 + cos 0{[4( A -  J ,)
+4(A  -  J 4)] cos (0 - 1 2 0 )+ [4( A -  J-)
+ 4 ( A - J 3)] cos (0 +  120)}
where J, is the experimentally determined value for 
the coupling constant of the appropriate monosubsti­
tuted ethane. This equation cannot.be used directly 
because the J, for hydrogen cannot be determined 
experimentally and is equivalent to A. Since the
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defined value of AS, for hydrogen is zero, the (A  -J ,)  
terms can be set to zero by an operator (£). When the 
substituent is hydrogen, £ «* 0, otherwise this operator 
is unity. The equation is recast as
*J(HCCH)
“  A  + B cos 0 + C co s 2 6 + cos 0 
x { [4 f ,(A -J ,)+ 4 f4(A - J 4)] cos (0 -1 2 0 )
+ [4fc(A -  J2) + 4{j(A -  J3)] cos (0 +120)}
By rearranging this expression, A  is isolated as an 
adjustable parameter:
SJ(HCCH) = - 4  cos 6[cos (0 -  120)(f, J , + f4 J4)
+ cos (0 + 120)(f2/ 2+ f j  Jj)]
+ A{1+ 4  cos 0[cos (0 -  120)(f, + f4)
+ cos (0 + 120)(f2+ £j)B
+ B c o s0  + C cos20  (91)
Eqn (8) can be manipulated in a similar fashion to give 
an equation, Eqn (8') (not shown), analogous to Eqn 
(9'). but where <j> replaces 0± 120.
From Eqn (9'), a best-fit value of A  can be deter­
mined. Substitution of this value into Eqn (10) to­
gether with the experimentally determined values of J, 
results in the definition of the AS, values.
E X P E R I M E N T A L
The spectra of the IS monosubstituted ethanes listed 
in Table 1 were recorded on a Broker WP-200 FT- 
NMR spectrometer at 300 K. The instrument was 
configured to give a maximum digital- resolution of 
'  0.031 Hz per point using a 32K block size. The experi­
ment employed quadrature detection with an acquisi­
tion time of 8.2 s and a pulse width of 5 ps. For this 
configuration the 90s pulse was IS fis. The instrument 
was tuned on 1,2-dichlorobenzene prior to running 
any samples. The optimum resolution obtained was 
0.07 Hz based on 1,2-dichlorobenzene.
Table 1. Chemical shuts (ppm) and coo­
pting constants (Hz) for the 
ethyl gronp In moaosafactitBted 
ethanes mtainred at 200 MHz6ub«ctaMM •ICH*J d ICH,) ■JIHCCHI
Ph 1.23 2.63 7.591 1.84 3.19 7.47SEt 1.26 2.65 7.41Cl 1.49 3.66 7.24CN 1.30 2.36 7.61Br 1.67 3.43 7.35OEt 1.20 3.48 7.02NO, 1.68 4.43 7.37
COEt 1.06 243 7.35OAc 1.26 4.12 7.14COOEt 1.14 232 7.601-Methyl ethenyl 1.03 202 740OH 1.22 268 6.87NEt, 1.03 252 7.17tert-Butyl* 0.88 0.92 7.66
* 22-Dimethylbutane was measured at 400 MHz.
Samples of monosubstituted ethanes were used with­
out further purification and were prepared as 5% 
solutions in CDClj with TMS as an internal reference. 
Deuteriochloroform (CDClj) and tetramethylsilane 
(TMS) (Aldrich) were used as received.
Peak positions (relative to TMS) for the ethyl frag­
ment of each respective compound were determined 
from a digital printout. Chemical shifts are given in 
Table 1. All spectra, with the exception of the 
200 MHz spectrum of 2,2-dimethylbutane, reduced to 
nearly first-ordered systems. The considerable second- 
order coupling observed in the 200 MHz spectrum of 
2,2-dimethylbutane necessitated obtaining a spectrum 
at a higher field. All coupling constants were inter­
preted rigorously according to the method of McGar- 
vey and Slomp.
Coupling constants are listed in Table 1. Table 2
Table 2. Substituent constants calcnlated
from Eqn (10) for > n 00 3
GutflftJtlMM UXHlI* as,(H>l iw.
Ph 7.69 232 bCN 7.61 244 bCOCH-CH, 7.32 240 27OEt 7.02 4.60 bOAc 7.14 4.12 bNEt, 7.17 4.00 bI 747 280 bBr 7.35 3.28 bCl 7.24 3.72 bF 6.9 6.1 20H 8.17 0.00 8, 23OH 6.87 5.20- bSEt 7.41 3.04 bSH 7.3 3.5 20OCIOIH 6.9 6.1 20COOH 7.4 3.1 20SiEt, 7.9 1.1 20N*Et, 7.2 29 28COOEt 7.60 2.28 bren-Butylc 7.66 2.44 b1-Methyl ethenyl 7.40 3.10 bIMH 7.2 29 21NO, 7.37 3.20 bCHO 7.4 3.1 29CH,CI 7.4 21 20CH,Br 7.3 3.6 20CH,I 7.2 29 20CH,CN 7.7 1.88 20CIOlEt 7.35 228 bCH-CH, 7.5 268 30U 8.4 -0.92 20HgEt 7.0 4.7 20PEt, 7.6 2.3 20SnEt, 8.2 -0.12 20PbEt, 8.2 -0.12 20OEt,'BF4- 4.7 13.9 310P(0)(0Et)(0C.CI4) 6.9 6.1 32BEt, 6.7 5.9 33BEtj'Na* 7.6 27 33
■Values of (J) were measured or were taken from the references listed. The value of (J) for hydrogen is sat equal to A "This work.* 22-Dimethylbutane was measured at 400 MHz.
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includes a compilation of literature values for several 
other substituents.
The molecular force field program, MMII,34 was 
obtained from the Quantum Chemical Program Ex­
change (No. 395). Default values were used for the 
calculations.
R E S U L T S _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Coupling constants CJct*) used in fitting Eqn (9') are 
listed in Table 3. Fitting was performed by FITFUN
on the PROPHET computer network.35 These com­
pounds are conformationally rigid systems for which 
the torsion angles have been determined by x-ray or 
calculated by molecular mechanics (MMII)34 (see foot­
notes to Table 3). Values of the parameters of Eqn (9') 
determined by the fit are given in Table 4. Fig. 4 
shows the plot of V,*, versus calculated by Eqn 
(9’) using the parameters in Table 4. This figure re­
v e ls  the quality of the fit and illustrates the variety in 
the data set used for the fit.
Using a best value for A  of 8.17 and J, values for
Table 3. The coafonaatioaaDjr rigid molecules aaed la determining tbe constants of Eqns (5), 
(80. (90 and (12)
'Jm* (Hz)
Nam* • n *J». (Hz) Eon (8) Son IB) Eon (SI Hal.t»r>s-Tetrehydropyranol2,3*ir)-1.4-dioxane* 178.4 7.1 9.0 8.6 9.2 36dS-Naphthodioxane* 55.6 88 3.3 82 82 37trans-4-fert-Butytnitrocyclohexane* 60.7 4.03 4.06 4.01 3.70 381784 11.55 1239 1868 182trans-85-Di-tart-butyM3-dioxane* 57.4 4.7 4.9 4.8 4.1 39178.7 12.1 12.3 180 11.7frsni-4-fe/t-ButylcydoheJtanol* 174.5 11.2 11.6 11.6 11.6 4057.1 4.2 6.0 5.0 4.16-endo-Acetyl-2-norbomene* 359.5 73 83 83 8.4 ' 41317.0 3.5 4.0 4.2 53S-endo-Nltro-2-norbomene* 357.3 73 9.1 88 83 415-endo-Chloro-2-nort>omene* 357.9 8.2 88 8.6 8.7 41317.3 3.76 865 878 6.335-endo-Bromo-2-nortx>meno* 357.1 8.2 9.0 88 8.8 41317.8 4.0 83 86 6.46-endo*Phenyl-2-norbomene 352.4 8.9 9.6 9.3 9.0 416-endo-carboxyllc acid-2-norbomane* 358.4 8.5 9.1 83 9.1 41316.0 3.4 3.8 4.0 5.25-e'ndo-£thoxycarbonyl*2-norbomone* 356.9 8.9 9.4 9.3 9,1 41S-endo-Cyano-2-norbornene* 3S9.1 9.2 9.4 9.2 9.1 41endo-7-Oxablcydo|881)hept-5-ene-2- 480 4.6 4.6 4.7 5.4 42carboxyllc add* 357.8 9.3 9.1 8.9 9.1320.5 4.7 4.3 4.5 6.781.2 0.0 0.9 1.0 1.4(•Cocaine* 51.7 3.3 2.7 86 3.7 43,4441.3 6.0 6.5 5.0 5.5196.7 180 180 11.6 10.8319.2 80 7.6 88 6.157.4 1.8 23 2.7 33Melampodinln-A* 72.5 13 1.5 1.4 1.5 45166.7 9.0 83 8.8 9.2Irani nolide* 188.6 11.0 10.7 10.8 11.2 46166.1 11.0 11.3 10.7 11.0
188.1 11.0 10.4 103 11.2182.7 11.0 181 182 11.7301.9 4.5 4.5 4.6 4.0Blotln* 403 4.4 4.9 5.2 5.2 47,48358.7 73 6.2 6.3 7.6330.6 43 4.3 4.6 5.8913 0.2 1.7 1.7 1.4Subcordatolide-C* 37.4 6.8 4.1 4.1 4.0 49189.7 10.0 9.6 10.1 10.8179.6 12.3 10.7 10.6 11.079.1 2.0 1.4 1.4 1.957.6 5.0 5.0 4.9 4.4176.7 180 11.7 11.6 11.7307.1 5.0 4.5 4.5 3.5187.1 14.0 14.3 14.3 14.0306.2 6.0 3.8 3.8 3.4
‘Torsion angles from MMII force field calculations.*4 "Torsion angles from x-ray crystatlographle analysis.
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Table 4. Bart f t  paramrttn for Eqaa (5), (tf), (? )  n d  (12)
Equation hW lN tlf Vahn (Hi)
Urnrmum 
v«h» (Hi)
(6) . A 6*8(53)* 0.0001 7.48b
B -2*7(54) 0.0001 -2 0 3
C 6*1(73) 0 .0001 4.60
a 0.64(26) 0 .0 2 0.74
b -0.42(29) 0.15 -0.17c 0.79(40) 0.06 0.23
d -0*0(42) 0.04 -0.06
a -0.51(39) 0.19 -0.62
<») A 8.13(6) 0 .0001 e
B -201(16) 0 .0001 c
C 6.30(29) 0 .0001 e
(S') A 8.17(6) 0 .0001 e
B -1.96(14) 0 .0001 c
C 6.64(28) 0.0001 e
(12) P, 1226(1*2) 0.0001 1288"
P , -209(20) 0 .0001 -0.81
P , 0 .0 fixed 0 .0
P4 0*5(63) 0.08 0 .6 6
P . -2*4(63) 0 .0001 -2 3 2
P.* 14.6*(46) 0.003 17.9°
* Standard deviation in parenthaae*. "Ret. 10.cThia work. dRef. 60.* Unite are degreea.
the monosubstituted ethanes, AS, values are calculated 
from Eqn (10). These values are listed in Table 2.
The variation of the AS, values defies a consistent 
explanation. Slightly negative values occur for elec­
tropositive groups such as Li, SnEtj and PbEt2. These 
are electron donating relative to hydrogen. The dieth- 
yloxonium ion gives an exceptionally large positive 
AS,, indicative of its strong electron-withdrawing 
capacity. Values of AS, for the halogens decrease in 
the expected order based on electronegativity, i.e. 
F > C l> B r > I .  This trend is reversed when a 
methylene group is inserted: CH2I> C H 2B r> C H 2Cl. 
Notable differences are seen in the values for oxygen 
substituents, which decrease in the order O H >  
0 C ( 0 ) H > 0 E t> 0 A c .  Carbonyl substituents, with 









0 20 4 6 B 10 12 14 16
C»LC.
Figure 4. JJ„,C calculated by Eqn (9) vs V*, for the data in Table 4.
closely related values. There are significant differences 
seen in the values of ethenyl, 1-methylethenyl and 
phenyl substituents. To date, the values of AS, have 
not been totally conelated with any other set of 
substituent constants or properties of the groups.
D I S C U S S I O N
C o m p a r is o n  w i th  p re v io u s  w o rk
Although many relationships have been constructed*'9 
for the purpose of determining torsion angles of 
molecules in solution from 'H  NMR coupling con­
stants, Pachler pioneered the development of a 
generalized form to encompass all torsion angles in 
any HCCH fragment.10 His equation, Eqn (5), is simi­
lar to Eqn (9). This is easily seen when Eqn (5) is 
rewritten as
SJ(HCCH)
= A + B cos 6 + C  cos 2 0 + (AEj + AE4) 
x ( - a  -  b cos 0 -  c cos 20 -  d  sin 0 -  e sin 20)
+ (AE2+ AEj) x ( - a  -  b cos 0 
- c c o s 2 0  + d s in 0  + esin  20)
An equation with a different form has recently been 
proposed by Haasnoot et al.:sn
SJ(HCCH) = P, cosJ 0 + P2 cos 0 + P3
+ t  AE;[P4+ Pt cosa(£,0 + P6 |A E, |)] ( 12)i-i
They also used Huggins electronegativity. The novelty 
of their equation is the P6 variable, which has units of 
degrees, and the operator £. The combination of the (, 
and PA account for the variability in the torsion-angle 
dependence of a substituent's effect.
Other equations have been presented over the past 
two decades, but Eqns (5) and (12) are the best 
evaluated. They have been fitted to large data sets of 
coupling constants and compounds, whereas others 
have relied on a much smaller data base or used data 
obtained from one or two compounds. The question is 
whether Eqn (9) with its set of constants (AS,) and 
only three parameters (A, B  and C) can give as good a 
fit as Eqn (5) with its set of constants (AE,) and eight 
parameters (A, B, C, a, b, c, d  and e) or Eqn (12) with 
its set of constants (AE,) and six parameters (P„ P2, 
P3, P4, Pi and P6).
To evaluate fairly, all the equations have been fitted 
to the data in Table 3. The fitted parameters are given 
in Table 4 and the measures of the goodness of fit are 
presented in Table 5. This allows for unbiased com­
parisons among the equations.
All the equations give statistically significant fits to 
the data. Based on the sum of the squares of the 
residuals and multiple R 3, Eqn (S) is slightly better 
than the others. However, when the degrees of free­
dom (observations-parameters) are considered in cal­
culating such measures, e.g. standard deviation of 
regression and F-value, Eqn (9') emerges as being
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Table 5. "annaij ol ( M U d  u il ja h  of coapdnc constant 
data la Table 3 Itted to Eqaa (5), (80, (90 and (12)
Equation
SS of nakkol a* OWKMeffmadom
- * -* ■ BnnCMfD OVrNDOn
cf CBQn—Ion 8-nhn
(B> 24.2 0992 41 0.768 610
» ) 31.1 0969 46 0923 1412
W) 27.0 0.991 46 0.766 1631(12) 35.9 0968 43 0914 571
more significant. The conclusion is that both Eqns (S) 
and (90 give good fits to the data. Eqn (12) is not as 
good as Eqn (5) or (90-
Examination of the fitted parameters for Eqn (5) 
reveals that parameters a, b, c, d  and e vary considera­
bly in their significance levels. In fact, b and e are 
marginally significant. It is doubtful that all five of the 
parameters are needed.
The philosophical difference between Pachler’s and 
this approach should be pointed out. The approach 
described here is purely empirical whereas Pachler's 
uses a quantity, electronegativity, not derived from the 
NMR experiment. His additional parameters are 
needed to conoct for the fact that not all of the 
substituent effect is embodied in electronegativity. The 
empirical approach, on the other hand, makes no 
attempt to explain the origin of the effect. In fact, the 
sole purpose of the approach is to produce a reliable 
equation for predicting coupling constants as a function 
of torsion angle. The variation in the empirical ap­
proach is the use of a single substituent constant for 
each functional group. In summary, Pachler’s ap­
proach is to use a limited set of constants and fit the 
data with eight adjustable parameters, whereas this 
approach is to use a larger number of constants and fit 
the data with only three adjustable parameters.
There is a clear difference between Eqns (5) [or (7)] 
and (9), which appears in the definition of the torsion- 
angle dependence of 3J(HCCH) expected for the un­
substituted case (ethane). A  plot of curves for ethane 
is given in Fig. 5 for Eqn (5), where AE, = 0, and Eqn 
(9), where AS, = 0, using the parameters in Table 4. In 
addition, there are curves calculated by Eqn (7), where 
AE, = 0, and INDO.8 The curve from Eqn (9) matches
w.
. 12. x £ 10
' /  E0N I5)
/  \ \  E0NI7) m0°
Ftflur* 5. Calculated curves for ethane, ’JIHCCH) as a functionof 8. --, Eqn (9); — — , Eqn (7); Eqn (5); and• • < ■, INDO MO* approximation.
more closely the curve from INDO than does either 
Eqn (5) or (7). Both Eqns (S) and (9) predict 
3-f(HOCH)—2 at 8 = 90, while Eqn (7) predicts a 
value of 3. This is not in accord with either INDO" or 
VB2 calculations or experiments with conformationally 
rigid compounds,42 which suggest a value of zero. The 
predicted 3J(HCCH) value for 8 = 180° is a good 
measure of success. The predictions are as follows: 
INDO, 18 Hz; Eqn (5), 15.6 Hz; Eqn (7), 14.1 Hz; 
and Eqn (9); 16.7 Hz. The reported23 value for ethane 
is approximately 18 Hz. For 8 = 0°, Eqns (5) and (7) 
predict values 2.7 Hz lower than those predicted by 
Eqn (9) and INDO. The conclusion from the above is 
that Eqn (9) is better than Eqns (5) or (7) at predicting 
the coupling constant curve for ethane.
The average coupling constant, </), for freely rotat­
ing ethane is reported8,11-22' 25 to range from 7.8 to
8.4 Hz. Eqn (9) predicts a value of 8.17 Hz and Eqns 
(5) and (7) predict 6.98 and 7.48 Hz, respectively. 
INDO ' predicts 8.37 Hz. The conclusion is that Eqn 
(9) is better than Eqns (5) and (7) at predicting (/> for 
ethane. This conclusion about Eqn (9) is not surpris­
ing. The aims in constructing Eqn (9) were (a) to 
reproduce the curve for ethane and (b) to account for 
substituent effects. As stated above (see Description of 
Equation), the premise is that the torsion-angle de­
pendence of 3J(HCCH) can be described as a perturba­
tion on the unsubstituted system (ethane). The fact 
that Eqn (9) does give a good description for ethane 
attests to its reliability. The fact that it accounts for 
substituent effects equally as well as other equations is 
testimony to its utility.
Caveats
Although Eqn (9) is good for predicting torsion angles 
from coupling constants, the large standard deviation 
(0.77 Hz) encountered is disconcerting. It has been 
thought that the assumption <f> = 0 ±  120 may not be 
valid and the general form, Eqn (8), should be used. 
[The tf> = 8 ±  120 approximation is certainly not a valid 
assumption for small (three- or four-membered) rings. 
For this reason, data for these compounds are ex­
cluded from Table 3]. Comparison of the statistics in 
Table 5 for the fits of Eqns (8) and (9) [as their 
rearranged forms Eqns (8') and (9')] reveals there is no 
difference. In fact, Eqn (9') is slightly better. Both 
equations give similar values for A, B  and C  (see 
Table 4).
Errors in the data arise from assigning torsion ang­
les and measuring coupling constants. One difficulty in 
accurately determining torsion angles can be attri­
buted to inherent problems in locating hydrogens by 
x-ray diffraction. Another difficulty is the difference 
between the actual torsion angle in solution and the 
torsion angle determined by x-ray (solid phase) or 
calculated by MMII (gas phase). The accuracy in de­
termining coupling constants experimentally is limited 
by the resolution and the precision of the instrument.
Errors described above are likely to account for the 
difference between the ethane curves (Fig. 5) pre­
dicted by INDO and by Eqn (9). A more exact de­
scription, by Eqn (9), of the ethane curve would
MAGNETIC RESONANCE IN CHEMISTRY. VOL 23. NO. S. 1985
87
W. J. COLUCCI, S. J. JUNGK AND R. D. GANDOUR
require a very large and accurate data set. Such a data 
set must contain an equal sampling of all 9 angles as 
well as a diversity of substituents, and combinations of 
both. Although it is always possible to increase the 
size of a data set, it is not possible to  meet these latter 
criteria. Since the ethane curve is accessible from 
INDO MO calculations, values of A, B  and C  deter* 
mined by best fit to  the INDO MO curve* could be 
used directly in Eqn (9) (the best fit values are 
A  =  8.37, B  = -2 .8 3 , and C  = 7.44 with R 2= 0.99999). 
This will result in a new set of AS, values. Such a 
combination of theory and experiment may prove 
useful in future applications.
Methods for u s in g  E q n  (9)
Below is an outline of bow Eqn (9) is employed in 
solving for 9 values. Before the torsion angle can be 
computed, the substituents on carbons must be as­
signed a positional number, 1-4. The correct assign­
ment can be made in one of two ways. One way is to 
draw the Newman projection of the ethane fragment 
so that 0 = 60s. The substituents are numbered clock­
wise as shown in Fig. 2. The Newman projection does 
not a priori imply the correct 9, but is merely used as a 
means of assigning substituents. The other way is to 
draw the Newman projection in any conformation. 
The numbering scheme is as follows: the back carbon 
is attached to the odd-numbered substituents, which 
are numbered clockwise; the front carbon is attached 
to the even-numbered substituents, which are also 
numbered clockwise.
Once the substituents have been assigned the cor­
rect numbers, the appropriate substituent constants 
(given in Table 2) are inserted into Eqn (9). A graphi­
cal solution of Eqn (9), for all 9s, is plotted. Normally 
there are four values of 9 which will give the observed 
coupling constant. Of these four solutions, usually one 
will make sense chemically for a rigid molecule.
CONCLUSIONS
Equation (9) offers a method for properly predicting 
the torsion-angle dependence of the vicinal coupling in 
substituted ethanes. Its application to HC—CH frag­
ments in large molecules is straightforward. The mul­
tiplicity of structures used to determine the substituent 
constants should encourage the application of this 
method to  a wide variety of molecules.
The method should improve with time. As the accu­
racy and precision of the measurement of coupling 
constants and of the determination of structures im­
prove, the AS, values will be refined and possibly the 
number of constants will increase. It is hoped that the 
method will be a useful addition to the techniques for 
determining structures in solution.
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Chapter 4. Conformational Analysis of Carnitine and 
Acetylcarnitine in Water by Application of the New Karplus 




The problem of how to determine the conformation of 
flexible molecules in solution has challenged researchers 
for decades and will likely continue to do so. The prob­
lem is even more difficult for flexible molecules that 
are either quite polar or charged, especially if these 
molecules interact with the solvent. The techniques of 
NMR spectroscopy1 and computational chemistry,2 espe­
cially when used in combination,3 have facilitated con­
siderable progress in conformational analysis during the 
past two decades. Even so the task of assigning meaning­
ful numbers to conformations and their populations is 
still in the early stages of development.
In NMR spectroscopy, the Karplus equation4 has 
enabled conformational analysis of simple organic mol­
ecules in solution. Extensions of this equation by 
Pachler® and others6 have permitted broader applications. 
In Chapter 3, a Karplus equation with empirically derived 
substituent constants, eq 1, has been introduced.7 This 
development makes possible an explicit accounting of sol­
vent effects.
Equation 1 shows the dependence of vicinal coupling 
constants, 3 J (.HCCH) on 0, the torsion angle between vici­
nal hydrogens, and ^hx » the torsion angle(s) . between 
hydrogen and substituent(s) Xi.7 The expression is the 
Karplus equation8 adjusted for the effect of substituents
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and -their orientation. For simplicity and ease of calcu­
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Figure 1. Newman projection showing the relation­
ship between 8 and <j> angles.
3J(HCCH) - A + Bcos 8 + Ceos 2 8 + 2  ASiCOS 8cos ^hx (1)
i s 1 i
Substituent constants, A S t ,  have been determined 
from ‘H NMR data. Integration of eq 1 for a monosubsti­
tuted ethane yields an expression, eq 2, that describes 
the average coupling in a freely rotating ethyl group. 
When the value of A is known, eq 2 affords a means of 
rapidly assigning a substituent data set for any compound 
containing HCCH fragments. Because ASi values are defined 
as S*-Sh (substituent x - hydrogen), A is the observed 
coupling in ethane. This equation allows for the genera­
tion of a novel substituent data set based on the
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observed coupling in monosubstituted ethanes. Solvent 
effects on 3J can be accounted for by measuring the 
coupling constant of representative monosubstituted eth­
anes under the same conditions in which 3J is measured in 
the compound of interest.
I
<3J> = A - 0.25 AS* (2)
In this chapter eq 1 has been utilized to determine 
the solution conformation of carnitine and acetylcarni­
tine. Proposed mechanisms of the translocase and trans­
ferase systems have been based on suggested conforma­
tional preferences of carnitine and acetylcarnitine.9-11 
These chemical mechanisms have emphasized widely diffei—  
ing importance on the potential charge interaction 
between quaternary ammonium and carboxylato groups.
Both carnitine and acetylcarnitine can exist as neu­
tral (zwitterion) or protonated (cation) forms, depending 
upon pH. A detailed X-ray study of zwitterion versus 
hydrochloride crystal structures (Chapter 2) has revealed 
a minimal effect of charge state on conformation in the 
solid state.11 Because the crystalline structures may not 
coincide with the solution structures, a detailed study 
of the conformations of carnitine and acetylcarnitine in 
solution has been undertaken. The NMR data fQr carni­
tine have been reported previously by Agostini &t al.,12 
while the data for acetylcarnitine are reported herein.
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This study is significant because it applies to these 
highly charged molecules in water, the new Karplus rela­
tionship in combination with molecular mechanics (MM2). 
The molecular mechanics is modified to handle these 
charged species by utilizing atomic point charges detei—  
mined by ab initio calculations. This combination of 
computational and experimental techniques provides a use­
ful approach for elucidating conformations of charged 
flexible molecules in solution. As such, this study 
should be viewed as the initial report of the application 
of this combined approach toward the long range goal of 
developing a method to determine structures in solution 
quantitatively.
Conformational preferences obtained through molecu­
lar mechanics studies are invaluable for assigning the 
diasteriotopic protons of carnitine and acetylcarnitine. 
The N1-C4-C3-03 torsion angle (Figure 2) assumes a gauche 
conformation in similar compounds such as choline;13 
therefore, the assignment of H4A' and H4£?' is straight­
forward. Because the C1-C2-C3-C4 torsion angle, on the 
other hand, exhibits much greater conformational freedom, 
assignment of H2A and H2S requires either specific label­
ing or knowledge of the conformational preference. These 
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Figure 2. Name conventions for the atoms of carni­
tine and acetylcarnitine.
EXPERIMENTAL
Materials. (/?S)-Acetylcarnitine hydrochloride was pre­
pared from racemic carnitine (Aldrich Chemical Co.) by 
method A of Ziegler, Bruckner, and Binon1* and crystal­
lized by vapor diffusion of acetone into a saturated 
methanolic solution.
The quaternary ammonium iodides were synthesized 
from their alkyl iodides (Aldrich Chemical Co.). Iodoe- 
thane or iodopropane (0.05 mol) was added to a mixture 
containing 60 mL of 20% aqueous trimethylamine (Aldrich 
Chemical Co., 5 mol excess of amine) and 20 mL of tetra- 
hydrofuran (THF). The biphasic reaction mixture was 
stirred vigorously at 50 °C until clear (about 30 min). 
The reaction mixture was then evaporated to dryness at 
reduced pressure and 70 °C.
A/,A/,/V-Triraethylethanaminium iodide was recrystallized
■twice from absolute ethanol (7.73 g, 80%): mp 322 °C
dec. (lit18 mp 320-322 °C dec); *H NMR (ref to TSP-d* in 
D 20) 3.42 (q, 2 H), 3.12 (s, 9 H) » and 1.38 (tt, 3 H).16 
/V,A/,A/-Trimethylpropanaminium iodide was recrystallized 
twice from anhydrous isopropyl alcohol (9.06 g, 77%): mp
192.0-192.5 °C (lit17 mp 188-189 °C); NMR (ref to
TSP-d* in D^O) 3.30 (m, 2 H), 3.13 (s, 9 H). 1.81 (m, 2
H ) , and 0.98 (t, 3 H).18
*H NMR. The 200-MHz spectra were recorded on a Bruker 
WP-200 FT-NMR at 300 K. Extra precision was required of 
the spectra for compounds in the substituent data set to 
yield very accurate coupling constants. The instrument 
was configured to give a maximum digital resolution of 
0.085 Hz/pt using a 32 K block size.
Samples of the mo'nosubstituted ethanes (Table 1) 
were prepared as 5% solutions in deuterium oxide. All 
compounds were obtained from commercial sources and used 
as received, with the exception of the quaternary ammo­
nium salts, which were prepared as previously described. 
The only detectable impurity was the residual water 
(HDO), which posed no problem for spectral interpreta­
tion. The pD of all samples was adjusted to acidic, neu­
tral, or basic conditions with 20% DC1 and 40% NaOD in 
D 20, and was measured with a Beckman Model 4500 digital 
pH meter equipped with an Ingold Model 6030-0 .NMR tube 
electrode. Solution pD was calculated as meter reading + 
0.4 units.19
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Table 1. Chemical Shifts (ppm). Coupling Constants (Hz) 
and Substituent Constants (Hz) for the Ethyl Group 
in Selected Monosubstituted Ethanes Measured at 200 
MHz.
substituent pD S(-CH*)“ S(-CHs-)* 3JiHCCH) ASb
-C00H 2.76 1 .09 2.39 7.59 3. 12
6.44 1 .06 2. 19 7.71 2.64
10.05 1.05 2. 18 7.66 2.84
-OAc 1 .34 1 .24 4. 13 7. 13 4.96
7.55 1 .26 4. 15 7. 18 4.76
10.80 1 .26 4. 15 7. 18 4.76
-OH 2.53 1 . 16 3.64 7. 10 5.08
7.40 1 . 17 3.64 7.08 5. 16
9.66 1 . 18 3.65 7. 10 5.08
-N+Me3 2.41 1 .36 3.39 7.33 4. 16
7.03 1 .38 3.42 7.30 4.28
10.58 1 .38 3.43 7.34 4. 12
-CH2N+Me3 3. 19 0.96 1 .79 7.34 4. 12
6.62 0.98 1 .81 7.36 4.04
10. 16 0.98 1 .81 7.33 4. 16
-CHzC00H 2.75 0.92 1 .60 7.44 3.72
6.41 0.90 1.56 7.49 3.52
10.34 0.90 1 .56 7.56 3.24
* Chemical shifts are referenced to internal standard 
sodium 3-trimethylsilylpropionate-dA (TSP-c/4). 
b Calculated for A=8.37.
Peak positions (relative to TSP-d4) for the ethyl 
fragment of each compound were determined from a digital 
printout. All spectra reduced to nearly first-order sys­
tems when measured at 200 MHz (ref Table 1 for chemical 
shifts and coupling constants). Coupling constants were 
interpreted rigorously according to the method of McGai—  
vey and Slomp.20
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Samples for NMR of acetylcarnitine hydrochloride 
were prepared by dissolving 40 mg in 0.5 mL of D 20 and 
adjusting the pD as described above. The spectra were 
recorded at both acidic and neutral pD, the former to 
form cation, and the latter, zwitterion. (The p/Cfl's of 
carnitine and acetylcarnitine are 3.80 and 3.60, respec­
tively. )2 1
The 200-MHz spectra of acetylcarnitine were measured 
at digital resolutions of 0.085 and 0.092 Hz/pt using a 
32 K block size. Peak positions (relative to tort-hutyl 
alcohol, S = 1.28 ppm) were determined from a digital
printout.
Spectral simulations. Chemical shifts and coupling con­
stants for acetylcarnitine were calculated by best fit to 
peak positions. These spectral simulations were performed 
on a Bruker ASPECT. 2000 computer using the Bruker PANIC 
(1981) program, a minicomputer version of the LA0C00N- 
type program22 used in larger computers. The root-mean- 
square errors for the fits were 0.034 and 0.041 for 
acetylcarnitine measured at pD 2.13 and 6.49, respec­
tively .
COMPUTATIONAL METHODS
Molecular mechanics. The molecular mechanics program
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(MM2)2a was obtained from Quantum Chemical Program 
Exchange (#395). The program was modified to include a 
dielectric constant in the calculation of charge interac­
tion energies according to eq 3, the classic Coulombic- 
type potential function used in similar applications.2A
He = k qi qj / e rij (3)
The variables qi and qj are the point charges cen­
tered on atoms i and j, e is the effective dielectric 
Constant, and rt j is the distance between atoms i and j. 
The program only computes interactions between atoms 1,4 
and greater''. In general, 1,2 and 1,3 interactions are 
not included in the electrostatic energy calculation 
because electrostatic effects are already included 
(implicitly) in the stretching and bending potentials. A 
range of dielectric constants has been evaluated, but 
only the results at the dielectric constant of water at 
25 °C, 6 = 78.3, are presented in detail.
The use of an electrostatic function was preferred 
over a dipole interaction energy. Dipole values were not 
available for many bond types found in carnitine, whereas 
point electronic charges could be determined from ab ini­
tio calculations as described below.
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The MM2 force field was further modified to include 
a Morse potential (eq 4) in place of the cubic function 
Ceq 5) used to describe bond-stretch energies. The Morse 
potential is proposed by Allinger as an alternative to 
the cubic function.2
E b =(1/2) ks [1-exp(-a a R)]2 (4)
E« =(1/2) kB U R 2 + C. a R 3] (5)
In eq 4 and 5, AR is the difference in the observed 
bond length from its equilibrium value. The stretching 
force constant, ks, has the same value in both equations. 
The exponential constant, a , is 1.00; from this a value 
of -2.00 is obtained for C8, the cubic stretch constant.
Development of force field parameters. Parameters for the 
quaternary ammonium and carboxylato groups (shown in 
Table 2) were chosen principally to reproduce distances 
and angles of the carnitine and acetylcarnitine crystal 
structures. Default values were used for all other 
parameters not cited in Table 2. The quaternary nitrogen 
stretching, bending, and torsion angle parameters were 
obtained from an analysis done on the crystal structures 
of several quaternary ammonium salts.28 The
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0 b p 3“C s p 3-Cb p 3-NBp 3 torsion angle function was similar to 
related systems such as 0 b p 3-Cb p 3“C b p 3“0b p 3 and 
N s p 3“C b p 3-C«p 3-Ns p 3• These systems show a minimum energy 
at approximately 60°, representing a considerable gauche 
effect, and a shallow minimum at 180°. The depth of the 
minimum well at 60° was adjusted to -0.60 kcal/mol, while 
the 0° barrier was set to 0.60 kcal/mol. Other values 
ranging from -1.0 to . -0.5 and 0.4 to 0.8 kcal/mol, 
respectively, were investigated empirically, but these 
values most closely reproduced torsion angles found in
Table 2. Force Constants Used in the Molecular Mechanics 
Calculations of Carnitine and Acetylcarnitine.
stretching 10 (A) kB (mdyn/A)
C « p 3- N + b p 3 1 .48 5.10
Csp2-0 s- 1 .24 7.90
bending 8 0 (deg) kb (mdyn A/rad2)
C b p 3-N+b p 3-Cb p 3 107.7 0.630
C b p 3- C b P 2-0 S- 1 17.9 0.500
S- 0-Cap2-0 S" 124.2 0.800
torsion Vi(kcal/mol/deg) V 2 V3
0 s p 3“ C b p 3- C b p 3- N + b p 3 -0.533 -0.267 1.133
C s p 3- C b p 3- N * b P 3- C 9 P 3 -0.200 0.450 0.800
H-Csp3-C8p2-0 S“ -0.167 0.000 -0.100
C s p 3-Cb P3-Cb p 2-0 S- -0.300 1.210 -0.350
van der Waals r* (A) e (kcal/mol)
o 1 .74 0.050
4 0 S' is the oxygen atom of the resonant carboxylate.
the carnitine and acetylcarnitine crystal structures.
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The parameters of the symmetrical carboxylate were
also fitted to reproduce geometrical features of the
crystal structures. The van der Waals parameter for O S -
was the same as 0Bp3, while the torsion angle parameters
H-CBp3-CBpz-0 S" and CBp3-CBp3-CBpz-0 S- were the same as
their counterpart H-CBp3-CBp2=0Sp2 and CBP3-CBp3“
*
CBpz=0Bp2 default values in the MM2 program.
Calculation of atomic point charges. All charges were 
determined from calculations employing the GAUSSIAN 80 
series of programs.26 Charges were obtained directly from 
the Mulliken population analysis.27 Charges determined in 
this manner are subject to several uncertainties,28 
including an interdependence of charge and conformation, 
and a strong dependence upon the*basis function.29
For carnitine and acetylcarnitine initial MO coeffi­
cients were determined at the ST0-3G level.30 These were 
subsequently used as an initial guess for calculations 
employing the split valence 3-21G basis set.3\ Because 
calculating the charges for all conformational states of 
carnitine and acetylcarnitine was impractical, single 
point calculations were performed only on coordinates 
determined from crystal structures.11 However, all hydro­
gen positions were calculated because hydrogen atoms were 
poorly located by X-ray. The solid-state geometries coi—  
respond to the most stable conformations determined by 
molecular mechanics.
1 0 2
Calculations employing equation 1. In general the 
observed coupling between vicinal protons can be 
described as a sum of populated states, eq 6, where Pi is 
the population of conformation i , and aJ(.Bt) is the
<aJ> = 2 Pi aJ(8i) (6)
angular dependence of aJ(HCCH) from eq 1. The number of 
known coupling constants for a particular system explic­
itly limits the number of calculable unknowns: 0's and
P's. For example, in an AB system only a single aJ is 
attainable, however as many as 3 conformations may exist. 
Because the sum of all populations is constrained to 
equal unity, a single population is eliminated leaving a 
maximum of 5 unknowns. Clearly, unless the molecule is 
biased toward a single conformation, a maximum of 4 
unknowns will have to be defined by other means.
In an ABX system (as in carnitine and acetylcarni­
tine) 2 coupling constants are attainable, and calcula­
tion of unknowns proceeds by simultaneous solution of eq 
6 for both HA and HB. The torsion angles 0 i are best 
defined as a function of a common heavy atom angle (e.g., 
N1-C4-C3-03 in carnitine). A graphical representation is 
often helpful for locating probable solutions. Figure 3 
shows the dependence of aJAX in carnitine on the
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N1-C4-C3-03, 8, torsion. Hypothetical 3J ( . 8 values can 
be interpolated for fixed conformations of 8 as shown. 
Due to the sinusoidal nature of curves such as Figure 3; 
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Figure 3. Graphical representation of equation 1 
for carnitine.
make chemical sense need be considered.
In the course of this study we developed several 
computer programs to handle the calculation of angles and 
populations in systems such as those discussed above. 
These programs are documented in Appendix 2.
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RESULTS
Atomic point charges. The charges obtained by ab initio
calculations (shown in Table 3) differ from charges
determined for similar systems by the methods of Del Re32
*or Huheey,33 which are based on the concept of group and 
orbital electronegativity.34 For choline, Huheey*s method 
results in a +0.286 electron charge on the quaternary 
nitrogen and +0.073 for the methyl hydrogens,24 whereas, 
for carnitine, 3-21G gives values of -0.801 and ~ +0.275 
respectively (Table 3). Thus the ab initio calculation 
predicts more dispersed positive charges onto surrounding 
hydrogens (i.e., increased electron density on the more 
electronegative nitrogen atom).
The MM2 calculations. Results from the MM2 calculations, 
for 6 = 78.3, are. shown in Table 4. Although the pre­
sented data correspond only to calculations at the die­
lectric constant of water, in the event that this dielec­
tric was arbitrarily high for some atom combinations 
having small Tt j values, the dependence of populations on 
dielectric constant was investigated. As Figure 4 demon­
strates, 6 will have only small effects on populations 
down to a value of about 6=40 at which point electrostat­
ics become a dominant factor in determining the energy of 
the zwitterions.
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Table 3. Atomic Point Charges Determined by 3-21G 
Calculations.8
electron charges
Atom Nameb carnitine acetylcarnitine
cation zwitterion cation zwitterion
C1 0.91 0.84 0.89 0.86
C2 -0.54 -0.52 -0.56 ' -0.56
C3 0.05 0.05 0.05 0.04
C4 -0.17 -0.20 -0.18 -0. 19
C5 -0.39 -0.38 -0.39 -0.40
C6 -0.40 -0.38 -0.40 -0.39
C7 -0.39 -0.39 -0.38 -0.37
C8 - - 0.86 0.85
C9 - - -0.67 -0.66
01 = -0.61 -0.73 -0.69 -0.75
02= -0.72 -0.80 -0.63 -0.80
03 -0.68 -0.66 -0.72 -0.73
• 04 - - -0.59 -0.61
N 1 -0.80 -0.79 -0.78 -0.78
HI 0.44 - 0.43 -
H2 A 0.30 0.22 0.34 0.25
H2 B 0.26 0.20 0.29 0.22
H3 0.26 0.24 0.28 0.30
H4A 0.27 • 0.26 0.29 0.32
H4S 0.29 0.28 0.30 0.26
H5A 0.27 0.27 0.29 0.32
H5B 0.27 0.28 0.28 0.28
H5C 0.28 . 0.26 0.27 0.24
H6A 0.27 0.25 0.28 0.28
H6B 0.28 0.27 0.27 0.26
H6C 0.28 0.27 0.28 0.25
H7 A 0.27 0.24 0.27 0.28
H7 B 0.29 0.29 0.28 0.26
E7C 0.28 0.26 0.27 0.24
H8 0.42 0.38 - —
H9 A - — 0.28 0.25
H9 B - - 0.25 0.25
H9 C — — 0.25 0.24
a Single point calculations from crystal structure 
coordinates; 3-21G//’crystal. 
b Atoms are named according to Figure 2. 
c The charges on 01 and 02 of the zwitterions were 
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Figure 4. Sensitivity of populations calculated by 
MM2 to changes in dielectric constant: (a) acetyl­
carnitine cation, Cb) acetylcarnitine zwitterion, 
(c) carnitine cation, (d) carnitine zwitterion 
( g-,g- conformer, O; a ,g- conformer, □; 
g+,g- conformer, •).
Interpretation of the acetylcarnitine spectra. Absorp­
tions for the protons of the C2 and C4 methylenes of 
acetylcarnitine consisted of distinct eight-line patterns 
indicative of simple ABX systems (Figure 5). Chemical 
shifts, shown in Table 5, for the diasteriotopic H4A' and 
H4B' protons were assigned so that the coupling constants
Table 4. Summary of Carnitine and Acetylcarnitine Conformers: Energies and 












acetylcarnitine 9~ >9~ -70.5 -78.8 0.000 0.000 0.53zwitterion a ,g~ -176.4 -72.8 0.387 0.279 0.28
9+ >9~ 62.2 -78.0 0.687 0.235 0. 17
a ,a -174.3 -148.2 2.097 — 0.02
a ,g+ -164:6 67.3 3. 195 — <0.01
acetylcarnitine 9~ >9~ -71 .2 -79.0 0.000 0.000 0.44cation a ,g~ -176.2 -73.4 0. 191 0. 134 0.32
9+ >9~ 63.2 -78.3 0.417 Cf. 104 0.22
a ,a -175.2 -146.4 1 .986 — 0.02
a ,g+ -163.2 68.0 3.010 — <0.01
carnitine a ,g~ -173.3 -68.7 0.000 0. 104 0.47
zwitterion 9~ >9~ -70.5 -74.4 0.087 0.000 0.40
9* >9~ 64.6 -68.2 0.831 0. 190 0. 12
a ,a -173.4 ->146.5 2.432 - 0.01
3 ,9+ -161.3 66.8 3.062 — <0.01
carnitine a ,g~ -173.3 -68.7 0.000 0.034 0.48
cation 9~ >9~ -70.7 -72.6 0. 182 0.000 0.35
9* >9~ 65.2 -6'8.6 0.659 0.088 0. 16
a ,a -174.1 -144.8 2.426 - 0.01
a ,g+ -161.3 67.3 3.025 — <0.01
a Energies (kcal/mole) were determined from,molecular mechanics calculations 
at dielectric 78.3. 
b Populations are from a Boltzmann distribution of the energies calculated.
(shown in Table 6), when manipulated by eq 1, agreed with 
a strong g- conformational preference about the 
N1-C4-C3-03 torsion angle. This assumption was in accoi—  
dance with the observed conformational preference of sim­
ilar systems such as choline and acetylcholine35 and was 
further supported by both X-ray crystal data (Chapter 2) 
and the MM2 calculations (Table 4).
Chemical shifts (Table 5) for the diasteriotopic H2.4 
and H2B  protons were assigned in a similar fashion. 
Because both the X-ray data and MM2 calculations (Table 
4) suggested a preference for the g- conformation about 
C1-C2-C3-C4, H2A and H2B were assigned so that popula­
tions calculated from coupling constants gave a prefer—  
ence for the g- conformation.
Carnitine spectral parameters. Agostini et al.lz measured 
the 240-MHz spectra of carnitine in D20 (data in Tables 5 
and 6). The spectrum at pD 2.30 was used for the cation, 
while the spectrum at pD 5.02 was used for the zwittei—  
ion. The latter pD, high enough to maintain the zwittei—  
ion, was selected because the spectrum under these condi­
tions gave the best resolution of the nearly coincidental 
H2A and H2S protons, and therefore the most reliable 
coupling constants. The 200-MHz *H NMR spectra of carni­
tine in D20 (Figure 6) was determined and agreed well 
with the 240-MHz spectra, except that at near neutral pD 
the C2 protons were not resolved by the lower field.
Table 5. *H NMR Chemical Shifts (ppm) for Carnitine and Acetylcarnitine Measured 
in Deuterium Oxide.
-CH* C00H -CH* N+ -C(0R)Hx -N(CH3)3 C(0)CH3
pD SH2 A SH2B SH4 A' 5H4B' SH3X S(CH3) S(CH3)
acetylcarnitine
zwitterion
6.49 2.67 2.55 3.65 3.89 5.63 3.24 2.18
acetylcarnitine
cation
2. 13 2.91 2.88 3.73 3.96 5.68 3.25 2.20
carnitine
zwitterion a
5.02 2.47 2.42 3.42 3.44 4.57 3.22
carnitine 
cation a
2.30 2.63 2.68 3.47 3.50 4.68 3.23






Figure 5. 1H NMR spectrum of acetylcarnitine determined at 200 MHz in D 20; pD = 2.13.
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Table 6. XH NMR Coupling Constants (Hz) for Carnitine and 
Acetylcarnitine Measured in Deuterium Oxide.
-1CH2C00H ■CH2N+
pD ZJ AB 3JAX 3JBX ZJ A' B' aJ A ' X 3JB' X
acetylcarnitine
zwitterion
6.49 15.46 5.64 7.68 14.45 1. 13 .8.89
acetylcarnitine
cation
2. 13 16.92 5.35 7.23 14.56 1 . 17 8.84
carnitine
zwitterion *
5.02 15.65 7.26 6.04 14.22 1 .92 9. 13
carnitine 
cation a
2.30 16.25 7.82 5.08 14. 10 1 .87 9.83
• The data on carnitine were taken from reference 12, 
measured at 240 MHz.
The parameters of Agostini et al. were used as 
interpreted, except for the spectrum at pD 5.02, where 
the assignments of H2A and H2B were reversed. Whereas 
they assigned H2B (H2A in their diagram) to the downfield 
signal, we assumed that these chemical shifts had crossed 
over at pD 4.03 where they coincided.
With their assignment, Agostini at al. found the g- 
conformer as the most stable for the C1-C2-C3-C4 torsion 
angle of the zwitterion. Using the alternative assign­
ment gives the anti conformer as the most stable. Both 
the crystal structure of the zwitterion11 and the MM2 
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Figure 6. *H NMR spectrum of carnitine determined 
at 200 MHz in D z0; pD = 2.30.
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Another reason for rejecting the previous assign­
ments for the chemical shifts of H2A and H2B in carnitine 
is the change in population that occurs upon ionization 
(see below). Because the molecule is charged and con­
tains an ionizable group (carboxyl), the solution confoi—  
mation is pH dependent. Using the assignments of Agos­
tini et al. leads to a 20% increase in g- conformer upon 
ionization, while the reverse assignment leads to a 9% 
increase, a value consistent with the MM2 result.
Substituent constants. The 200-MHz data and substituent 
constants for the six monosubstituted ethanes, comprising 
the relevant substituents of carnitine and acetylcarni­
tine, are shown in Table 1. These AS values are calcu­
lated from eq 2 for A = 8.37, a value determined by INDO 
calculations.36 The substituent constants differ from 
those reported in Chapter 3, largely as a consequence of 
the value chosen for A.
Table 1 shows that in some cases the substituent con­
stants are solvent dependent. Especially noteworthy are 
the differences in 3J(.HCCH) for propionic acid .and etha­
nol measured in Dz0 versus CDC13. The values in CDC13 are 
7.4 Hz for propionic acid and 7.01 Hz+ for ethanol.7 Also 
significant are the pH effects seen for the ionizable 
substituents -C00H and -CHzC00H. Fortunately, in the cal-
+The 3J coupling for ethanol in CDC13 was redetermined.
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culation of conformations and populations, these solvent 
effects are included when eq 1 and 2 are used together.
Calculation of conformations. For eq 1, the values: A =
8.37, B = -2.83, and C = 7.44, determined from INDO cal­
culations,36 are used. These values differ slightly from 
those determined by a best fit to conformationally rigid 
compounds:7 A = 8.17, B = -1.96, and C = 6.30. The
errors associated with attempting to fit values for the 
parameters A, B and C using data from rigid compounds 
are discussed in Chapter 3. Using these fitted parame­
ters in eq 1 does not give a 3J value small enough to fit 
3JA'X. This points out the sensitivity of eq 1 to these 
parameters.
In the interest of comparison with previous methods, 
the results from calculations employing the equations of 
Pachler® (eq 7) and Haasnoot et al.6 (eq 8) have been 
included. The parameters employed for these equations 
are those reported by the respective authors. Results 
are given in Tables 7 and 8.
C1-C2-C3-C4 torsion angle. As the MM2 calculations indi­
cate, the C1-C2-C3-C4 torsion angles of both carnitine 
and acetylcarnitine can be treated as freely rotating 
systems involving three possible minimum energy staggered 
conformations O  ~ 60, 180, or -60°). In this case the 
observed coupling for either H2A or H2B  with H3X can be
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3J (H c c m =7.48-2.O3cos0+4.6Ocos20+(aE x +aE4M  -0.74+0.17X 
cos8—0.23cos20+O.O6sin0+O.62sin20)+(aE2+aE3)X 
(-0.74+0.17cos0-O.23cos20-O.O6sin0-O.62sin20) (7)
a J (H C C m  = 13.22cos 20-O.99cos0+2aEi{0.87-2.46Xl = i
cos2(  ̂i0+19.91a E i|)? (8)
described as a sum of populated states, according to eq 
6. For rotation about C2-C3 there are three possible 
conformations and therefore three corresponding popula­
tions. However, because the sum of all populations must 
be unity, (2Pt=1), any one population may be expressed as 
a function of the other two; one is left with five 
unknowns: three 0's and two populations. The unknowns are 
matched by only two observed coupling constants: 3JAX and 
3JBX. As a result the three torsion angles, 8 if must be 
estimated and only solutions for populations are possi­
ble.
Estimates for the three torsion angles were taken 
from the MM2 calculations. The three lowest energy popu­
lated states occurred for the three staggered conforma­
tions as anticipated. These torsion angles were assumed 
accurate to within ± 5°, and thus populations were calcu­
lated for all permutations of 0i , 0 2 and 0 3 within this
10° range.
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Mean values and standard deviations for the 
populations calculated in this manner are shown in Table
7, while the conformers are illustrated in Figure 7. 
Within acceptable error, no significant differences are 
noted among the three equations employed.
The N1-C4-C3-03 torsion angle. In contrast to the signif­
icant population of each of the three conformers about 
C2-C3, only one conformer, g-, about the C3-C4 bond of 
both carnitine and acetylcarnitine was substantially pop­
ulated. MM2 calculations predicted that greater than 98% 
of the population was in this conformer. Thus the 
N1-C4-C3-03 torsion angle could be treated as a two-con­
formation problem. Because the, population was so skewed 
toward one conformer and despite the fact that there were 
more variables (0t , 0 2 and Pi) than observed coupling
constants i3JA'X and 3J B ’X ) , the mathematics approxi­
mated a single-conformation problem and unique solutions 
for 6 i and Pi were possible in theory. While in prac­
tice a unique solution for 0 i was possible, 02 could not 
be precisely determined. Small variations (0.1°) in 0i , 
which were within acceptable error, resulted in large 
variation in 02 .
Solutions for the N1-C4-C3-03 torsion angle and cal­
culated values of the minor conformer are shown in Table
8. Equations 7 and 8 predict larger populations 
of g- than does eq 1 and in the case of acetylcarnitine
Table 7. Populations of the C1-C2-C3-C4 Torsion Angle Calculated
from *H NMR Coupling Constants.
C1-C2-C3-C4 populations
conformer® torsionb eq 1 eq 7 eq 8
acetylcarnitine a — 176.4±5.0 0.36C1>« 0.33(2) 0.35(2)
zwitterion 9~ —70.5±5.0 0.55(2) 0.57(2) 0.59(2)
9+ 62.2±5.0 0.09(3) 0.10(3) 0.06(4)
acetylcarnitine a — 176.2±5.0 0.35(1) 0.31(1) 0.33(2)
cation 9~ -71.2±5.0 0.54(2) 0.51(2) 0.52(2)
9+ 63.2±5.0 0.11(3) 0.18(3) 0.15(4)
carnitine a — 173.3±5.0 0.53(1) 0.53(1) 0.55(2)
zwitterion 9~ —70.5±5.0 0.42(2) 0.40(2) 0.45(3)
9* 64.6±5.0 0.05(3) 0.07(3) 0.00(5)
carnitine a — 173.3±5.0 0.60(2) 0.60(1) 0.62(2)
cation 9 ' —70.7±5.0 0.33(2) 0.29(2) 0.34(3)
9+ 65.2±5.0 0.07(3) 0.11(3) 0.04(5)
® Conformers are depicted in Figure 7.
b The C1-C2-C3-C4 torsion angles were estimated from the MM2 
calculations. 
c Standard deviations are shown in parentheses.
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Figure 7. Rotational conformers of carnitine and 
acetylcarnitine.
both produced non-real solutions (Pi >1 or <0). But in 
all fairness to these methods, a 5% error may be expected 
and thus these values may be taken to mean 100% 
g- conformer.
Comparison between computational and *H NMR methods. Is
it valid to compare molecular mechanics and the lH NMR 
results since the former are used to produce the latter? 
The lH NMR assignment of the protons on C2 and C4 has 
been made so that the most populated conformation in 
water is the lowest energy conformation calculated by MM2 
(as well as the conformation seen in X-ray crystal struc-
DISCUSSlON
Table 8. Populations of the N1-C3-C4-03 Torsion Calculated from
*H NMR Coupling Constants.
conformer
N1-C4-C3-03 torsions populations
eq 1 eq 7 eq 8 eq 1 eq 7 eq 8
acetylcarnitine 9~ -83 -87 -81 0.98 (1.05)b (1.03)zwitterion a [— 142]a [-151] [-140] 0.02 (-0.05) (-0.03)
acetylcarnitine 9~ -83 -87 -81 0.98 (1.04) (1.02)cation a [-146] [-153] [-140] 0.02 (-0.04) (-0.02)
carnitine 9~ -77 -80 -75 0.91 0.95 0.95zwitterion a [-154] [-154] [-162] 0.09 0.05 0.05
carnitine 9~ -74 -76 -71 0.93 0.98 0.98cation a [-147] [-168] [-166] 0.07 0.02 0.02
a Because of large uncertainties, angles in brackets are approximate 
values only.
b Populations <0 and >1 are not real but represent mathematical 
solutions, which are presented for completeness.
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tures). However, -the relative energies as calculated by 
MM2 in no way bias the relative populations as determined 
by NMR. As discussed above, the assignments at C2 and 
especially C4 are additionally supported by experimental 
evidence.
The results obtained from MM2 and lH NMR methods are 
in close agreement for structures and their populations. 
Both methods predict minimum energy conformers that coi—  
respond to the X-ray structures: g-,g- for acetylcarni­
tine and a,g- for carnitine. These conformations have 
been described previously as folded and extended forms, 
respectively.9 * 10
Both MM2 and XH NMR methods indicate a significant 
gauche effect11 about the N1-C4-C3-03 torsion angle. MM2 
calculations predict greater than 98% com­
bined g- conformers for both carnitine and acetylcarni­
tine. Equation 1 gives virtually the same result for 
acetylcarnitine regardless of the solution pD. In con­
trast, the populations of g- conformer determined for 
carnitine by use of eq 1 are slightly pD dependent and 
are lower than those found by use of MM2 or eq 7 and 8.
The slight discrepancy between MM2 and eq 1 may be 
due to specific solvation effects, that is, the hydroxy 
group of carnitine may be more heavily hydrated than the 
acetoxy group of acetylcarnitine). This increased hydra­
tion could reduce the gauche effect between quaternary
121
ammonium and hydroxy portions o£ the molecule. A spe­
cific hydration of hydroxy is not included in the MM2 
calculations, because the solvent effect is approximated 
only by a dielectric term.
The greater population of g- conformers in acetyl­
carnitine than in carnitine, also observed in acetylcho­
line and choline,38 may be due to an increased gauche 
effect. As the ab initio calculations suggest, 03 of
acetylcarnitine carries a larger negative charge than 
that of carnitine (-0.72 vs. -0.68 and -0.73 vs. -0.66 
for cations and zwitterions, respectively, Table 3). 
Because the increased charge makes the C3-03 bond more 
polar, the gauche effect should be enhanced.
As Table 9 shows, the ‘H NMR and MM2 methods predict 
similar values for the N1-C4-C3-03 torsion angle of 
acetylcarnitine, but different values for carnitine.
*H NMR predicts the largest value, followed by MM2 and 
then X-ray. Because only the *H NMR method can fully 
account for the effect of specific hydration, it may be 
that the N1-C4-C3-03 torsion angle opens in. solution 
because of the greater effective size of carnitine’s hy­
drated hydroxy. On the other hand, the small angle
(-61.5°) observed in the zwitterionic crystal of carni­
tine may be due to crystal packing.
1 2 2
Table 9. Comparison of Selected Torision Angles for Minimum 
Energy Conformations of Acetylcarnitine and Carnitine 
Determined by X-ray, Molecular Mechanics and *H NMR.
torsion angle
acetylcarnitine CI-C2-C3-C4 NJ-C4-C3-03 C2-C3-03-C8
crystal, zwitterion® 
monohydrate
-74.3 -83. 1 -91.8
crystal, cation 
hydrochloride
-71 .4 -88.0 -78.8
crystal, cation 
hydrochloride•H20







*H NMR, eq 1 
cation
- , -83 —




crystal, zwitterion- -171.6 -61.5 -
crystal, cation 
hydrochloride







*H NMR, eq 1 
cation
- -74 —
*H NMR, eq 1 
zwitterion
— -77 —
* A complete summary of crystal data on carnitine and 
acetylcarnitine can be found in Chapter 2.
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Contribution of electrostatics to conformational prefei—  
ence. How large a contribution charge stabilization 
(between carboxylate and quaternary ammonium ion) makes 
to conformational preference in both carnitine and 
acetylcarnitine has been a subject of controversy.9"11 
Electrostatic stabilization increases with decrease in 
distance between these groups and thus would favor 
the g-.g- (folded) conformation where the approximate 
C1...N+ distance is 4.3 A compared to 5.1 A in 
the a,g- (.extended') conformation. A comparison of crystal 
structures (Chapter 2) shows no shortening in C1...N+ 
distances nor change in conformation in going from cation 
to zwitterion; hence electrostatic stabilization is neg­
ligible in this state.
Is this also true in solution? Both eq 1 (Tables 7 
and 8) and MM2 (Table 4) reveal a moderate increase in 
population of the g-,g- (folded) conformer upon tran­
sition from cation to zwitterion in carnitine. A similar 
result is seen for acetylcarnitine by MM2, while eq 1 
suggests a somewhat diminished effect. The MM2 results 
show that electrostatic energy accounts for enhancement 
of the folded conformer. Increase in attraction between 
carboxylato and quaternary ammonium groups occurs for 
both carnitine and acetylcarnitine. The enhancement for 
acetylcarnitine compared to carnitine arises from relief 
of both electrostatic and steric repulsion between cai—  
boxylato and acetoxy groups.
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In contrast to the results of Agostini et al. , in no 
case is the stabilization due to electrostatics large 
enough to cause the g-,g- (folded) conformer of carnitine 
to be more stable than the a,g- (extended) conformer, 
which dominates regardless of charge state. However, the 
population of folded conformer at physiological pH is 
significant when one considers which conformation is 
important for binding to a protein receptor site.
Solution conformation: Implications for mode of binding
to enzyme. Both carnitine and acetylcarnitine show a 
large conformational bias for g- conformations about the 
N1-C4-C3-03 torsion angle in solution. Hence binding of 
carnitine or acetylcarnitine to CAT should occur with the 
N1-C4-C3-03 torsion angle in this highly preferred g- 
conformation.
In contrast, the C1-C2-C3-C4 torsion angle of both 
carnitine and acetylcarnitine has substantial rotational 
freedom and a strong preference for both g- and a con­
formations. For carnitine the a conformation dominates 
in both cation and zwitterion, whereas in acetylcarnitine 
the g- conformer is most prevalent.
What can be inferred about the conformation of bound 
substrate from the solution conformation? In the zwit­
terion, which exists at physiological pH,
the g-,g- (folded) conformer is 38% of carnitine's popu­
lation and 54% of acetylcarnitine's , while the a ,g-
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(extended) conformer is 48% of carnitine's and 35% 
acetylcarnitine's.t It was suggested previously11 that 
the folded conformer is the more favorable for binding 
of either carnitine or acetylcarnitine to the enzyme 
(Chapter 2). Moreover, this conformer is also favored 
when stabilization of the enzyme-bound transition struc­
ture is considered,11 because the a,g- mode of binding 
would increase steric crowding about the acetoxy and con­
sequently the energetics for reaction. This effect is 
illustrated in Figure 8, which shows a proposed enzyme 
bound transition structure for transferring an acetyl 
group between carnitine and Coenzyme A or, alternatively, 
a sulfhydryl group on the enzyme.
CONCLUSION AND CAVEATS
A Karplus relationship, eq 1, has been presented 
that accounts for solvent effects on 3J by employing 
empirically derived substituent constants. Together with 
MM2 calculations (with atomic charges determined from MO 
calculations) and lH NMR 3J coupling data, this equation
+For lH NMR, using eq 1, the determination of the popula­
tion of the C1-C2-C3-C4 torsion angle is independent of 
the N1-C4-C3-03 torsion angle, which is nearly fixed in 
a g- conformation. To calculate the approximate popula­
tion of folded and extended conformers, the populations 
about the two torsion angles are multiplied.
1 2 6
Figure 8. Proposed tetrahedral intermediate formed 
by acetyl transfer between 0 and S. Attachment of 
S is proposed to occur on the re face of the ace- 
toxy. Molecule is proposed to bind in
the folded conformation.
has been used to investigate the solution conformation 
and population of conformers of carnitine and acetylcai—  
nitine. Although the results are presented numerically, 
they should only be viewed as semiquantitative. In fact, 
these results are highly dependent on the parameters cho­
sen for eq 1 as well as for the force field in MM2, espe­
cially those involving the charged atoms.
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The inclusion of solvent effects on the intrinsic 
vicinal coupling constant is important. However, there 
are limitations with the present approach of using ethyl 
compounds. Solvation of the ethyl compound will be some­
what different from the molecule of interest. Solvation 
is also likely to be conformationally dependent. When 
water is employed as a solvent, the structure of hydrogen 
bonding to the substituent becomes a critical factor as 
do differences in substituent ionization compared to the 
ethyl compounds.
In summary, this chapter demonstrates the combination 
of lH NMR coupling methods, MM2 and MO calculations (the 
latter for parameterization purposes only), and X-ray 
structural data for structure elucidation of charged, 
flexible molecules in water. The success of the modified 
MM2 force field offers optimism for the future develop­
ment of this combined approach. All of the equations 
used in this study that predict conformations from 
coupling data give similar results. Equation 1 is pre­
ferred because of its simplicity and general applicabil­
ity to all molecules and conditions under which the spec­
tra are measured. Equations 7 and 8 are theoretically 
satisfying because they provide some insight into the 
origin of the effect of substituents on coupling con­
stants. On the other hand, eq 1 employs experimentally 
determined substituent constants, and its sole purpose is
1 2 8
■to reliably predict torsion angles from coupling data. 
In its present form eq 1 assumes complete additivity of 
substituent effects. As more is learned about the influ­
ence of substituents on vicinal coupling constants, the 
methods used in the development of eq 1 and 2 can be 
readily extended to include secondary effects arising 
from non-additivity of substituents.
REFERENCES
1. Bystrov, V. F. Prog. Nucl. Magn. Reson. Spec- 
trosc. 1976, 10, 41-81.
2. Allinger, N. L. Adv. Phys. Org. Chem. 1976, 13, 
1-82.
3. (a) Schneider, H.-J.; Buchheit, U.; Becker, N.;
Schmidt, G. ; Siehl, U. J. Am. Chem. Soc. 1985, 107, 
7027-7039. (b) Jaime, C.; Osawa, E. ; Takeuchi, Y.;
Camps, P. J. Org. Chem. 1983, 48, 4514-4519.
4. Karplus, M. J. Chem. Phys. 1959, 30, 11-15.
5. Pachler, K. G. R. J. Chem. Soc., Perkin Trans. 2 , 
1972, 1936-1940.
6. Haasnoot, C. A. G.; de Leeuw, F. A. A. M.; Altona, 
C. Tetrahedron, 1980, 36, 2783-2792.
7. Colucci, W. J.; Jungk, S. J.; Gandour, R. D. Magn. 
Reson. Chem. 1985, 23, 335-343.
8. Karplus, M. J. Am. Chem. Soc. 1963, 85, 2870-2871.
9. Fellman, J. H . ; Fujita; T. S. Biochim. Biophys. 
Acta, 1965, 97, 590-593.
10. (a) Murray, W. J.; Reed, K. W.; Roche, E. B. J.
Theor. Biol. 1980, 82, 559-572. (b) Reed, K. W.;
Murray, W. J.; Roche, E. B. J. Pharm. 
Sci. 1980, 69, 1065-1068.
129

















Gandour, R. D.; Colucci, W. J.; Fronczek, F. R. 
Bioorg. Chem. 1985, 13, 197-208.
Agostini, G.; Coletta, F.; Gambaro, A.; Castellano,
S. Spectrochim. Acta, Part A, 1979, 35, 733-737.
Culvenor, C. C. J.; Ham, N. S. Chem. Commun. 1966, 
537-539; 1970, 1242-1243.
Ziegler, H. J.; Bruckner, P.; Binon, F. J. Org. 
Chem. 1967, 32, 3989-3991.
Wawzonek, S. ; Meyer, D. J. Am. Chem. 
Soc. 1954, 76, 2918-2920.
Randall, E. W. ; Shaw, D. Spectrochim. Acta, Part 
A , J967, 23, 1235-1242.
Kato, T.; Morikawa, T.; Suzuki Y. J. Pharm. Soc. 
Jpn. 1952, 1177-1182.
Eisenbach, C. D.; Schnecko, H.; Kern, W. Macromol. 
Chem., Suppl. I 1975, 151-66.
Glasoe, P. K.; Long, F. A. J. Phys. Chem. 1960, 64, 
188-191.
McGarvey B. R.; Slomp, G., Jr. J. Chem. 
Prog. 1959, 30, 1586-1589.
Yalkowsky, S. H.; Zografi, G. J. Pharm. 
Sci. 1970, 59, 798-802.
Castellano, S.; Bothnei— By, A. A. J. Chem. 
Phys. 1964, 41, 3863-3869.
Allinger, N. L. J. Am. Chem. Soc. 1977, 99,
8127-8134.
Terui, Y. J. Chem. Soc., Perkin Trans. 2 , 1975, 
1 18- 127.
Personal communication with Dr. Salvatore Profeta, 
Jr., Allergan Pharmaceuticals, Irvine, CA.
Binkley, J. S.; Whiteside, R. A.; Krishnan, R.; 
Seeger, R.; DeFrees, D. J.; Schlegel, H. B.; 
Topiol, S.; Kahn, L. R.; Pople, J. A.; van Kampen, 
P. N. ; de Leeuw, F. A. A. M.; Smits, G. F.; Altona, 
C. QCPE 1980, No. 437.
Mulliken, R. S. J. Chem. Phys. 1955, 23, 1833-1840.
130
28. (a) Julg, A. Top. Curr. Chem. 1975, 58, 1-37. (b)
Jug, K. Theor. Chim. Acta, 1973, 31, 63-73. (c)
Flisza'r, S.; Goursot, A.; Dugas H. J. Am. Chem.
Soc. 1974, 96, 4358-4363.
29. Cox, S. R.; Williams, D. E. J. Comput. 
Chem. 1981, 304-323.
30. Hehre, E. J.; Stewart, R. F.; Pople, J. A. J. 
Chem. Phys. 1969, 5/, 2657-2664.
31. Binkley, J. S.; Pople, J. A.; Hehre, W. J. J. Am.
Chem. Soc. 1980, 102, 939-947.
32. Del Re, G. J. Chem. Soc. 1958, 4031-4040.
•33. Huheey, J. E. J. Phys. Chem. 1965, 69,
3284-3291; 1966, 70, 2086-2092.
34. Hinze, J.; Whitehead, M. A.; Jaffe', H. H. J. Am.
Chem. Soc. 1963, 85, 148-154.
35. Feeney, J. Proc. R. Soc. London, Ser. A , 1975, 345,
61-72.
36. Maciel, G. E.; Mclver, J. W.; Ostlund, N. S.;
Pople, J. A. J. Am. Chem. Soc. 1970, 92, 4497-4506.




The advent, of solid state structural analysis of pro­
teins has sometimes enabled researchers to directly 
observe substrate-enzyme interactions.1 However, when 
structural data are unavailable from X-ray crystallo- 
graphic analyses, a topographical description of the 
active site must be deduced by indirect studies such as 
enzyme-substrate and enzyme-inhibitor interactions. Even 
with the aid of crystallographic structures, all impoi—  
tant mechanistic pathways of catalysis are not always 
obvious.
The newly developed technique of site-directed muta­
genesis in combination with X-ray analysis offers a means 
of actually mapping the functional portions of enzymes, 
and thus deducing pathways of catalysis.2 A carefully 
chosen set of engineered mutant enzymes may be used to 
dissect the unique- interactions and functions of cata­
lytic residues in the native enzyme. Although still in 
its infancy, this method promises to be a useful adjunct 
to the more classical design, synthesis, and testing of 
active site-directed agents.
The successful design of active inhibitors, suicide 
substrates, and alternative substrates is contingent upon 
a thorough understanding of the specific covalent and 
non-covalent binding interactions that occur between the 
enzyme and its substrate(s). These are themselves
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entirely dependent upon both the chemical architecture of 
the inhibitor and its conformational bias. Therefore, 
the ability to predict the conformational structure of 
enzyme-bound substrate molecules is central to the 
rational design of inhibitors.
Design considerations for inhibitors of CAT. Chapters 2, 
3 and 4 were devoted to (but not limited to) understand­
ing the conformational preferences of carnitine and 
acetylcarnitine. The knowledge of the solution conforma­
tions of these molecules, and previous inhibitor studies 
that revealed the •importance of the carboxylate site in 
binding, allowed us to proceed with the rational design 
of a new class of conformationally rigid analogues and 
sulfonate substrates. The following points had been cred­
ibly established: 1. The N1-C4-C3-03 torsions of carni­
tine and acetylcarnitine exhibit a strong tendency toward 
g- conformations. . Any successful inhibitor should favor 
this conformation. 2. For energetic reasons, the folded, 
g-,g~, conformer is the most likely form that binds to 
the enzyme and should therefore be freely accessible to 
the inhibitor. 3. The stereospecific requirements of CAT 
demand a three-point binding of the chiral substrate for 
chiral recognition. The three sites possible are the cai—  
boxylato, the quaternary ammonium, and the reactive OH 
(or OAc) groups on the molecule. The apparent need for a 
free carboxyl group is probably a reflection of an
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extremely tight binding pocket and a major enzyme confoi—  
mational reorganization, instead of the need for a chemi­
cally active catalytic function as previously suggested 
(Chapter 1). A tight pocket serves two purposes: first, 
chiral recognition, and second, discrimination between 
carnitine and choline. 4. The quaternary ammonium bind­
ing pocket is comparatively loose. The observed gradual 
decline in binding of carnitine analogues having N-alkyl 
substituents larger than methyl indicates that modifica­
tions may be possible near the quaternary ammonium site 
(i.e., at the nitrogen of carnitine). 5. The mechanism 
for catalysis is most likely via a direct addition-elimi- 
nation mechanism involving formation of a tetrahedral 
intermediate between CoASH and acetylcarnitine, and not 
the formation of a high energy anhydride intermediate as 
has been suggested (Chapter 1). However, because of the 
presence of a sulfhydryl moiety in or near the active 
site, the formation of an acyl thio-enzyme intermediate 
(serving as a go-between to the addition-elimination 
mechanism) cannot be precluded. The close proximity of 
carnitine acetoxyl and CoASH sulfhydryl functions has 
been demonstrated through the bisubstrate inhibitors of 
Chase and Tubbs (Chapter 1). Because enzymes often cata­
lyze by binding and stabilizing high energy reaction 
intermediates or transition structures,3"3 a successful 
inhibitor should show some features of the tetrahedral
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intermediate, that is, it should be a reactive intermedi­
ate analogue.6
Analogues. Conformationally constrained systems offer the 
best possibility for testing hypotheses concerning the 
active site topography. The basic framework chosen for 
the conformationally rigid analogues is that of the moi—  
pholinium cation shown in Figure 1. This class of com-
Figure 1. Basic structure of the morpholinium 
class of inhibitors.
pounds satisfies many of the above stated requirements 
for a successful inhibitor design. The morpholinium ring 
conformation is well characterized. Generally a chair 
conformation is observed,7"9 and therefore the 
N4-C5-C6-01 torsion (Figure 1) adopts the
desired g- conformation. Furthermore, the R substituents 
are unconstrained and can therefore, by simple rotation, 
adopt the desired folded conformation. Although the 
anionic binding pocket limits R to such groups as 
-CH2C00" (carnitine analogues) and -CH2S03" (sulfonate 
analogues), R = H was included to further explore the 
relative importance of this binding site vs. the quatei—  
nary ammonium and acetoxy sites.





Substitution at C2 was chosen in order to 
investigate the proposed tetrahedral intermediate. The 
possibility of numerous substituent combinations at C2 
(Z,Y) allows for the generation of novel reactive inter—  
mediate analogues. In addition, there is the possibility 
of constrained axial and equatorial substitution pat­
terns, hence, the stereochemical requirements of the tet­
rahedral intermediate can be investigated.
Synthetically, morpholinium analogues attracted our 
attention for three reasons: First, their synthetic pre­
cursors exhibited predictable stereospecific ring clo­
sures. Second, these systems were accessible by several 
different routes.10 Finally, they were always crystalline 
solids and therefore generally easy to purify. Two 
approaches leading to stereospecific ring closures were 
employed with success.
Scheme I depicts the synthesis of morpholinium ana­
logues from condensation of an allylic halide with the 
appropriate dimethylamino alcohol and subsequent ring 
closure to give the cyclic products. The ring closure 
step is stereospecific and yields only the diequatorial 
(cis) enantiomers with relative stereochemistry as shown 
in Scheme I. The resulting stereospecificity may be 
attributed to a chair transition structure in the ring 
closure reaction (Figure 2). The effect of temperature 
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examined: Thus, the condensed acyclic intermediate prod­
uct is found predominantly when the reaction is carried 
out at room temperature and in non-protic solvents,
gives exclusively the cyclic Michael addition product.
closure yielding diequatorial substituents.
The second approach employed was the condensation of 
dimethylamino alcohols with a-halo ketones as shown in 
Scheme II. Facile ring closure occurs in all cases. As 
with the previous ring system, closure always occurs to 
give an equatorial R substituent. In fact, chirality at 
C6 completely directs stereochemistry at C2, with the 
relative stereochemistry of the products as shown in
whereas, refluxing this intermediate product in alcohols
Figure 2. Proposed transition structure for ring
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S c h e m e  II
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Me^ + V Me X "
X = Cl, Br
R , =  A l k y l ,  A ry l
R = H ,  CH j C O j H,  C H ,S O jH
Scheme II. The combination of a dominant gauche effect 
about the N4-C3-C2-0H torsion, and anomer.ic effect+ for 
the ring hemiketal (or hemiacetal) leads to cyclic prod­
ucts exhibiting exclusively axial OH groups. To the con­
trary, an equatorial OH would exclude the favorable anom- 
eric effect as well as the stabilizing gauche interaction 
between N + and 0 (see Chapter 2 for a discussion on the 
gauche effect).
+The anomeric effect is a very general effect in organic 
chemistry that controls conformation in compounds such as 
ketals and hemiketals. Specifically stated, it is the 
tendency of lone-pair electrons on heteroatoms to be 
located antiperiplanar to polar bonds (Figure 3). stabi­
lization effect results from the favorable interaction of 
nonbonding electrons with the antibonding orbital of the 
polar bond.11
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a n t l p a r l p l a n a r  Io n a  p a i r
p o l a r  C - 0  b o n d
OH
Figure 3. Anomeric effect in 2-hydroxyraorpholinium 
hemiacetals and hemiketals.
RESULTS AND DISCUSSION
Syntheses of intermediates. The syntheses of the
1-substituted dimethylamino alcohols were prerequisites
2-(yV,A/-dimethylamino)ethanol (DMAE, R= H) is commercially 
available, and racemic 1-(A/,yV-dimethylamino)-2-propanol 
(DMAP, R= -CH3) could be easily prepared from propylene 
oxide and dimethylamine (eq 1). However, the syntheses of 
sodium norcarnitine (1, R= -CH2C00Na), its methyl ester 
(2, R= -CH2C00CH3) and N,7V-dimethylamino-2-hydroxy-
propanesulfonic acid (3, R= -CH2S03H) required greater
(S)-3 were desired because these configurations gave ana­
logues matching the configuration of biologically active 
(R)-carnitine.
to preparation of the morpholinium inhibitors.
(0
effort. Enantiomerically pure (R)-1, (/?)-2 and
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Sodium 3-chloro-2-hydroxypropanesul£onate (4;
precursor to 3) was prepared by a literature procedure 
from epichlorohydrin and sodium bisulfite12 (Scheme III).
Scheme III
a CHlc, ,
Z - V '  H»0, 60 *C
NaOjS
EtOH HCI 0 C
Cl
HO,S 1) s t r y c h n i n e  NaOjS
2) NaOH Ht o "
Cl




THF H ,0  M e -N - M eI +
R
(r ) - 3  , R =  H 
( R ) - 5  . R =  Me
Resolution was attempted according to a literature 
method,13 but yielded only a single enantiomer in pure 
form. Reaction with excess trimethylamine in tetrahydro- 
furan-water gave sulfocarnitine (5, Scheme III). The 
X-ray structuret of 5 revealed a backbone conformation 
similar to that of carnitine (Figure 4). The X-ray anoma­
lous scattering data of 5, which had been synthesized 
from resolved 4, revealed an R-configuration at C2 of 5.
tAppendix 1 contains detailed crystallographic data for 
all structures appearing in this chapter.
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Hence, the S-isomer of 4 must have been isolated in the 
resolution step, because it is unlikely that inversion 
of 4 occurred. The synthesis of 3 proceeded as described 
for 5 but from dimethylamine.
Figure 4. Single crystal X-ray structure of 
(ff)-sulfocarnitine, 5.
Several methods exist for the preparation of enan- 
tiomerically pure norcarnitine. Methylation of
4-ammonio-3-hydroxybutyrate CGABOB) with formaldehyde and 
hydrogen catalyzed by palladium on carbon has been 
reported.14 However, this approach was abandoned because 
large quantities of (fl)-GABOB were not readily available. 
In a second approach, chemomicrobiological reduction of 
chloroacetoacetates by yeast gives (fi)-4-chloro-3-hy- 
droxybutanoates,15>16 which can in theory be converted to 
norcarnitine by reaction with dimethylamine. Neverthe­
less, the overall yield of carnitine by this method is 
only 45%, and it therefore seemed inappropriate for large 
scale preparations of norcarnitine. The best approach
14 2
for the large scale synthesis of sodium (R)-norcarnitine 
and its methyl ester was demethylation of commercially 
available (fl)-carnitine. Because of considerable interest 
in preparing methyl-labeled (R)-carnitine, several meth­
ods for the demethylation had been reported: One approach 
is to use sodium thiophenoxide for demethylating the pro­
pyl ester of carnitine in 2-butanone.17 However, thio- 
ester formation is an undesirable sid6 reaction, and the 
hydrolysis of the thioester of carnitine introduces an 
additional step. In addition, others18 have reported dif­
ficulty in reproducing this procedure. In an alternative 
approach, sodium thiophenoxide in A/,yV-dimethylformamide 
(DMF) is used to demethylate carnitine directly18. Unfoi—  
tunately, this method, which includes a laborious ion-ex­
change workup, produces a product in the form of a hygro­
scopic glass. In addition, it is limited to the 
preparation of one to two gram quantities of product. 
Attempts at scale-up in our laboratory resulted in very 
low yields. The need for large scale preparations and 
product in the free-base form prompted a reinvestigation 
of the demethylation procedure.
Because demethylations in 2-aminoethanol had been 
previously reported,19 use of this compound as both a 
solvent and demethylating agent was investigated. 
Although 2-aminoethanol was an unusually good solvent for 
carnitine hydrochloride, demethylations required tempera­
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tures in excess of 150 °C, which led to considerable 
decomposition. A return to thiophenol in 2-aminoethanol 
led to successful demethylation of carnitine hydrochlo­
ride at 100 °C but produced almost exclusively the 
/V-(2-hydroxyethyl) amide of norcarnitine. It was however 
encouraging to see that the difficult-to-prepare sodium 
thiophenoxide was not required when the demethylation was 
conducted in this basic solvent. Presumably a signifi­
cant amount of ionized thiol existed in solution for 
demethylation to occur. Because a tertiary amine could 
not lead to amide formation, DMAE was the solvent of 
choice. The inner salt of carnitine is soluble in DMAE 
but becomes extremely soluble when thiophenol is added. 
Ionization of the thiophenol by the amine probably 
increases the polarity of the medium. Reaction was con­
ducted at 100 °C and was complete after 24 hours. Sol­
vent, thiophenol, and methylated byproduct (methyl phenyl 
thioether) were all removed by azeotropic distillation 
with water. Crystalline (R)-norcarnitine (zwitterion) was 
isolated in 91% yield and was readily converted to the 
free-base (sodium salt) with sodium hydroxide by adjust­
ing the pH of a 100 mM solution to 11.5 (Scheme IV).
Because of the unusual nucleophilicity of the car—  
boxylato group of norcarnitine (see discussion below), 
the successful preparation of some inhibitors required 
protection of the carboxylate. In these cases the previ-
1 4 4
S c h e m e  IV
-o.c ■o,c
OH
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►OH 2)Na j C O j *
H
'OH
Me Me Me Me
00-1 (R)-2
ously reported20 methyl ester was employed. Synthesis 
o£ 2 was accomplished in refluxing methanolic HCI fol­
lowed by neutralization with sodium carbonate (Scheme
Although not specifically an aim of this research, a 
procedure for the important re-methylation of norcarni­
tine was nevertheless developed. Literature methods for 
reaction of the betaine or hydrochloride forms of norcai—  
nitine with methyl iodide in aqueous methanolic sodium 
hydroxide17 and in aqueous methanolic barium hydroxide18 
have been reported. On the other hand sodium norcarni­
tine could be methylated without the addition of inoi—  
ganic bases. Addition of methyl iodide to sodium norcai—  
nitine in a methanol-acetone mixture gives soluble sodium
IV)
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iodide and insoluble carnitine, which crystallizes read­
ily from solution (eq 2). This procedure was successfully
N a O , C ^  " O jC
14c h , i t
MeOH Action* M
H .C -N — CH, 
"C H ,
employed by Davis for the preparation of 14C-labeled 
(R)-carnitine.21 He finds 97% of the radioactivity in the 
crude material, which shows only one peak during HPLC 
analysis.
Syntheses of 2-carboxymethylmorpholiniums. Scheme V 
depicts the synthesis of the first class of morpholinium 
inhibitors. The condensation of DMAE or DMAP with methyl 
4-bromo-trans-crotonate in tetrahydrofuran yielded mostly 
acyclic forms. The charged products separated from the 
tetrahydrofuran as dense oils, which when refluxed in 
methanol for several hours gave the cyclic Michael addi­
tion products. Hydrolyses of the esters in hydrobromic 
acid yielded the bromide salts 6 and 7 from R= -H and R= 
-CH3 respectively.
Figure 5 shows the X-ray structure of 7 and confirms 
the anticipated stereospecific ring closure leading to 
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this inhibitor adopt a conformation like that of 
the extended form of carnitine.
Due to the insolubility of I in pure tetrahydro­
furan, a one-step condensation with methyl
4-bromocrotonate was carried out in a methanol-tetra- 
hydrofuran mixture. The cyclic product 8 crystallized 
when the refluxed solution was cooled. Hydrolysis of 8 in 
hydrobromic acid gave 9.
The X-ray structure of 9, shown in Figure 6, veri­
fied the stereospecific ring closure for formation of 8.
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Figure 5. Single crystal X-ray structure of 7.
Because diastereomeric forms of 8 were notably absent in 
its *H NMR spectrum, the meso form of 9 was anticipated 
upon hydrolysis. The solid state structure of 9, in fact, 
displays a meso form with a mirror plane containing the 
atoms 03, N, C3 and C4. Again the backbone atoms, extend­
ing from C6 to N, resemble the extended form of carni­
tine. The relative stereochemistry of 9 cannot, by this
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synthetic route, be controlled to produce the unobserved 
diastereomer, because, synthesis from (R)-1 would still 
give only the meso form.
Figure 6 . Single crystal X-ray structure of 9.
Syntheses of hemicholiniums. The simplest members of the 
second class of inhibitors synthesized were the hemicho­
liniums; compounds 10 through 18' in Scheme VI, and 19 in 
eq 3. These compounds were chosen because some were known 
substrates of choline acetyltransferase,22 an enzyme sys-
149
S c h e m e  VI
CO H  NMe, \Br OH°v L r-ja.Q
Me Me Br*
10 R =  CH, 14 x' = N H C (0 )C H ,
11 R =  CF, 15 x' = N H ,+
16 x '  — Cl
12 X '=  H 17 x' = N O ,
13 X ' =  O C H , 16 x' = CN
tern closely related to CAT. Hemicholinium-3 was previ­
ously tested on CAT (Chapter 1). The minor activity that 
was observed was encouraging and prompted the investiga­
tion o£ less bulky substituents. Except for R= H these 
compounds were synthesized by condensation of DMAE and 
appropriate a-bromo ketones as shown in Scheme VI (only 
one of two possible enantiomers is shown). The hydro 
derivative was synthesized from chloroethanal dimethyl 
acetal (eq 3). It should be pointed out that 12 (also 
known as hemicholinium-15), 16, and 17 have been
reported previously.23 Likewise, the perchlorate salt of 
the hydro-derivative has been reported , although its 
synthesis proceeded by a different method.24
Attempts at solving the crystal structures of the 
chloride and bromide salts of 19 failed because of highly
150
19
disordered crystals. The crude structures did, however, 
reveal the regiospecific ring closure that resulted in an 
axial hydroxy group. The X-ray crystal structures for 
all other compounds in the series, except 15 (crystals 
unsuitable) were solved, and each revealed the antici­
pated axial hydroxy group. The structure of 12, shown in 
Figure 7, is typical of the entire aromatic series; while 
the structures of 10 and 11 (Figure 8 ) were surprisingly 
homologous.
Syntheses of hemiacylcarnitiniums. The carnitine equiva­
lent to hemicholinium was synthesized from sodium norcai—  
nitine by reaction with chloroacetone in refluxing 
2-propanol. However, reaction with one equivalent of 
chloroacetone always produced a significant amount of the 
ester 20 (identified by lH NMR), shown in Scheme VII. 
The exceptional nucleophilicity of the norcarnitine cai—  
boxylate was unexpected and posed a problem for the 
syntheses of other analogues. However, in this case the 
ester was readily hydrolysed in hydrochloric acid, thus
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Figure 7. Single crystal X-ray structure of 12.
giving the desired product, hemiacetylcarnitinium, 2 1 .+
The X-ray crystal structure of 21 is shown in Fig­
ure 9. Ring closure is observed to be completely stereos- 
pecific, with relative configuration of the two chiral 
centers fixed to give only axial hydroxy and equatorial 
carboxymethyl groups. Hence, synthesis of 21 from sodium 
(/?)-norcarnitine gives the configuration shown in Scheme
+By analogy with the hemicholiniums, 21 is given the 
trivial name hemiacetylcarnitinium, and the class of 
inhibitors is referred to as hemiacylcarnitiniums.
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10 1 1
Figure 8 . Single crystal X-ray structures of 
10 and 11.
Scheme VII
N . O , C - ^ O H  . H,C> 0  .PA, 8 2 * ^
^NMe, \ CI
J ?  S ? H H OHCH>CCH,OC-^°Vj>CHl „♦ Ho c ^ O ^ C H ,
Cl M e ^  + S M e  Cl“ / VMe + Me
2 0  21
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VII. In contrast to the structures of 7 and 9, the back­
bone atoms of 2 1 (extending from Cl to N) exist in 
the folded conformation.
Figure 9. Single crystal X-ray structure of hemi­
acetylcarnitinium, 2 1 .
In an effort to synthesize long-chain hemiacylcarni- 
tiniums for testing with CPT, sodium norcarnitine was 
condensed with 1-bromo-2-heptadecanone yielding the ester 
derivative of hemipalmitoylcarnitinium (22). However, 
hydrolysis of the double-addition ester gave a mixture 
that was difficult to purify because of the surfactant 
properties of hemipalmitoylcarnitinium. On the other 
hand, reaction from 2 , and subsequent hydolysis, 
yielded 2 2 , which precipitated from the chilled hydro-
bromic acid solution and could be crystallized from etha­
nol by vapor diffusion with ether (eq 4).
o
MaOjC
j) CH) (CH>) 14 C CHt Br  ̂ H0£
2) 2N  H B r, 100 ‘C
NMe,
2 22
Synthesis of hemiacetylsulfocarnitinlum. The preparation 
of hemiacetylsulfocarnitinium+ (23) is shown in eq 5. 
Hexamethylphosphoramide (HMPA) was required to dis­
solve 3 and to promote the Sn2 reaction. In addition, 23 
was isolated directly, because esterification of the sul­
fonate does not occur as with the carboxylates of 2 1 , 
and 2 2 .
tBy analogy with hemiacetylcarnitinium and sulfocarni- 
tine, compound 23 was given the trivial name hemiacetyl- 
sulfocarnitinium.
N ajC O j
00
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The single crystal X-ray structure of 23 was found 
to be homologous with that of hemiacetylcarnitinium (Fig­
ure 10).
Figure 10. Single crystal X-ray structure of hemi- 
acetylsulfocarnitinium, 23. .
EXPERIMENTAL
General data. Tetrahydrofuran was distilled from potas­
sium metal. Hexane was distilled from calcium hydride, 
and ethyl ether was distilled from sodium benzophenone 
ketyl. The alcohols were reagent grade, as was acetone, 
which was stored over 4 A sieves. Hexamethylphosphoram- 
ide (HMPA, Aldrich) was used as received. Acetophenones 
were used as received and brominated by the procedure of
Langley.23 Acetone was mono-brominated by the procedure 
of Levene26, and 1,1,1-trifluoroacetone (Aldrich) was 
brominated by the method of Shapiro et al.Z7 
2-Bromo-4’-methoxyacetophenone (Aldrich), thiophenol 
(Aldrich) and 2-(A/,A/-dimethylamino)ethanol (DMAE, Aid- 
rich) were used as received. 1-(4’-Aminophenyl)ethanone 
(Aldrich) was converted to 2-bromo-4'-acetamidoaceto- 
phenone with acetic anhydride in a potassium acetate- 
buffered solution. (f?S)-1-(A/,A/-Dimethylamino)-2-propanol 
(DMAP) was prepared from propylene oxide and aqueous 
dimethylamine using the method of Garcia-Guajardo.28 
2-Heptadecanone was prepared from 1-heptadecene (Aldrich) 
by the method of Rogers et al.,2 9 and was converted to
1-bromo-2-heptadecanone by bromination in hexane-methanol 
1:1 according to the method of Gaudry and Marquet.30 
Sodium (RS)-3-chloro-2-hydroxypropanesulfonate (4) was 
prepared according to the method of Cambre and Theile.12
(S)-4 was isolated by strychnine resolution of (RS)-4 by 
use of the procedure.described by Tsunoo.13 Reaction of 
(RS)-4 with aqueous dimethylamine (40% solution, Aldrich) 
in tetrahydrofuran gave (RS)-3-(A/,A/-dimethyl-
aminio)-2-hydroxypropanesulfonate (3) as a 1:1 salt 
with sodium chloride. The methyl ester of norcarni­
tine (2 ) was prepared in 86% yield by refluxing sodium 
norcarnitine in methanolic HCI for several hours; after 
the reaction mixture was neutralized with sodium carbo­
nate, the ester was extracted into tetrahydrofuran.
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Vapor diffusion crystallizations were carried out by 
dissolving the compound in an appropriate solvent (typi­
cally an alcohol) in an ovei— sized beaker or test tube, 
placing this container in a sealed jar containing an 
appropriate volatile co-solvent, and allowing the assem­
bly to stand for several days. Alternatively, crystalli­
zations on a larger scale were more conveniently done by 
placing the solution in a single-neck round bottom flask 
and attaching a sealed co-solvent reservoir.
An Electrothermal apparatus was used for melting 
point determinations (uncorrected). Proton and carbon-13 
NMR spectra were recorded on either a Bruker WP-200 or an 
IBM NR-100 spectrometer. Aqueous samples were prepared by 
dissolving 20 mg of the pure compound in 0.5 mL of D20 
containing sodium 3-(trimethylsilyl)-1-propanesulfonate 
(DSS) as reference. IR spectra were recorded on either a 
Perkin Elmer 727B or a 238B spectrophotometer. All ele­
mental analyses were performed by MicAnal Organic Microa­
nalysis of Tucson, Arizona. The optical rotations were 
recorded with a Rudolph Research Autopol III automatic 
polarimeter at Tulane University School of Medicine.
Sodium (/?S)-4-(A/,A/-dimethylamino)-3-hydroxybutyrate 
(sodium norcarnitine, 1). (RS)-carnitine (34.43 g, 0.214 
mol) was added to 427 mL of DMAE in a 1 L round bottom 
flask. The mixture was heated to 50 °C under a nitrogen 
atmosphere. After 15 min, thiophenol (70.61 g, 0.641 mol)
158
was added in one portion, and the temperature was raised 
to 100 ^C. The reaction mixture was maintained at 100 °C 
under nitrogen with continuous stirring for 24 h; it was 
then cooled and transferred to a 3 L 3-neck flask 
equipped with a nitrogen bleed tube and a 50-cm vacuum 
distilling column with head. Thiophenol, DMAE, and 
byproducts (methyl phenyl thioether) were removed by 
azeotropic distillation with water. The pot was filled to 
2 L with distilled water, which had been previously 
sparged with nitrogen. The cloudy mixture was distilled 
while a steady flow of nitrogen was introduced through 
the bleed tube by way of the inlet side of a Matheson 
model 49 vacuum regulator. The pressure was set initially 
at 360 mm but was raised gradually to 540 mm after 
removal of the thiophenol (after about 2 L). The pot was 
repeatedly refilled with nitrogen-sparged water during 
distillation of the watei— DMAE azeotrope (91 °C, 540 mm). 
A total of 12 L was collected at a rate of 2 L every 5 h. 
The final volume was reduced to 500 mL. After filtration 
through a 2 n fritted glass filter, the remaining water 
was stripped off under vacuum (65 °C, 1 mm), and the oil 
that resulted was dried under vacuum at 50 °C, ca. 12 h. 
A 2 L solution of this material in distilled water was 
prepared, and the pH was adjusted to 11.5 with NaOH (8.54 
g, 0.214 mol in 136 mL water). Water was stripped from 
the solution, yielding a pale yellow solid, which was
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dried under vacuum and crystallized from 400 mL of 
2-propanol cooled gradually to -10 °C. The resulting
white solid was filtered and washed with 2-propanol. 
(Material recovered from the supernatant was crystallized 
from successively smaller volumes of 2-propanol.) The 
combined product was recrystallized from ethanol (100 mL) 
by vapor diffusion with ethyl ether (200 mL); colorless 
orthorhombic crystals (31.99 g, 89%): mp 149-151 °C; ‘H
NMR (100 MHz, ref to DSS in D20, pD=1.59) S 4.49 (m,
CH-OD), 3.30 (m, CH2-N), 2.98 (d, (CH3)2-N), 2.70, 2.55
(dd, dd, CH2-C00); IR (KBr) 3400 (b, OH), 2795 (m,
CH3-N), 1584 (s, 0-C-0), 1400 (s, C-0 acid), 1100 (m, CO 
alcohol) cm-1. Anal. Calcd for C6Hi2NNa03: C, 42.60; H, 
7.15; N, 8.28. Found: C, 42.19; H, 7.32; N, 8.03.
Sod i um (R )-4-(N ,N-di methy1ami no)-3-hydroxybutyrate 
[(R)-l]. The synthesis of sodium (R)-norcarnitine pro­
ceeded as described' for the racemic compound with a few 
exceptions: A semi-crystalline solid resulted after azeo- 
tropic distillation. The solid was triturated with 
2-propanol until white. Recrystallization from 2-propanol 
(300 mL), yielded colorless, hygroscopic crystals (34.31 
g, 91% based on 41.16 g of (R)-carnitine): mp 112 °C;
[a]d2 2 * 5 -71.5° (c=0.154, H20). Anal. Calcd for
C 6Hi3N03 : C, 48.96; H, 8.90; N, 9.52. Found: C, 48.75;
H, 9.06; N, 9.31. This product was converted to the 
sodium salt by neutralization with one equivalent of
sodium hydroxide in water. Crystallization from boiling 
2-propanol produced white dendritic crystals: mp
121.5-122.5 °C; [a]D22,s -15.6° <c=0.855, H z0) . Anal.
Calcd for C 6H lzNNa03 : C, 42.60; H, 7.15. Found: C,
42.36; H, 7.38.
Methylation of 1.- Sodium (.R)-norcarnitine (300 mg, 1.77 
mmol) was dissolved in 4 mL of hot methanol in a 50 mL 
sealed tube reactor. The solution was diluted with ace­
tone (25 mL), and a limiting quantity of methyl iodide 
(Aldrich, 227 mg, 1.60 mmol) was added in a single poi—  
tion. The tube was sealed and placed in a 50 °C water 
bath for 5 h. Crystals of (/?)-carnitine formed in the 
first 30 min. Crystallization was completed by cooling 
the tube to 4 °C. The white crystals were filtered,
washed with acetone, and dried under vacuum. This
material (214 mg) melted over a wide range: mp 185-190 °C 
dec (lit32 mp 197-198 °C dec), and was assumed to be con­
taminated with a trace quantity of sodium iodide. The 
filtrate was concentrated under vacuum, and the solid
obtained was dissolved in 5 mL of water along with the
white crystals. The solution was passed through 863 mg 
(dry weight) of Dowex 1-X8 resin (0H“ form, 50-100 mesh, 
ca. 3.1 meq) in a 3 mm I.D. column and eluted with water. 
The basic fraction (ca. 15 mL) was collected and poured 
directly onto a second 3 mm I.D. column containing 201 
mg (dry weight) of Amberlite CG-50 resin (H+ form,
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200-400 mesh, ca. 2.0 meq) and eluted with water. Water 
was stripped off under vacuum, and the solid was dried by 
azeotropic distillation with small portions of absolute 
ethanol and was then vacuum dried (245 mg, 98%): mp 196
°C dec; *H NMR and IR (KBr) spectra agreed with those of 
an authentic sample of carnitine.
(RS) -3-Hydroxy-4- (.N,N, N-trL methy lami ni o) propanesul f onat e 
(sulfocarnitine, 5). (RS)-4 (20.00 g, 102 mmol) and 25%
aqueous trimethylamine (200 mL) were added to tetrahydro­
furan (100 mL) in a stainless steel reaction bomb. The 
bomb was maintained at 100 °C for 2 h, then allowed to 
cool. The contents were evaporated to dryness, and the 
white solid that resulted was dried under vacuum, and 
then extracted with several portions of boiling metha­
nolic HCI. The methanolic HCI extracts were pooled and 
evaporated, and the solid that resulted was crystallized 
from boiling methanol-water, 95:5. Evaporation over sev­
eral days gave white crystals (15.01 g, 75%): mp 281-284
°C (lit33 mp 286-287 °C); ‘H NMR (100 MHz, ref to DSS in 
D 20) S 4.7 (m, CH-0), 3.9-3.3 (m, CH2-N+), 3.24
(s,(CH3)3-N+), 3.15 (d, CH2-S03"); IR (KBr) 3300-3650 (b, 
OH), 717 (s, S-0) cm-*.
(R)-3-Hydroxy-4-(A/,A/,AHtrimethylaminio) propanesul fonate 
[(R)-sulfocarnitine, (R)-5]. Synthesis proceeded as 
described for the racemate but from (S)-4: mp 310-317 dec
1 6 2
(lit13 mp 295 °C); [oc]Dzz-s +30.3° (c=0.892. H 20) flit13
[а]D13 +28.54° (c=10.85, H 20)$. »H NMR and IR spectra 
were identical with those of the racemic compound. Anal. 
Calcd for C 6HisN04S: C, 36.56; H, 7.67; 7.11. Found: C, 
36.69; H, 7.86; N, 6.93.
iRS)-2-carboxymethyl-4,4-dimethylmorpholinium bromide
(б ). DMAE (8.91 g, 100 mmol) in 50 mL of tetrahydrofuran 
was added dropwise to a stirred solution of methyl 
4-bromocrotonate (Aldrich, 8.95 g, 50 mmol) in 75 mL of 
tetrahydrofuran at 25 °C. The solution became cloudy dui—  
ing addition, which took about 15 min. After several 
hours, the solution was decanted and the oil that had 
settled was washed with tetrahydrofuran, vacuum dried, 
and then refl'uxed in methanol (70 mL) for 4 h. The solu­
tion was concentrated and the oil (methyl ester of 6 ) was
hydrolysed in 2 M HBr (50 mL) at 25 °C. After 3 days the 
solution was concentrated and the oil was redissolved in
40 mL of water, which was then removed on a rotary evapo­
rator under vacuum. This procedure was repeated twice to 
ensure complete removal of excess HBr. The resulting oil 
was then dried under vacuum until crystalline (ca. 3 
days). The crystals were triturated with 2-propanol (3X50 
mL) and ethanol (2x30 mL) until white and then dissolved 
in boiling ethanol (50 mL). White crystals formed upon 
cooling (2.22 g, 26%): mp 168-170 °C; *H NMR (100 MHz,
ref to DSS in D z0) S 4.3 (m, HC-0), 4.1 (m, CH2-0),
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3.6-3.1 Cm, CH2-N+), 3.28 (s, CH3-N+), 3.23 (s, CH3-N+),
2.39 (d, CHz-COO); IR (KBr) 2820 (b, OH), 1710 (s, C=0)
cm-1. Anal. Calcd for C 8Hi6BrN03: C, 37.81; H, 6.35; N,
5.51. Found: C, 37.51; H, 6.41; N, 5.72.
(2R,6S ;2S,6R )-2-Carboxymethy1-4,4,6-tr1methy1norphol1n i um 
bromide (7). DMAP (1.13 g, 11.0 mmol) in tetrahydrofuran 
(10 mL) was added dropwise to methyl
4-bromo-^trans-crotonate (Aldrich, 1.79 g, 10.0 mmol) in 
tetrahydrofuran (10 mL) with constant stirring at 25 °C. 
An oil formed instantly and was allowed to completely 
settle. The solution was decanted, and the oil was 
washed with tetrahydrofuran, and then dissolved in metha­
nol (40 mL). The solution was refluxed for 8 h, and then 
concentrated, and the oil was dissolved in 40 mL of 2 M 
HBr and allowed to stand at 25 °C. After 3 days, the 
solution was concentrated to a thick oil and allowed to 
remain under high vacuum for 2 days. The crystals that 
formed were washed with 2-propanol until white and vacuum 
dried. Crystallization from 50 mL of boiling ethanol 
gave colorless clustered plates upon cooling (1.86 g, 
69%): mp 225.5-226.5 °C; *H NMR (100 MHz, ref to DSS in
D 20) S 4.5-4.0 (m, HC-0-CH-), 3.7- 2.9 (m, CH2-N+-CH2),
3.28 (s, CH3-N+), 3.24 (s, CH3-N+), 2.6 (m, CH2-C00),
1.23 (d, CH3-C); IR (KBr) 2900 (b, OH), 1720 (s, C=0)
cm"1. Anal. Calcd for C 9Hi8BrN03: C, 40.31; H, 6.77; N, 
5.22. Found: C, 40.59; H, 6.77; N, 4.90.
1 6 4
Sodium (2/?,6S:2S,6/?)-6-carboxylatomethyl-2-methoxycar- 
bonylmethyl-4,4-dimethylmorpholinium bromide (8 ). 
(RS)-1 (5.08 g, 30 mmol) was dissolved in methanol (80 
mL) at 25 °C, then tetrahydrofuran (240 mL) and methyl
4-bromocrotonate (5.91 g, 33 mmol) were added sequen­
tially while stirring. The mixture was refluxed under 
nitrogen for 3 h, cooled, and allowed to stand for 12 h. 
The crystalline aggregates that formed were filtered, 
washed with tetrahydrofuran/methanol, and dried under 
vacuum. Recrystallization of 3.00 g of this material from 
methanol (20 mL) by vapor diffusion with ethyl ether gave 
slightly hygroscopic white aggregated plates (2.50 g, 
83.3%): mp 245 °C dec; *H NMR (100 MHz, ref to DSS in
D20) S 4.4 (m, HC-0), 3.72 (s, 0-CH3), 3.7-3.1 (m,
CH2-N+), 3.32 (s, CH3-N+), 3.26 (s, CH3-N+), 2.69 (d,
CH2-C(0)0C), 2.41 (d, CH2-C00); IR (KBr) 3110-2935 (b,
C-H), 1110 (s, C-0-C), 962, 918, 880 (s, CH3-N+) cm"1.
Anal. Calcd for C»»Hi9BrNNaOB C, 37.95; H, 5.50; N, 4.02. 
Found: C, 38.03; H, 5.67; N, 3.93.
(meso)-2,6-Bis(carboxymethyl)-4,4-dimethylmorpholinium 
bromide (9). 8 (83 mg, 0.24 mmol) was dissolved in 2 M
HBr (5 mL), and the solution was allowed to stand at 25 
°C. After two days the solution was concentrated, and the 
oil that resulted was dried under vacuum, and then washed 
with ethyl ether (3X5 mL) and ethanol (2X2 mL). After 
further drying under vacuum, the oil was dissolved in
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methanol (5 mL). Crystallization by vapor diffusion with 
ethyl ether gave colorless plates (31 mg, 42%): mp
235-236 °C; *H NMR (100 MHz, ref to DSS in D20) S 4.5 (m, 
HC-0), 3.7- 3.1 (m, CHZ-N+), 3.33 (s, CH3-N+), 3.28 (s,
CH3-N+), 2.7,2.5 (dd, dd, CH2-C00); IR (KBr) 3140 (b, 
OH), 1759 (s, C=0) cm-1. Anal. Calcd for Ci0Hi8BrN04: C, 
38.48; H, 5.81; N, 4.49. Found: C, 38.62; H, 5.95; N, 
4.32.
2-Hydroxy-2,4,4-trimethylmorpholinium bromide (10). A 
solution of 1-bromo-2-propanone (11.0 g, 0.13 mol) in 
tetrahydrofuran (100 mL) was slowly added (10 min) to a 
solution of DMAE (11.6 g, 0.13 mol) in tetrahydrofuran 
(50 mL) at 25°C. The solution was stirred for 30 min, 
and a white, gummy precipitate formed. In a glove bag 
under N 2, the solvent was decanted, and the precipitate 
was washed twice with tetrahydrofuran, dissolved in 250 
mL of hot 2-propanol:ethanol (2:1), and vapor diffused 
with tetrahydrofuran (dried over Na2S04) . After 24 h at 
25 °C, 6.1 g of a white crystalline solid was obtained.
An additional 14.3 g crystallized at 5 °C giving opaque 
white tetragonal prisms (total yield 70%): mp 161-162 °C; 
»H NMR (200 MHz, ref to DSS in D 20) S 4.45 (m, 1H), 3.93
(d, 1H), 3.6-3.3 (m, 4H), 3.41 (s, 3H), 3.20 (s, 3H),
1.47 (s, 3H); l3C NMR (25 MHz, ref to CH30H; 49 ppm, in
D z0) 5 93.49 (s, C D ,  65.22 (t, C2, V(CN) 2.5 Hz), 62.81
(t, C3, »J(CN) 2.8 Hz), 58.01 (t, CH3-N+, D(CN) 4.0 Hz),
1 6 6
54.72 (s, C4). 50.65 (t, CHa-N+, ^(CN) 3.3 Hz), 26.76
(s. C5); IR (KBr) 3451 (b, OH), 3071 (m, CH3), 1116,
1071, 1051 (s, C-O-C-O) 961, 901, 874 (s, CHa-N+) cm"*.
Anal. Calcd for C 7H 16BrN02: C, 37.18; H, 7.13; N, 6.19.
Found: C, 36.98; H, 7.40; N, 6.07.
2-Hydroxy-4,4-di methy1-2-(trlf1uoromethy1)morpholi nlum 
bromide (11). A solution of 1-bromo-3,3,3-tri- 
fluoro-2-propanone (3.4 g, 17.9 mmol) in tetrahydrofuran
t(50 mL) was added to a solution of DMAE (1.6 g, 17.9 
mmol) in tetrahydrofuran (25 mL) at 25°C. After the solu­
tion was stirred for 30 h, the solvent was decanted, and 
3.8 g (.77%) of a white solid was isolated. The solid was 
washed three times with tetrahydrofuran and dissolved in 
80 mL of methanol:2-propanol (2:1). Vapor diffusion with 
ethyl ether for 30 h produced colorless tetragonal 
prisms: mp 254 °C dec; lH NMR (200 MHz, ref to DSS in
D z0) S 4.50 (m, 1H), 4.17 (d, 1H), 3.8-3.6 (m, 4H), 3.49
(s, 3H), 3.32 (s, 3H); IR (KBr) 3177 (b, OH), 1397-897 
(b, CFa) cm-1. Anal. Calcd for C 7Hj3BrF3N02 : C, 30.02; 
H, 4.68; N, 5.00. Found: C, 30.17; H, 4.82; N, 5.00.
4,4-Di methyl-2-hydroxy-2-pheny1morpholi ni um bromi de
(12). A solution of 2-bromoacetophenone (2.0 g, 10.1 
mmol) in tetrahydrofuran (50 mL) was stirred at 25 °C 
while DMAE (1.05 mL, 10.4 mmol) in tetrahydrofuran (25 
mL) was added dropwise. After one night, a white precipi-
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tate that formed was filtered, washed with tetrahydro­
furan, dried under vacuum, dissolved in cold etha­
nol :2-propanol (3:1). The solution was vapor .diffused 
with ethyl ether:tetrahydrofuran (1:1) at 25 °C to yield 
2.3 g (79.1 %) of colorless crystals: mp 185-187 °C; *H
NMR (200 MHz, ref to DSS in D 20) S 7.50-7.62 (m, 5H),
4.66 (m, 1H), 4.15 (d, 1H), 3.9-3.3 (m, 4H), 3.20 (s,
3H); IR (KBr) 3309 (b, OH), 3059 (w, Ar-H), 1099, 1081,
1059 (m,m,s, C-0-C-0) 969, 938, 917 (s, CH3-N+) cm"1.
Anal. Calcd for C 12H 18BrN02: C, 50.01; H, 6.30; N, 4.86.
Found: C, 50.05; H, 6.48; N, 4.81.
4 ,4-Dimethyl-2-hydroxy-2-(4'-methoxypheny1)morpholinium 
bromide (13). A solution of 2-bromo-4'-methoxyacetophen- 
one (4.32 g, 18.9 mmol) in tetrahydrofuran (50 mL) was 
stirred at 25 °C while DMAE (1.9 mL, 19.1 mmol) in tetra­
hydrofuran (25 mL) was added dropwise. After 30 min a 
white precipitate that formed was filtered, washed with 
tetrahydrofuran, dried under vacuum, and dissolved in 
warm methanol. That solution was vapor diffused with 
ethyl ether at 5 °C to yield 3.8 g (63.2J5) of clear col­
orless crystals: mp 201-202 °C; lH NMR (200 MHz, ref to
DSS in CD30D) S 7.54 (m, 2H), 6.93 (m, 2H), 4.60 (m, 1H),
4.06 (d, 1H), 3.9-3.5 (m, 4H), 3.79 (s, 3H), 3.53 (s,
3H), 3.17 (s, 3H); IR (KBr) 3301 (b, OH), 3046 (w, Ar-H),
2692 (w, CH3-O), 1224, 1051 (m,s, Ar-0-CH3) 961, 926, 903 
(m, CH3-N+) cm-1. Anal. Calcd for Ci3H 2oBrN03 : C, 49.07;
H, 6.33; N, 4.40. Found: C, 48.98; H, 6.47; N, 4.23.
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4.4-Dimethyl-2-hydroxy-2-(4'-acetamidophenyl)morpholinium
bromide (14). A solution of 2-bromo-4’-acetamidoaceto-
phenone (0.528 g, 2.06 mmol) in tetrahydrofuran (40 mL)
was stirred at 25 °C while DMAE (0.4 mL, 3.9 mmol) in
tetrahydrofuran (15 mL) was added dropwise. After 90 min
a precipitate that formed was filtered, washed with 
%tetrahydrofuran, dried under vacuum and dissolved in hot 
methanol:2-propanol (1:2). Vapor diffusion with tetra­
hydrofuran at 25 °C gave 0.60 g (84%) opaque light yellow 
rhomboidal crystals: mp 190-195 °C dec; *H NMR (200 MHz, 
ref to OSS in D 20) & 7.63 (d, 2H), 7.51 (d, 2H), 4.67 (m, 
1H), 4.17 (d, 1H), 3.9-3.3 (m, 4H), 3.55 (s, 3H), 3.22
(s, 3H), 2.18 (s, 3H); IR (KBr) 3261 (b, OH, NH), 1645
(m, NHC=0) cm"1. Anal. Calcd for Ci*H2 xBrNzOa: C, 48.71; 
H, 6.13; N, 8.11. Found: C, 48.76; H, 6.22; N, 7.95.
4.4-Di methyl-2-hydroxy-2-(4'-ami ni opheny1)morpholi ni um 
dibromide (15). A solution of 14- (3.0 g, 6.69 mmol) in 
40 mL of 2 M HBr was refluxed for 3 h. After cooling, the 
solution was concentrated, and the dark yellow solid was 
dissolved in methanol. Vapor diffusion with ethyl ether 
at 25 °C yielded 2.54 g (76%) of light yellow crystals: 
mp 207 °C dec; ‘H NMR (100 MHz, ref to DSS in D 20) S 7.76 
(m, 2H), 7.48 (m, 2H), 4.63 (m, 1H), 4.16 (d, 1H),
3.8-3.2 (m, 4H), 3.52 (s, 3H), 3.20 (s, 3H); IR (KBr)
3320 (b, OH), 3120-2570, 1930 Cb,m, N-H), 1250, 1089,
1070 (s, C-0-C-0), 970, 931, 920 (s, CH3-N+) cm"1. Anal.
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Calcd for C x2H 20Br2N 202 : C, 37.52; H, 5.25; N, 7.29.
Found: C, 37.95; H, 5.50; N, 7.25.
4 .4-Dimethyl-2-hydroxy-2-(4'-chlorophenyl)morpholiniurn 
bromide (16). A solution of 2-bromo-4'-chloroacetophen- 
one (1.5 g, 6.4 mmol) in tetrahydrofuran (25 mL) was 
stirred at 25 °C while DMAE (0.7 mL, 6.9 mmol) in tetra­
hydrofuran (25 mL) was added dropwise. After 10 min a 
white precipitate that formed was filtered, washed with 
tetrahydrofuran, dried under vacuum, and dissolved in 
cold ethanol. That solution was vapor diffused with ethyl 
ether:tetrahydrofuran (1:1) at 25 °C to yield 1.73 g 
(83.8 %) of colorless crystals: mp 196-197 °C; lH NMR
(200 MHz, ref to DSS in D 20) S 7.60 (d, 2H), 7.49 (d,
2H), 4.60 (m, 1H), 4.15 (d, 1H), 3.6-3.3 (m, 4H), 3.53
(s, 3H), 3.20 (s, 3H); IR (KBr) 3258. (b, OH), 2808 (w, 
Ar-H), 1033 (w, Ar-Cl) cm'1. Anal. Calcd for
C 12Hi7BrClN02: C, 44.67; H, 5.31; N, 4.34. Found: C,
44.84; H, 5.44; N, 4.23.
4.4-Dimethyl-2-hydroxy-2-(4’-nitropheny1)morpholinium 
bromide (17). A solution of 2-bromo-4'-nitroacetophenone 
(4.9 g, 20.1 mmol) in tetrahydrofuran (50 mL) was stirred 
at 25 °C while DMAE (2.05 mL, 20.3 mmol) in tetrahydro­
furan (25 mL) was added dropwise. After 10 min a yellow 
precipitate that formed was filtered, washed with tetra­
hydrofuran, dried under vacuum, and dissolved in warm 
methanol. That solution was vapor diffused with ethyl
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ether:tetrahydrofuran (1:1) at 25 °C to yield 6.03 g
(90.1%) of clear yellow crystals: mp 210 °C dec; XH NMR
(200 MHz, ref to DSS in D z0) S 8.33 (d, 2H) , '7.86 (d,
2H), 4.70 (m, 1H), 4.22 (d, 1H), 3.9-3.3 (m, 4H), 3.57
(s, 3H), 3.23 (s, 3H); IR (KBr) 3234 (b, OH), 3049 (w,
Ar-H), 1459, 1319 (s, N0Z), 1088, 1059, 1014 (s,s,m,
C-0-C-0) 968, 937, 919 (s, CH3-N+) cm"1. Anal. Calcd for 
CizHi7BrNz0 A: C, 43.26; H, 5.14; N, 8.41. Found: C,
43.40; H, 5.24; N, 8.34.
4,4-D i methy1-2-hydroxy-2-(4'-cyanopheny1)morpho1i n i urn 
bromide (18). A solution of DMAE (0.10 mL, 1.0 mmol) in 
tetrahydrofuran (3 mL) was stirred in an ice bath, while 
2-bromo-4'-cyanoacetophenone (0.0185 g, 0.084 mmol) in 
tetrahydrofuran (3 mL) was added dropwise. After 10 min a 
white precipitate that formed was filtered, washed with 
tetrahydrofuran, and recrystallized from cold methanol to 
yield 22.5 mg (85.6 %) of colorless crystals: rap 219-220
°C dec; »H NMR (200 MHz, ref to DSS in D z0) S 7.86 (m, 
2H), 7.78 (m, 2H), 4.67 (m, 1H), 4.18 (d, 1H), 3.9-3.5
(m, 4H), 3.54 (s, 3H), 3.20 (s, 3H); IR (KBr) 3260 (b,
OH), 2262 (s, -C=N), 1090, 1070, 1041 (s,s,s, C-0-C-0),
965, 930, 920 (m, CH3-N+) cm-1. Anal. Calcd for
Ci3Hi7BrNz0 z: C, 49.85; H, 5.47; N, 8.94. Found: C,
49.56; H, 5.64; N, 8 .8 6 .
2-Hydroxy-4,4-dimethylmorpholinium chloride (19). Chlo-
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roethanal dimethyl acetal (Aldrich, 74 g, 600 mmol) was 
combined with 100 mL of 18% hydrochloric acid. The mix­
ture was distilled, and the fraction with boiling point 
83-90 °C was condensed and dripped through a 15-cm column 
(13 mm i.d.) packed with 4A molecular sieves into a solu­
tion of DMAE (71.3 g, 800 mmol) in 100 mL of tetrahydro- »
furan at 25 °C. The solution was stirred overnight and 
yielded a white, gummy precipitate that was washed three 
times with tetrahydrofuran. The white solid, 25.6 g 
(26%), was dissolved in methanol, and the solution was
vapor diffused with tetrahydrofuran:ethyl ether at 5 °C 
for two days, producing deliquescent colorless plates: mp 
215 °C dec; lH NMR (200 MHz, ref to DSS in Dz0) S 5.38 
(d, 1H), 4.26 (m, 1H), 4.04 (m, 1H), 3.6-3.2 (m, 4H),
3.33 (s, 3H), 3.24 (s, 3H); 13C NMR (25 MHz, ref to
CHgOH; 49 ppm, in D 20) S 87.85 (s, Cl), 63.03 (t, C2,
iJ(CN) 2.8 Hz), 60.31 (t, C3, 'J(CN) 2.9 Hz), 56.14 (s, 
C4), 54.37 (t, CH3-N+ , lJ(CN) 3.6 Hz), 53.19 (t, CH3-N+, 
*J(CN) 3.8 Hz); IR (KBr) 3337 (b, OH), 1127, 1102, 1080, 
1047 (s, C-0-C-0), 960, 912, 897 (s, CH3-N+) cm"1. Anal. 
Calcd for C 6Hi4C1N02 : C, 42.99; H, 8.42; N, 8.36.
Found: C, 42.90; H, 8 .6 6 ; N, 8.18.
(2S,6ft:Z R ,6S )-6-Carboxymethyl-2-hydroxy-2,4,4-trimethy1- 
morpholinium chloride (hemiacetylcarnitinium, 2 1 ). 
(RS)-1 (3.38 g, 20.0 mmol) was dissolved in hot
2-propanol (175 mL), and chloroacetone (Aldrich, 5.55 g,
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60.0 mmol) was added to the solution in a single portion. 
After 12 h reflux 1.125 g of sodium chloride was col­
lected by filtration. The filtrate was concentrated to a 
thick oil, which was triturated with ethyl ether and 
dried under vacuum. The deliquescent yellow solid (20) 
that resulted was dissolved in 60 mL of 2 M HC1, and the 
solution was refluxed for 12 h. The concentrated solution 
yielded a yellow glassy solid, which was triturated with 
acetonitrile (4X20 mL). The white solid that resulted was 
collected, dried under v&cuum (3.68 g, 77%), and then 
dissolved in a 190 mL ethanol/10 mL methanol mixture. 
Vapor diffusion with ethyl ether produced, over several 
days, large colorless needles: mp 210 °C dec; *H NMR (100 
MHz, ref to DSS in Dz0) 5 4.9 (m, HC-0), 3.75-3.15 (m,
CHZ-N+), 3.46 (s, CH3-N+), 3.22 (s, CH3-N+), 2.80, 2.60
(dd.dd, CHz-C00), 1.48 (s, C-CH3); IR (KBr) 3462-2662
(b, OH), 1722 (s, C=0) cm"1. Anal. Calcd for C 9H 18C1N04 :
C, 45.10; H, 7.57; N, 5.84. Found: C, 45.28; H, 7.78; N,
5.59.
(2S,&R)-6-Carboxymethyl-2-hydroxy-2,4,4-tri methylmorpho- 
linium chloride [ (2S,6/?)-21 ] . The synthesis of 
(2S, 6/if)-hemiacetylcarnitinium chloride proceeded as 
described for the racemate but from (/?) — 1 : mp 200 °C dec;
[a ]Dzz.B +42.9° (c=0.884, Hz0). Anal. Calcd for
C 9H ieClN0A : C, 45.10; H, 7.57; N, 5.84. Found: C, 45.20 
H, 7.84; N, 5.60.
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(ZS,6R :2R,6S )-6-Carboxymethyl-2-hydroxy-2-pentadecy1-4,4- 
dimethylmorpholinium bromide (hemipalmitoylcarnitinium, 
22). (RS)-2 (9,00 mg, 4.57 mmol) and 1 -bromo-2-heptadec- 
anone (1.52 g, 4.56 mmol) were dissolved in tetrahydro­
furan (30 mL), and the solution was refluxed under nitro­
gen. After 24 h the solvent was removed, and the oil that 
resulted was triturated with ethyl ether until white, and 
then dried under vacuum. A solution of the oil dissolved 
in 2 M hydrobromic acid (45 mL) was refluxed for 4.5 h. 
The solution was then cooled in a glycol bath (-12 °C) 
until formation of product (a fluffy white precipitate) 
was complete (several min). The precipitate was collected 
in a medium fritted glass filter, washed with 10 mL ice 
cold water, dried by azeotropic distillation with etha­
nol, and vacuum dried overnight. The resulting white 
solid was recrystallized twice from 95% ethanol by vapor 
diffusion with ethyl ether. Flaky white crystals formed 
within 12 h (605 mg, 28%): mp 149-150.5 °C; »H NMR (100
MHz, ref to TMS in d 6-DMS0) S 4.6 (m, HC-0), 4.1-3.1 (m,
CH2-N+), 3.35 (s, CH3-N+), 3.18 (s, CH3-N+), 2.5 (m, 
CH2-C00), 1.6-0.9, 1.26, 0.85 (m, s, t, Ci5-hydrocarbon); 
IR (KBr) 3460-2650 (b, OH), 1717 (s, C=0) cm"1. Anal.
Calcd for C22H 44BrN04 : C, 56.64; H, 9.51; N, 3.00.
Found: C, 56.88; H, 9.80; N, 2.80.
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(2S,6 S :ZR,&R)-2-Hydroxy-6-sulfonatomethy1-2,4,4-tri meth- 
ylmorpholinium+ [2- (6-hydroxy-4,4,6-trimethyl)morpholi-
niomethanesulfonate, hemiacetylsulfocarnitinium, 23].
(RS) -3- (N , A/-Dimethy laminio) -2-hydroxypropanesulfonate 
(sodium chloride complex, 2.42 g, 10 mmol), sodium carbo­
nate (3.18 g, 30 mmol), and chloroacetone (Aldrich, 3.70 
g, 40 mmol) were added sequentially to HMPA (40 mL) in a 
sealed tube reactor and the mixture was heated at 100 °C 
for 5 h with vigorous stirring. After cooling, the sol­
ids were collected by filtration (2 n fritted glass fil­
ter), washed with 2-propanol (3x15 mL), dried, and dis­
solved in 40 mL water. The solution was adjusted to pH 4 
with concentrated HC1. The water was stripped away, and 
the solid was triturated with ether (3x25 mL) and dried. 
The product was extracted into methanolic HC1 at 25 °C 
(3X40,mL). The methanolic HC1 was removed, first under 
vacuum, then by three successive azeotropic distillations 
with methanol on a rotary evaporator. The white solid 
that resulted was dissolved in hot methanol and filtered. 
Vapor diffusion employing tetrahydrofuran produced coloi—  
less clustered plates (840 mg, 35%): mp 265 °C dec; lH
NMR (100 MHz, ref to DSS in Dz0) S 4.9 (m, HCO), 3.7-3.1 
(m, CH2-N+-CH2, CHz-S03), 3.47 (s, CH3-N+), 3.23 (s,
tThis compound is more precisely named as a methanesulfo- 
nate. However, in the interest of comparison with other 
morpholines appearing in this dissertation it is more 
conveniently named as a morpholinium.
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CHa-N+), 1.50 (s, CHa-C); IR (KBr) 3240 (b, OH), 785 (s,
S-O) cm"1. Anal. Calcd for CbHi7N0bS: C, 40.16; H, 7.16; 
N, 5.85. Found: C, 39.87; H, 7.34; N, 5.56.
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Chapter 6. Effect of Active-Site Probes on Carnitine 




The purpose o£ the present study was two-fold: 
First, we wished to model the active sites of CAT and CPT 
from data on the binding of inhibitors. Second, we sought 
to delineate any differences that might exist between 
substrate recognition by CAT versus that by CPT. Although 
acyl chain-length effects were already well described 
(Chapter 1), recognition of carnitine by CPT was not well 
characterized. Very few carnitine analogue inhibitors of 
CPT had been previously reported.
In fact, few syntheses of carnitine analogues have 
been reported, despite the physiological relevance of 
carnitine and acetylcarnitine. This lack of carnitine 
analogues is possibly due in part to the practical diffi­
culties involved in synthesizing compounds of low molecu­
lar weight and high functionality, as well as in manipu­
lating hygroscopic quaternary ammonium salts and 
zwitterions.
The compounds described in Chapter 5 were tested as 
specific inhibitors of CAT and CPT by Drs. Linda and Paul 
Brady of the Department of Food Science and Human Nutri­
tion, Washington State University. Specific conditions 
for their assays are described below. The results of 
their studies are presented and discussed.
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EXPERIMENTAL
Enzymes. Purified pigeon-breast-muscle CAT was obtained 
from Sigma Chemical Co. (St. Louis, MO). Crude CAT activ­
ity was also assayed in rat-liver mitochondria following 
solubilization with 0.1% Triton X-100. Rats were fed chow 
diets supplemented with 2% diethylhexyl phthalate for 2-3 
weeks prior to isolation of liver mitochondria by previ­
ously described techniques.1 Rat-liver CPT was purified 
as described by Brady and Brady2 with the modification 
that Tween 20 was substituted for Triton X-100 and sizing 
on Sephacryl S-300 was performed both as initial and 
final steps. In brief, this procedure utilizes a sizing 
step (Sephacryl S-300, Pharmacia Fine Chemicals, Piscata- 
way, NJ) after Clarke and Bieber,3 an anion exchange step 
(DEAE Toyopearl, EM Science, NJ) after Miyazawa et al.,* 
and a chromatofocusing step (Chromatofocusing media, pH 
gradient 7 to 5, Pharmacia Fine Chemicals, Piscataway, 
NJ). This step was followed by a final sizing on SepHa- 
cryl S-300 to exchange the buffer.
Enzyme assays. The activities of CAT and CPT were assayed 
in the forward direction (formation of acy1-carnitine and 
CoA) spectrophotometrically at 412 nm with DTNB reagent 
at 25 °C. This method is comparable to the one described 
by Bieber et al.B for CPT, except that Triton X-100 is 
omitted. The formation of CoA is followed by observing
the release of 2-carboxy-4-nitrothiophenolate ion (eq 1). 
Although DTNB slowly inactivates CAT, it is nonetheless a 
suitable assaying reagent, because formation of CoA and 
subsequent reaction are many-times faster.
Final concentrations in the assay of hemiacetylcai—  
nitinium (HAC) were: 80 /nM AcCoA (or palmitoyl-CoA); 116
mM Tris HC1, pH 8.0; 1.1 mM EDTA; 0.12 mM DTNB; 0.05, 0.5 
and 5 raM (/?)-carnitine; and 0-5 mM inhibitor. Under these 
conditions the observed kinetics were linear for a mini­
mum of 2 min. Dixon plots were generated and analyzed 
according to Segel.6 The reported Ki values are the avei—  
ages determined from three repetitive experiments. Stan­
dard error of the mean (SEM) is 0.065 for both pigeon or 
rat-liver enzymes.
For kinetic determinations using sulfocarnitine, the 
concentrations of palmitoyl-CoA varied from 10 to 160 mM; 
of (fl)-carnitine, from 0.08 to 8 mM; and of racemic sul­
focarnitine, from 0.16 to 16 mM. Apparent kinetic con­
stants are reported because of difficulties encountered 
in the assay. Only limited ranges of palmitoyl-CoA and 
palmitoylcarnitine concentrations could be used. The con-
C o A  +
COOH
C o A S - S
COOH
^m ax  412  nm
182
centrations employed spanned the reliable sensitivity 
range of the equipment used. Kinetic parameters were 
determined from Lineweavei— Burk plots, as well as from
secondary slope and intercept plots generated and ana­
lyzed according to Segel.6
For kinetic determinations using hemipalmitoylcai—
nitinium (HPC), CPT was assayed in the reverse reaction
(palmitoyl-CoA formation) by monitoring either CoA 
thioester formation at 232 nmA or [1“C]-carnitine release 
from palmitoyl-[1 AC-methyl']-(/?)-carnitine. 2 Concentra­
tions of reactants were as noted in the figure legends of 
Dixon plots.
The assay of other inhibitors followed the method 
described for hemiacetylcarnitinium.
Assay of respiration in isolated mitochondria. State 3 
(ADP-stimulated) respiration in isolated hepatic mito­
chondria1 was assayed with a Clark-type oxygen elec­
trode;7 the specific substrate concentrations are 
detailed in Table 2.
Materials. (R)-Carnitine was a gift from Sigma-Tau (Rome, 
Italy). Palmitoyl-CoA was synthesized as described by 
Seubert.8 (R)-Palmitoylcarnitine and palmitoyl-[1AC- 
methyl]-(/?)-carnitine were synthesized as described by 
Brendel and Bressler.9 Acetyl-CoA was synthesized accord­
ing to Stadtman.10 Coenzyme A was purchased from PL Bio­
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chemicals (Piscataway, NJ). (/?)-Acetylcarnitine was pui—  
chased from Life-Sciences Resources (Milwaukee, WI). 
[14C-Methyl]-(R)-carnitine was synthesized according to 
Ingalls et al.11 The following additional compounds were
prepared at LSU and were also assayed by Brady and Brady.
\
Synthesis of 4,4-dimethylmorpholinium chloride (24). The 
compound was prepared by a method similar to that 
described by Usher et al.lz Excess methyl chloride (Math- 
eson, reagent grade) was bubbled through a solution 
of A/-methylmorpholine (Alfa, 1 0 . 8 7  g, 1 0 7  mmol) in ben­
zene ( 5 0  mL) at 2 5  °C. A dry ice-acetone condenser was 
employed during reaction, which lasted 3  h. The white 
precipitate that formed was filtered, washed with ben­
zene, and dried under vacuum. Recrystallization from 
ethanol by vapor diffusion with ethyl ether gave 
deliquescent, colorless, cubic crystals ( 8 . 1 1  g, 5 0 % ) :  mp 
indistinct; *H NMR ( 1 0 0  MHz, ref to D S S  in D z O )  S 4 . 0  (m, 
C H z - 0 ) ,  3 . 5 0  (t, CHZ-N+), 3 . 2 5  (s, (CH3)2-N+); IR (KBr)
1 1 0 5  (s, C-O-C), 9 6 2 ,  9 2 0 ,  8 8 1  (s, CH3-N+) cm"1. Anal.
Calcd for C 6H j * C 1 N 0 :  C, 4 7 . 5 2 ;  H, 9 . 3 1 ;  N,  9 . 2 4 .  Found: 
C, 4 7 . 7 5 ;  H, 9 . 5 7 ;  N ,  9 . 1 3 .
Synthesis of 4,4-dimethyl-2-oxomorpholinium bromide 
(25). This compound was prepared by Gabriel Garcia Gua­
jardo in these laboratories, by a previously described 
method.14 The compound, recrystallized from methanol, was
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characterized by single crystal X-ray diffraction analy­
sis:13 mp 247-248 °C dec; *H NMR (100 MHz, ref to DSS in 
D20) S 4.80 (m, CHz-O), 4.50 (s, CH2-C=0), 4/3-3.2 (m,
CH2-N+), 3.45 (s, (CH3)2-N+); IR (KBr) 1738 (s, C=0),
1228 (m, 0-C=0) cm-1. Anal. Calcd for C 6Hi2BrN02: C,
34.31; H, 5.76; N, 6.67. Found: C, 34.61; H, 6.07; N, 
6.49.
Synthesis of (E)-3-carboxy-1,1,1-trimethyl-2-propen-
aminium bromide (26). The compound had been previously 
prepared through dehydration of carnitine by Brendel and 
Bressler.9 However, the following alternative method was 
employed with success: Anhydrous dimethylamine (Matheson, 
3.36 g, 57 mmol) was condensed in a 50 mL sealed tube 
reactor at -42 °C. Tetrahydrofuran (10 mL) was added 
slowly, and the solution was mixed and then returned to 
the dry ice bath. To this solution was added methyl 
4-bromocrotonate (Aldrich, 7.5 g, 42 mmol) in THF (15 
mL). The tube was sealed and warmed to 25 °C. A yellow 
precipitate (methyl ester of 26) formed immediately. 
After 30 min the tube was once again cooled and then 
relieved of pressure. The tube was transferred to a 
glove bag (purged with nitrogen), and the precipitate was 
filtered, washed with acetone until white, and dried 
under vacuum (8.7 g, 87%). The ester (6.50 g, 27 mmol) 
was dissolved in 2 M HBr (50 mL), placed in a brown glass 
bottle, and allowed to stand at 25 °C. After four days
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the solution was concentrated under vacuum on a steam 
bath, then dried under vacuum for 10 h. The light orange 
solid was washed with a minimum of ethanol until white. 
Crystallization from hot IPA (250 mL) gave white flakes 
upon cooling (3.95 g, 65%): mp 205 dec; NMR (100 MHz,
ref to DSS in Dz0) S 6.97 (qn, H-C=CH-C00) 6.36 (d,
H-C=CH-C00), 4.14 (d, CHZ-N+), 3.17 (s, (CH3)3-N+); IR
(KBr) 3550 (b, OH), 1760 (b, C=0) cm"1. Anal. Calcd for 
C 7H 14BrN0z: C, 37.52; H, 6.30; N, 6.25. Found: C, 37.49; 
H, 6.45; N, 6.06.
RESULTS AND DISCUSSION
Activity of and inhibition by hemicholiniums. The racemic 
hemicholiniums, compounds 10-19+ in Figure 1, were found 
to be only weak competitive inhibitors of CAT, with 
respect to carnitine. They were, however, completely 
inactive with CPT from rat liver. The class of compounds 
exhibited Ki values in the range of 3000-4000 /uM for the 
pigeon CAT, and hence they bound to enzyme about 10-fold 
less efficiently than (R)-acetylcarnitine (Km=350 /iM15). 
When the compounds were employed as sole possible subs­
trate, at 10 mM concentration, enzyme catalyzed acetyl 
transfer from AcCoA was observed (eq 2), but at a much
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Figure 1. Hemicholinium analogues of carnitine and 
acetylcarnitine.
slower rate than with (/?)-carnitine. Relative V'max val­
ues [(R)-carnitine=100 /iraol min_1mg“ l] in the range 4.1 
(compound 11) to 8.0 (compound 19) were observed.
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The hemicholiniums present the possibility for three 
distinct modes of binding to the enzyme that depend upon 
recognition of one of three N-C-C-0 torsion angles, coi—  
responding with the N1-C4-C3-03 torsion angle of carni­
tine. Figure 2 shows a comparison between the Newman 
projection of the folded conformation of carnitine (Fig­
ure 2a), which is proposed to be the conformation that 
binds to enzyme, and the Newman projections of the (2S)- 
and (2R)-isomers of the hemicholiniums. Recognition of 
the 01-C2-C3-N4 torsion angle of the (2/?)-isomer (Fig­
ure 2c) would result in a strictly competitive (inhibi-
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Figure 2. Comparison of Newman projections 
for: (a) (R)-carnitine, viewing along the C4-C3
bond; (b) (2S)-isomer of the hemicholiniums, view­
ing along the C3-C2 bond; (c) (2ff)-isomer of the
hemicholiniums, viewing along the C3-C2 
bond; (d) (2S)-isomer of the hemicholiniums, view­
ing along both the C3-C2 and C5-C6 bonds.
tory) mode of binding. Likewise, recognition of the 
01-C6-C5-N4 torsion angle of the (2S)-isomer (Figure 2d) 
would also result in a competitive (inhibitory) mode of 
binding, but one in which the C2 center mimics the tetra­
hedral intermediate of acetyl transfer. On the other 
hand, recognition of the H0-C2-C3-N4 torsion angle of the 
(2S)-isomer (Figure 2b) leads to a mode of binding that 
may give rise to both competitive inhibition and the 
observed activity. Kinetic constants for competitive 
inhibition are measurable, apart from activity, because 
acetyl transfer is much slower than for (/?)-carnitine.
In theory, the individual contributions from com- 
formers shown in Figure 2 to observed kinetic parameters 
might be partitioned by examination of resolved isomers.
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Unfortunately, the assay of resolved isomers is not prac­
tical, because, like the sugars, the hemiketal or hemi- 
acetal center in these compounds can lead to mutarotation 
in solution.16
Fortunately, the possible modes of interaction of 
hemicholiniums with CAT become clearer when it is noted 
that neither morpholinium 24 nor lactone 25 (syntheses 
described in experimental methods) are inhibitors of CAT. 
Therefore, the morpholinium ring alone is not sufficient 
for recognition.
o a
Me Me Me Me
24 25
Activity of sulfocarnitine. The sulfonic acid analogue of 
carnitine was examined for its effectiveness as a sub­
strate of both CAT and CPT. Racemic sulfocarni­
tine (5) was not an effective substrate of the pigeon CAT 
[V'max < 10% of (i?)-carnitine rate]; however, it sup­
ported an apparent V'max for purified rat-liver CPT that 
was 82% of that observed for (/?)-carnitine. + As antici-
+Griffith et al.,17 working concurrently, have also 
observed that racemic sulfocarnitine is a substrate ana­
logue of carnitine for crude rat-liver CPT, but is a less 
favorable substrate for pigeon CAT.
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pated, because o£ its incorrect stereochemistry,
(CHJ)lN/ S s y''^VVs0»'
OH
5 «
(/?)-5 was inactive with both enzyme systems. The appai—  
ent Km of (/?S>-5, determined from a Lineweavei— Burk plot 
(Figure 3), was 3900 which is almost 20-fold greater
than that for (R)-carnitine with CPT (200 mM) .
The kinetics observed for sulfocarnitine closely 
paralleled those observed for IR)-carnitine. When either 
(.R)-carnitine or racemic sulfocarnitine was employed as 
variable substrate at several palmitoyl-CoA concentra­
tions, the apparent Km values for palmitoyl-CoA in both 
cases were nearly identical (20 and 18 respectively). 
Likewise, the Ki observed for (/?)~palmitoylcarnitine with 
(.R)-carnitine as substrate (14 was similar to that
observed when racemic sulfocarnitine was employed as 
substrate (22 /uM).
It is possible that, in spite of the similarities of 
reactions that are catalyzed by CAT and CPT, the require­
ments for substrate recognition differ. This observation 
applies not only to the size of the acyl group, but also 
to the requirements for carnitine recognition. The low 
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Figure 3. Lineweavei— Burk and secondary plots for sulfocarnitine as a substrate of 
purified rat-liver CPT. Concentrations are described in the experimental methods.
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observed for CPT suggests that the carboxyl group is more 
important for CAT than for CPT. This observation supports 
the hypothesis that CAT and CPT may have different cri­
teria for (/?)-carnitine recognition.
Inhibition by hemiacylcarnitiniums. Although structurally 
similar to the hemicholinium compounds, which showed some 
activity toward acetyl transfer, the hemiacylcarnitiniums 
were strictly competitive inhibitors. The presence of the 
carboxymethyl group in the hemiacylcarnitiniums appai—  
ently precluded recognition in the fashion depicted in 
Figure 2b. As Table 1 shows, the activity of the hemi­
acylcarnitiniums on CAT or CPT was dependent upon the 
hemiketal chain length. The acetyl derivative, 21, 
inhibited CAT but not CPT. Conversely, the palmitoyl 
derivative, 22, showed no activity with CAT but was a 
potent inhibitor of CPT.
Racemic hemiacetylcarnitinium (HAC), which is a 
structural isomer of AcCn, is a competitive inhibitor, 
with respect to (R)-carnitine, of both the purified 
pigeon (Ki=890 and crude rat-liver (Ki=4720
CAT.18 The Ki for the rat enzyme is about an order of 
magnitude higher than binding constants reported for cai—  
nitine and acetylcarnitine (see Table 7 of Chapter 1). 
Likewise, the Ki value for the pigeon enzyme (890 *iM), 
determined from the Dixon plot shown in Figure 4, is also 
higher than that observed for either XR)-carnitine
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(Km=120 or (/2)-acetylcarnitine (Km=350 /uM). However, 
when the (25,6/2)-isomer of 21, which corresponds to the 
stereochemistry of carnitine, is employed as inhibitor, 
the observed Ki decreases substantially (Table 1) and is 
about equal to the Km of (R)-carnitine.
The inhibitory activity of HAC is explained by its 
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Figure 4. Dixon plot showing competitive inhib­
ition by racemic HAC on pigeon CAT catalyzed ace- 
tylation o*f (S)-carnitine by AcCoA. The concentra­
tion of AcCoA was fixed at 80 /xM and that of 
(/?)-carnitine was varied at 0.05 mM, 0.5 mM, and 5 
mM. HAC concentration, [I], was varied as indi­
cated .
mediate in the acetyl transfer between CoASH and acetyl- 
carnitine (Chapter 2). Thus HAC could be classified as a 
reaction intermediate analogue.19 Evidence has been pre­
sented from X-ray studies (Chapter 2) as well as XH NMR 
and molecular mechanics studies (Chapter 4) that
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the folded conformation of acetylcarnitine is most popu­
lated and should be preferred for binding to CAT, because 
it is in this conformation that the acetoxy is the most 
sterically accessible. In the X-ray crystal structure of 
HAC (Chapter 5), the carboxymethyl is also in the 
folded conformation. The rigid morpholinium fragment in 
HAC mimics the gauche conformation of the trimethylammo- 
nium nitrogen and ester oxygen on the acetylcarnitine 
backbone.
On CAT and CPT, the points of carboxy and the tri- 
methylammonium attachment along with the CoASH location 
give the three loci required to create a chiral binding 
site for the substrate (Chapter 2). CAT and CPT are 
stereospecific for (H)-acylcarnitine, which corresponds 
to the 6R configuration of 21.
The hemiketal carbon of 21 and the hemiortho thio- 
ester carbon of the-proposed tetrahedral intermediate are 
chiral. CAT and CPT may prefer one configuration at this 
center, just as they prefer one configuration of the chi­
ral center of acetylcarnitine. The preferred absolute 
configuration of the tetrahedral intermediate is R, 
because the most likely approach of the thiol group is on 
the Re face of the acetoxyl group. Figure 5 illustrates 
the structural similarity between (2S,6/?)-21 and the pro­
posed tetrahedral intermediate; OH and CH2 are located 
where S and 0~ are in the tetrahedral intermediate.
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Therefore, the 2S configuration of 21 has the same rela­
tive configuration as the proposed tetrahedral intermedi­
ate, and only (2S,6/?)-21 of the four possible diastereo- 
mers is expected to have activity.
Figure 5. Structural relationship between the pro­
posed tetrahedral intermediate in' the acetyl 
transfer reaction (shown on the right) and the 
X-ray crystal structure of (2S,6/?)-HAC (shown on 
the left).
Because the hydroxy is more stable in the axial 
position, there is complete asymmetric induction when the 
hemiketal is formed and only one pair of enantiomers, 
(2fl,6S:2S,6/?)-21 , is produced. This stereoselectivity 
prevents the formation of (2S,6S:2/?,6/?)-21 in which the 
hydroxy is equatorial. The intriguing possibility of 
determining the chirality of the reaction center by com­
paring (2S,6/?)-21 activity with that of (.2R ,6R)-Z\ is 
unfortunately not possible with this inhibitor.
Table 1 shows the results obtained for inhibition of 
CPT by racemic hemipalmitoylcarnitinium (HPC). Dixon
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plots, shown in Figures 6 and 7, reveal that HPC competes 
with (i?)-carnitine and palmitoyl-CoA in the forward reac­
tion and with (fl)-palmitoylcarnitine in the reverse reac­
tion, but is uncompetitive with respect to CoA.
Because of the structural similarity of HPC to 
(/?)-palmitoylcarnitine, we examined (/?)-palmitoylcarni- 
tine, the product of the forward reaction, as a competi­
tive inhibitor with both palmitoyl-CoA and (/?)-carnitine, 
the substrates of the CPT forward reaction. Dixon plots 
are shown in Figure 8. The Ki for (/?)-palmitoylcarni- 
tine, relative to (fl)-carnitine, is 14.2 /uM; while the 
value relative to palmitoyl-CoA is 8.7 ^M. These values 
are of about equal magnitude to those determined for 
racemic HPC. Thus, HPC may be such an effective inhibitor 
because it is an analogue of palmitoylcarnitine. In addi­
tion, as is true with HAC, HPC may be classified as a 
reactive intermediate analogue; that is, an inhibitor 
that mimics the reaction intermediate in the progression 
from palmitoyl-CoA and (fl)-carnitine to palmitoylcarni­
tine and CoA.
Inactivity of heraiacetylsulfocarnitinium. It was apparent 
from the inhibition studies of hemiacylcarnitiniums and 
sulfocarnitine that CPT and CAT do not use the same cri­
teria for (R)-carnitine recognition. Therefore, racemic 
heraiacetylsulfocarnitinium was synthesized in order to 
investigate the possibility of shifting the short-chain
(B)
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Figure 6. Dixon plots showing HPC inhibition of purified rat-liver CPT. HPC was vai—  
ied as indicated. The forward reaction (palmitoylcarnitine formation) was monitored 
by complexing CoA with DTNB as described in the experimental meth­
ods. CA) (ft)-Carnitine was constant at 0.8 mM and palmitoyl-CoA was varied: 160
pM, B  ; 40 fiM, A ; 20 yuM, • . (B) Palmitoyl-CoA was constant at 80 /uM and
(ft)-carnitine was varied: 8 mM, B ; 0.8 mM, A ; 0.08 mM, • . Reciprocal velocity
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[H em ipalm itoylcarnitinium ], uM
Figure 7. Dixon plo-ts showing HPC inhibition of purified rat-liver CPT. HPC was vai—  
ied as indicated. The reverse reaction (palmitoyl-CoA formation) was measured as 
the release of [1 *C-methyl]-(/?)-carnitine from palmitoyl-[1 4C-raethyl]-(R)-carnitine 
as described in experimental methods. (A) (R)-Palmitoylcarnitine was constant at 80 
/*M and CoA was varied: 5 mM, ■  ; 2.5 mM, ▲ ; 0.675 mM, • . (B) ,CoA was constant at
2.5 mM and (R)-palmitoylcarnitine was varied: 160 pM, ■  ; 40 pM, A ; 20 pM, O .
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Figure 8. Dixon plots showing product inhibition 
of purified rat-liver CPT by (fl)-palmitoylcarni- 
tine. The forward reaction (palmitoylcarnitine 
formation) was monitored by complexing CoA with 
DTNB as described in. experimental methods. • 
(A) (.R)-carnitine was constant at 0.8 mM and pal- 
mitoyl-CoA was varied: 160 /uM, ■ ; 40 /xM, A ; 20
/uM, • . (B) Palmitoyl-CoA was constant at 80 /xM 
and (/?)-carnitine was varied: 8 m M , ■ ; 0.8
mM, A ; 0.08 mM, • .
hemimorpholiniums (e.g., 21) from CAT inhibitors to CPT 
inhibitors. The substitution of sulfonate for carboxylate 
did indeed result in loss of CAT inhibitory activity, but 
surprisingly, binding to CPT was not enhanced (Table 1).
Effect on oxidation by intact mitochondria. Both racemic
200
HAC and racemic sulfocarnitine were investigated for 
their effects on fatty-acid oxidation by intact mito­
chondria. As Table 2 shows, HAC is not an inhibitor of 
state 3 oxygen consumption18 in isolated hepatic mito­
chondria using palmitoyl-CoA or palmitoylcarnitine as
Table 2. Effect of Hemiacetylcarnitinium (21) on-Hepatic 
Mitochondrial State 3 Oxygen Consumption.*
ng-atoms 1 o 0 3
i B ID 1 mitochondrial protein"1wUDo vi&XwS
control + 2 mM (21) SEMb '
40 mM palmitoylcai—  
nitine +2.5 mM malate 82 87 (5)
40 /xM palmitoyl-CoA 
+ 2 mM (/?)-carnitine 
+ 2.5 mM malate 95 94 (5)
200 mM octanoyl-CoA 
+ 2 mM (/?)-carnitine 
+ 2.5 mM malate 82 81 (4)
200 /uM octanoate 
+ 2.5 mM malate 47 50 (4)
10 mM pyruvate 
+ 2.5 mM malate 37 38 (4)
* State 3 respiration is defined as ADP-stimulated
(addition of ADP to achieve a concentration of 2.0 mM). 
b SEM = standard error of the mean.
substrates. Because palmitoyl-CoA oxidation requires 
(fl)-carnitine, the absence of an effect on its oxidation 
implies that neither CPT nor the translocase system is 
affected by HAC. On the other hand, sulfocarnitine sup­
ported oxidation (data not shown) of both palmitoyl-CoA 
[50% of (/?)-carnitine] and octanoyl-CoA [75% of 
(fl)-carnitine]. Sulfocarnitine is, therefore, an effi­
cient alternative substrate of COT, CPT, and the translo- 
case system.
Inhibition by 2-carboxymethylmorpholiniums. The 2-cai—  
boxymethylmorpholiniums were synthesized primarily to 
examine the importance of substitution at C6 of the con- 
formationally rigid morpholinium ring system. These com­
pounds (Figure 9) were competitive inhibitors, with 
respect to (fl)-carnitine, of pigeon CAT, but showed no
values that were calculated for inhibition of the forward 
reaction, assayed according to methods described in the 
experimental section.
The least effective inhibitor in the class is 8. The 
presence of the methyl ester function results in an 
apparent 16-fold reduction in binding compared to 9. How­







Figure 9. 2-Carboxymethylmorpholinium analogues of 
carnitine.
effect on purified rat-liver CPT. Table 3 shows the Ki
202
Table 3. Inhibition of Pigeon CAT by 2-Carboxy- 






• Ki relative to (R)-carnitine, forward reaction.
it is always capable of presenting the correct stereo­
chemistry for binding [i.e., a stereochemistry equivalent 
to the (fl)-isomer of carnitine]. On the other hand, 
the effective concentrations (that fraction of mixed 
isomers that actually interacts with enzyme) of the 
racemic mixtures of 6-8 might actually be one-half that 
measured. Thus, Ki values might be reduced by a factor of 
one-half, but only in the case that the incorrect isomer 
acts strictly as a spectator, that is, a noninhibitor. 
From this perspective, 8 binds about 8-fold less effi­
ciently than 9, a result that is still significant. The 
difference in binding may be caused by a specific inter—  
action of the carboxyl group of 9 with the enzyme, or by 
a steric interaction caused by the larger ester group.
When the Ki values of 6 and 7 are reduced by a fac­
tor of one-half, they agree very closely with the Ki
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of 9; hence, indicating only minor effects on binding as 
a result of substitution at C6. However, the conclusions 
of this analysis might be criticized when the results 
obtained for racemic- and (2tf,6S)-21 are included. 
Although the Ki of racemic 21 is approximately equal to 
that of racemic 6 or racemic 7, the Ki of resolved 21 is 
nearly 7-fold lower; instead of the 2-fold difference 
that was expected. This result is difficult to explain. 
However, it may still be safely concluded, when- comparing 
(2ff,6S)-21 to the compounds shown in Table 3, that the 
combination of both hydroxy and methyl at C6 results in 
superior binding, which would be expected of a reaction 
intermediate analogue.
CONCLUSIONS
The morpholinium compounds, which form the basis of 
this chapter, represent an effective class of CAT inhib­
itors. This conformationally rigid ring system constrains 
the N-C-C-0 torsion angle to gauche conformations only. 
Conformers having a gauche conformation about the N-C-C-0 
torsion angle correspond to the lowest energy conforma­
tions of both carnitine and acetylcarnitine. Evidence has 
been presented, from X-ray studies (Chapter 2) as well as 
from *H NMR and molecular mechanics studies (Chapter 4), 
that the folded conformation of acetylcarnitine is most
204
populated and should be preferred for binding to CAT. 
A folded conformation is observed in the crystal struc­
ture of HAC, which is the most successful inhibitor of
liniums, 7 and 9, showed extended conformations in the 
solid state but were still moderately effective. As is 
true with acetylcarnitine and carnitine, it might be 
safely assumed that only a small energy difference exists 
between the folded and extended conformations of 7 and 9, 
or, for that matter, 21. Hence, no definitive conclusions 
concerning the preference for folded conformations could 
be drawn from these data. However, we have noted that 
the trans-crotonate (26, synthesis described in experi­
mental methods), which models the extended conformation 
of carnitine, is not an inhibitor of CAT or CPT.
The superior inhibition observed for 21 is attrib­
uted to its resemblance to the proposed tetrahedral 
intermediate in the acetyl-transfer reaction (Figure 5). 
A comparison of inhibition by 21 with that of the analo­
gous heraicholinium, 10, reveals, once again, the impoi—
tance of the carboxylate binding site. A change at this 
site, as seemingly minor as from carboxylate to sulfonate
CAT. On the other hand, the 2-carboxymethylmorpho-
26
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(e.g., carnitine vs. sulfocarnitine, and 21 vs. 23), is 
sufficient to disrupt interaction at what must be an 
extremely specific and highly ordered binding pocket.
The sulfonate analogue of carnitine, 5, reveals a 
previously unrecognized difference in the criteria by 
which CAT and CPT recognize carnitine. The carboxylate 
site of CPT is much less specific than that of CAT. The 
dominant site of recognition in CPT apparently occurs 
instead at the long-chain alkyl group. Hence, the most 
successful inhibitors of CPT are palmitoylcarnitine ana­
logues, such as 22.
These results suggest that novel analogues can be 
designed to further distinguish differences in the bind­
ing sites of CAT and CPT, and that highly selective and 
therapeutically significant compounds might be engi­
neered. Such compounds, which are ultrapotent effectors 
of one enzyme but not the other, have immediate practical 
applications. A compound specific for CAT could be used 
in physiological studies where, for example, it might be 
desirable to turn off the acetyltransferase activity and 
observe only the long-chain transferase. Likewise the 
opposite would be possible with CPT specific inhibitors. 
The prospect of inhibiting the oxidation of long-chain 
fatty acids, while not affecting short-chain metabolism, 
suggests obvious clinical application in the condition of 
obesity. Moreover, compounds of the nature described
206
might show promise toward restoring the normal balance of 
long-chain/short-chain fatty acid metabolism in the 
ischemic heart.
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Appendix 1. Crystallographic Data.
208
Table A 1.1. Crystal Data and Data Collection3 Summaries for Inhibitors of Carnitine
Acyltransferase Enzymes, Part A.
Compound (R)-5 7 9 10
Formula C 6H 1sN04S C9H 18BrN03 CioHisBrNOs C7Hi6BrN02
Form. Wt. 197.3 268.2 312.2 226. 1
Crystal system orthorhombic monoclinic orthorhombic orthorhombic
Space group P2l2i21 P2x/c Pnma Pna2i
a( A) 5.623(1) 12.704(2) 11.422(2) 11.763(1)
b(A) 8.490(2) 7.605(2) 15.051(2) 9.307(2)
c(A) 19.067(4) 12.485(2) 7.7620(10) 10.025(1)
j3 C°) 90.0 105.07(1) 90.0 90.0
Z 4 4 4 4
Radiation MoKa MoKa MoKa CuKa
X(A) 0.71073 0.71073 0.71073 1.54184
Dc (g cm-3) 1 .439 1 .529 1 .554 1 .368
fi (cm-1) 3. 19 34.78 30.57 48.59
Crystal size 0.60x0.56X 0.12X0.24X 0.08X0.24X 0.32x0.44X
(mm3) 0.40 0.32 0.28 0.48
9 limits (°) 1 - 35 1 - 25 1 - 25 2 - 7 5
N 3996 2067 1219 1716
No 3480 1340 696 1513
Variables 170 199 123 164
R 0.0388 0.038 0.048 0.0256
Rw 0.0524 0.037 0.035 0.0364
Extinction coeff. 3.0(2)X10“6 2.0(1)X10~6
Max. resid. (eA-3) 0.59 0.60 0.54 0.60
a Crystal data were collected on an Enraf—Nonius CAD4 diffractometer in the X-ray 
crystallographic laboratories of Frank R. Fronczek, LSU Chemistry Department.
Table A1.2. Crystal Data and Data Collection3 Summaries for Inhibitors of Carnitine
Acyltransferase Enzymes, Part B.
Compound 11 12 21 23
Formula C7H 13BrF3N02 C 12H 18BrN02 C9H 18C1N0, C 8H 17N05S
Form. Wt. 280. 1 288.2 239.7 239.29
Crystal system orthorhombic monoclinic monoclinic orthorhombic
Space group Pna2i P2x/c P2x/c Pbca
a(A) 12.966(2) 8.705(2) 8.2919(7) 11.791(4)
b(A) 8.613(1) 11.969(3) 12.1585(12) 14.675(2)
c(A) 9.941(4) 13.280(2) 12.7930(12) 12.731(1)
3 (°) 90.0 104.95(2) 106.961(7) 90.0
Z 4 4 4 8
Radiation MoKa MoKa MoKa MoKa
X(A) 0.71073 0.71073 0.71073 0.71073
Dc (g cm-3) 1 .676 1 .432 1 .291 1 .44
p. (cm-1) 36.83 30.31 3.025 2.8
Crystal size 0.28X0.32X 0.24X0.28X 0.28X0.48X 0.36X0.32X
(mm3) 0.44 0.40 0.56 0.06
8 limits (°) 1 - 30 1 - 27 1 - 27.5 1 - 30
N 1695 3740 2820 3005
No 1255 2060 1930 1360
Variables 178 217 209 136
R 0.032 0.029 0.042 0.058
Rw 0.025 0.037 0.049 0.056
Extinction coeff. 1.3(9)X10*7
Max. resid. (eA~3) 0.31 0.59 0.55 0.49
* Crystal data were collected on an Enraf-Nonius CAD4 diffractometer in the X-ray 
crystallographic laboratories of Frank R. Fronczek, LSU Chemistry Department.
Table AI.3. Coordinates and Isotropic Thermal Parameters £or 5.
Atom X y z B or Seq Atom X y z B or Beq
S -0.84748(5) -0.04396(3) -0.38884(1) 2.412(4) H2 -0.796(3) -0.122(2) -0.5293( 8) 2.2(3)
01 -1.0098(2) -0.0253(2) -0.32252(5) 4.78(3) H31 -1.150(3) -0.030(2) -0.5899( 9) 3.0(3)
02 -0.6524(2) 0.0677(2) -8.37946(6) 5.49(2) H32 -1.067(3) 0.140(2) -0.5831( 8) 2.2(3)
03 -0.7711(3) -0.2047(1) -0.38970(6) 4.25(2) H41 -1.032(3) 0.041(2) -0.7505(12) 3.9(4)
04 -0.6592(2) 0.0958(1) -0.52224(5) 3.98(2) H42 -1.180(4) 0.125(2) -0.7055(10) 4.3(4)
H -0.9013(2) 0.0299(1) -0.65836(4) 1.94(1) H43 -1.194(3) -0.063(2) -0.7052(10) 4.0(4)
Cl -1.0103(2) 0.0043(1) -8.45834(6) 2.33(2) H51 -0.708(3) -0.125(2) -0.7158( 8) 2.5(3)
C2 -0.8577(2) -0.0063(1) -0.52450(5) 2.04(1) H52 -0.879(3) -0.208(2) -0.6605( 9) 3.3(4)
C3 -1.0154(2) 0.0371(1) -0.58612(5) 1.96(1) H53 -8.634(3) -0.133(2) -0.6370C 8) 2.4(3)
C4 -1.1003(2) 0.0352(2) -0.71113(6) 3.03(2) H61 -0.682(3) 0.163(2) -0.7167( 8) 3.0(3)
C5 -0.7652(2) -0.1198(1) -0.66854(7) 2.76(2) H62 -0.622(3) 0.171(2) -0.635BC 9) 2.8(3)
C6 -0.7421(2) 0.1688(1) -0.67141(6) 2.65(2) H63 -0.825(3) 0.268(2) -0.6634C 8) 2.5(3)
H U -1.145(3) -0.069(2) -0.4602(10) 3.7(4) H40 -0.617(3) 0.088(2) -0.4855(10) 5.2(5)
H12 -1.078(4) 0.113(2) -0.4554(10) 4.4(4)
Estimated standard deviations in the least significant digits are shoun in parentheses*
Table A 1.4. Coordinates and Isotropic Thermal
Atom X y x Beq or P
Br- 0.10239(3) 0.21730(0) 0.08965(4) 3.94(1)
Cn 0.6001(2) 0.3272(4) 0.1432(2) 2.57(7)
02 0.3502(2) 0.2110(4) 0.2023(2) 3.34(7)
03 0.3991(2) 0.0151(5) 0.0915(2) 4.21(9)
N 0.0236(2) 0.1705(5) 0.2175(3) 2.62(9)
Ci 0.7326(3) 0.1423(6) 0.2704(3) 2.8(1)
C2 0.6219(3) 0.1544(6) 0.1090(3) 2.4(1)
H20 0.264(5) 0.176(0) 0.137(5) 11.2(19)
Hll 0.741(3) 0.043(5) 0.299(3) 2.8(9)
H12 0.734(3) 0.242(5) 0.330(3) 2.4(8)
H2 0.613(2) 0.052(5) 0.135(2) 1.9(8)
H3 0.604(3) 0.272(6) 0.033(3) 4.3(11)
H41 0.012(3) 0.454(6) 0.210(3) 3.6(10)
H42 0.056(3) 0.369(5) 0.115(3) 3.0(9)
H51 0.909(4) 0.297(7) 0.362(4) 7.4(14)
H52 0.935(4) 0.000(7) 0.348(3) 6.8(13)
Parameters for 7.
Atom X y z 8ocj or 8
C3 0.6872(3) 0.3682(7) 0.0837(3) 3.0(1)
C4 0.8017(3) 0.3531(7) 0.1591(3) 3.0(1)
C5 0.9282(3) 0.1946(8) 0.3089(4) 4.0(1)
C6 0.8354(3) 0.0342(7) 0.1402(4) 3.9(1)
C7 0.5341(3) 0.1273(6) 0.2492(3) 2.7(1)
C8 0.4219(3) 0.1119(7) 0.1709(3) 2.6(1)
C9 0.6658(4) 0.5520(8) 0.0401(4) 4.0(1)
H53 0.982(3) 0.214(5) 0.273(3) 3.4(9)
H61 0.765(3) 0.025(6) 0.078(3) 5.3(12)
H62 0.895(3) 0.065(6) 0.111(4) 5.7(12)
H63 0.850(3) -0.072(6) 0.174(3) 4.7(11)
H71 0.531(3) 0.228(5) 0.295(3) 2.5(8)
H72 0.549(3) 0.027(5) 0.283(3) 2.8(9)
H91 0.718(3) 0.581(5) 0.085(3) 3.3(9)
H92 0.593(3) 0.560(6) -0.002(3) 4.6(11)
H93 0.673(3) 0.634(7) 0.100(3) 6.3(13)
Table AI.5. Coordinates and Isotropic Thermal Parameters for 9.
Atom X y z 8eq or 6 Atom X y z Beq or B—— — ** ^ • *• — —
Br 0 0 0.5 4.22(1) C2 0.2727(4) 0.1675(3) 0.9002(7) 3.0(1)
01 0.3121(4) 0.25 0.6368(6) 2.7(1) C3 0.4138(6) 0.25 1.0863(10) 3.2(2)
02 0.3516(3) 0.0421(2) 0.3390(5) 4.12(9) C4 0.2050(7) 0.25 1.1548(10) 3.9(2)
03 0.4967(3) 0.1140(2) 0.4676(4) 4.28(8) C5 0.3176(4) 0.0926(3) 0.6210(6) 2.8(1)
N 0.2932(5) 0.25 1.0087(8) 2.6(1) C6 0.3986(4) 0.0856(3) 0.4697(6) 2.8(1)
Cl 0.3417(4) 0.1717(3) 0.7329(6) 2.6(1) H41 0.112(6) 0.250(0) 1.080(10) 7.0(22)
HI 0.426(3) 0.174(2) 0.762(4) 0.1(7) H42 0.220(3) 0.199(2) 1.225(4) 1.9(10)
H21 0.301(3) 0.115(2) 0.975(5) 3.1(10) H51 0.243(3) 0.092(2) 0.572(4) 1.2(8)











H20 0.413(5) 0.040(4) 0.266(8) 10.4(20)
Table AI.6. Coordinates and Isotropic Thermal
Atom X y z Beq or 8
Br 0.17419(3) 0.06666(3) 0 4.506(6)
0(1) 0.3611(2) 0.6719(3) -0.0844(3) 5.74(6)
0(2) 0.2480(2) 0.7469(3) 0.0939(4) 5.84(6)
N 0.3338(2) 0.4424(2) 0.1064(3) 3.83(6)
CCD 0.3952(3) 0.5813(3) 0.1373(4) 4.26(7)
C(2) 0.3575(3) 0.7006(3) 0.0534(4) 4.57(7)
C(3) 0.2932(5) 0.5499(4) -0.1143(5) 5.80(10)
C(4) 0.3376(3) 0.4203(4) -0.0402(4) 4.53(8)
C(5) 0.2133(4) 0.4406(4) 0.1575(4) 4.88(8)
CCS) 0.3965(3) 0.3215(3) 0.1737(4) 5.20(8)
C(7) 0.4420(4) 0.8287(4) 0.0723(5) 6.60(10)
HC11) 0.476(3) 0.560(3) 0.119(4) 3.4(7)
H(12) 0.384(4) 0.598(3) 0.239(4) 5.6(9)
H(31) 0.310(5) 0.533(6) -0.212(6) 9.8(17)
Parameters for 10.
Atom X y z B
H(32) 0.204(4) 0.568(3) -0.089(5) 6.1(12)
H(4!) 0.408(4) 0.390(4) -0.052(4) 7.2(11)
H(42) 0.295(4) 0.318(5) -0.063(5) 8.6(13)
H(51) 0.218(4) 0.467(4) 0.250(5) 6.4(10)
H(52) 0.166(3) 0.506(6) 0.114(5) 5.8(9)
H(53) 0.181(3) 0.349(5) 0.141(5) 6.7(11)
HC61) 0.393(4) 0.’44(5) 0.263(5) 8.5(11)
H(62) 0.352(4) 0.215(4) 0.151(5) 8.0(12)
H(63) 0.474(3) 0.324(4) 0.140(4) 5.4(8)
H(71) 0.417(5) 0.892(4) 0.013(7) 10.3(12)
H(72) 0.448(3) 0.848(4) 0.171(4) 6.6(9)
H(73) 0.521(3) 0.804(4) 0.044(3) 5.6(9)
H(20) 0.234(3) 0.810(3) 0.077(4) 5.4(9)
Table At.7. Coordinates and Isotropic Thermal Parameters for 11.
Atom X y z Beq Atom X y z B (A )— — '- •• *“ •
Br 0.14403(2) 0.08859(4) 0 3.422(5) H (11) 0.395(2) 0.631(4) 0.216(3) 1.9(6)
F(l) 0.5335(1) 0.8196(2) -0.0065(4) 6.03(5) H(12) 0.467(2) 0.573(3) 0.111(3) 2,7(7)
F(2) 0.4655(2) 0.9128(3) 0.1727(3) 6.98(7) H(3!) 0.227(3) 0.585(3) -0.093(4) 3.3(8)
FC3) 0.4151(2) 0.9923(3) -0.0197(3) 6.29(7) H(32) 0.297(4) 0.554(5) -0.215(4) 7.2(12)
0(1) 0.3530(2) 0.7046(3) -0.0901(3) 3.86(6) H(41) 0.390(3) 0.412(4) -0.078(4) 3.8(9)
0(2) 0.2716(2) 0.7966(3) 0.1032(3) 3.95(6) H(42) 0.292(3) 0.312(4) -0.055(4) 5.6(11)
H 0.3363(2) 0.4586(3) 0.1064(3) 2.89(6) H(51) 0.197(3) 0.381(4) 0.150(4) 4.3(9)
C(l) 0.3992(3) 0.6039(4) 0.1312(4) 2.94(7) H(52) 0.229(3) 0.497(6) 0.269(4) 7.2(12)
C(2) 0.3625(3) 0.7410(4) 0.0477(4) 3.29(7) H(53) 0.188(3) 0.562(3) 0.124(4) 3.3(B)
C(3) 0.2924(3) 0.5697(5) -0.1154(4) 4.24(9) H(61) 0.354(2) 0.234(5) 0.162(4) 4.6(9)
C(4) 0.3317(3) 0.4301(5) -0.0423(4) 3.63(8) H(62) 0.453(2) 0.322(3) 0.136(3) 2.5(7)











H(20) .0.243(3) 0.078(4) 0.055(3) 4.6(10)
Table A1.8. Coordinates and Isotropic Thersal Parameters for 12.
Atom X y z Beq or B
Br 0.34704(3) 0.09109(2) 0.18376(2) 4.014(6)
0(1) 0.8813(2) 0.0577(2) 0.2651(1) 3.15(4)
0(2) B.98SK2) -0.0018(2) 0.1298(1) 3.63(4)
N 0.7030(2) -0.1305(2) 0.1558(2) 2.85(4)
C(l) B.7104(3) -0.0184(2) 0.1857(2) 2.68(5)
C(2) B.B58B(3) 0.0508(2) 0.1549(2) 2.75(5)
C(3) B.8859(3) -0.0494(3) 0.3129(2) 3.59(6)
C(4) 0.7333(3) -0.1121(2) 0.2714(2) 3.34(6)
C(5) 0.8166(3) -0.2141(2) 0.1309(2) 3.90(6)
C(6) 0.5374(3) -0.1760(3) 0.1151(2) 3.97(6)
C(7) 0.8262(3) 0.1690(2) 0.1127(2) 2.88(5)
C(8) 0.8679(3) 0.1985(2) 0.0224(2) 3.62(6)
C(9) 0.8263(3) 0.3018(3) -0.0223(2) 4.20(7)
C(1B) 0.7424(4) 0.3756(3) 0.0219(3) 4.31(7)
CC11) 0.7009(3) 0.3482(2) 0.1122(2) 4.08(7)
C( 12) 0.7422(3) 0.2442(2) 0.1560(2) 3.39(5)
H(20) 1.065(3) 0.031(2) 0.152(2) 3.3(6)
Atom X y z B
H(011) 0.703(2) -0.031(2) 0.032(2) 1.9(5)
H(012) 0.623(2) 0.022(2) 0.111(2) 1.8(4)
H(31) 0.899(3) -0.041(2) 0.386(2) 3.0(5)
H(32) 0.981(3) -0.086(2) 0.308(2) 3.6(6)
H(41) 0.645(3) -0.070(2) 0.280(2) 3.3(6)
H(42) 0.736(3) -0.174(2) 0.303(2) 3.8(6)
H(51) 0.802(3) -0.282(2) 0.162(2) 4.1(6)
H(52) 0.795(3) -0.222(2) 0.052(2) 4.2(6)
H(53) 0.923(3) -0.186(2) 0.160(2) 3.2(6)
H(61) 0.534(3) -0.243(2) 0.147(2) 5.1(7)
H(62) 0.458(3) -0.121(2) 0.131(2) 4.0(6)
H(63) 0.526(3) -0.185(2) 0.047(2) 3.4(6)
H(8) 0.917(3) 0.147(2) -0.007(2) 4.0(6)
H(9) 0.852(3) 0.322(2) -0.084(2) 4.2(6)
H(10) 0.717(3) 0.441(2) -0.008(2) 4.2(6)
H(ll) 0.652(3) 0.397(2) 0.144(2) 4.0(6)
H( 12) 0.710(3) 0.224(2) 0.217(2) 2.8(5)
Table At.9. Coordinates and Isotropic Thernal Parameters for 21.
Atom X y z Beq or B
Cl 0.61600(7) 0.16737(5) 0.36045(5) 3.75(1)
01 0.2709(2) 0.6206(1) 0.4979(1) 6.11(5)
02 0.2394(3) 0.5210(2) 0.6275(1) 7.06(6)
03 0.1325(2) 0.2632(1) 0.4000(1) 3.21(3)
04 -0.0062(2) 0.1410(1) 0.4061(1) 3.07(4)
N 0.3629(2) 0.1706(1) 0.5940(1) 2.02(4)
Cl 0.2451(3) 0.5332(2) 0.5363(2) 3.52(5)
C2 0.2117(3) 0.4452(2) 0.4524(2) 3.41(5)
H10 0.315(4) 0.671(3) 0.553(3) 10.4(10)
H40 -0.090(3) 0.153(2) 0.443(2) 5.5(6)
H21 0.296(2) 0.447(2) 0.410(2) 4.3(5)
H22 0.123(2) 0.450(2) 0.405(2) 3.6(5) .
H3 0.122(2) 0.329(1) 0.539(1) 2.5(4)
H41 0.412(2) 0.335(2) 0.627(1) 2.3(4)
H42 0.440(2) 0.294(2) 0.517(1) 3.1(4)
H51 0.530(2) 0.057(2) 0.659(2) 4.4(5)
H52 0.594(3) 0.130(2) 0.576(2) 4.5(5)
Atom X y z Beq or B■1 “ • • • — •
C3 0.1970(2) 0.3304(2) 0.4952(2) 2.79(4)
C4 0.36BS(2) 0.2009(2) 0.5620(2) 2.09(4)
C5 0.5410(3) 0.1295(2) 0.6303(2) 3.00(5)
C6 0.2799(3) 0.1500(2) 0.6039(2) 3.60(5)
C7 0.2767(2) 0.1037(2) 0.4940(2) 3.00(5)
C0 0.1096(3) 0.1510(2) 0.4265(2) 3.12(5)
C9 0.0531(3) 0.0917(2) 0.3177(2) 4.42(6)
H53 0.592(2) 0.175(2) 0.690(2) 3.9(5)
H61 0.277(2) 0.001(2) 0.690(2) 4.1(5)t
H62 0.353(3) 0.205(2) 0.746(2) 4.5(5)
H63 0.160(2) 0.103(2) 0.660(2) 4.2(5)
H71 0.261(2) 0.029(2) 0.520(1) 2.0(4)
H72 0.356(2) 0.103(2) 0.449(1) 2.3(4)
H91 -0.050(3) 0.110(2) 0.274(2) 5.7(6)
H92 0.130(3) 0.097(2) 0.202(2) 5.0(6)
H93 0.030(3) 0.010(2) 0.327(2) 5.0(6)
Table Al.tO. Coordinates and Isotropic Thermal Parameters for 23.
Atom X Z z B(R2) Afcon X Z z B(82)
SI 0.43127(9) 0.41788(7) 0.23000(8) 2.74(2) H52 0.534 0.505 0.119 4.0
01 0.6872(2) 0.4315(2) 0.0270(2) 2.79(6) H61 0.834 0.197 0.161 5.5
02 0.6702(3) 0.3569(2) -0.1335(2) 3.45(7) H62 0.730 0.132 0.158 5.5
03 0.3870(3) 0.5033(2) 0.2720(2) 4.29(7) H63 0.826 0.138 0.065 5.5
04 0.4680(3) 0.3569(2) 0.3086(3) 5.78(9) H71 0.584 0.233 -0.048 4.8
05 0.3552(3) 0.3786(2) 0.1553(3) 4.80(8) H72 0.668 0.152 -0.058 4 .9
N1 0.7130(3) 0.2390(2) 0.0589(2) 2.66(7) H73 0.580 0.154 0.032 4.8
Cl 0.6019(3) 0.3816(3) 0.0827(3) 2.48(9) H81 0.810 0.496 -0.119 4.8
C2 0.7448(4) 0.3806(3) -0.0522(3) 2.67(9) H82 0.889 0.458 -0.027 4.8
C3 0.7948(4) 0.2947(3) -0.0052(3) 2.38(8) H83 0.883 0.411 -0.142 4.8
C4 0.6546(4) 0.3007(3) 0.1372(3) 2.70(9) H21 0.641 0.418 -0.166 4.4
C5 0.5540(4) 0.4521(3) 0.1584(3) 3.2(1) H31 0.822 0.258 -0.061 2.9
C6 0.7801(4) 0.1686(3) 0.1169(3) 4.2(1) H32 0.856 0.311 0.039 2.9
C7 0.6286(4) 0.1902(3) -0.0101(4) 3.9(1) H41 0.709 0.322 0.187 3.5
C8 0.8398(4) 0.4418(3) -0.0900(4) 3.8(1) H42 0.597 0.267 0.173 3.5
Hll 0.550 0.365 0.030 3.3 H51 0.611 0.473 0.207 4.0
218
Appendix 2. Microcomputer Programs for the Calculation
of Angles and Populations from Coupling Constants.
219
Definitions of Input Variables.
Program A.
JBobs: Coupling constants of proton B.
JAobs: Coupling constants of proton A.
A, B, C: Values for constants of eq 8 in 
Chapter 2.
LT1, HT1: Low and High 8 values for conformer 1.
LT2, HT2: Low and high 8 values for conformer 2.
LT3, HT3: Low and High 8 valyes for conformer 3.
S1,S2,S3,S4: Substituent constants based on proton A.
Program B.
J1,J2,J3,J4: Coupling constants of monosubstituted 
ethanes of the substituents.
Jobs: Observed coupling in the AX system.
CRITERION: Desired closeness of agreement (Hz) 
between observed and calculated 3J .
Program C.
JA1,JA2,JA3,JA4: Coupling constants of monosubstituted
ethanes of the substituents for proton A
JB1,JB2,JB3,JB4: Coupling constants of monosubstituted
ethanes of the substituents for proton B
PH11low,PH11 high: Low and High values representing















Low and High values representing 
a range of <1 (heavy atom angles) for 
conformer 2.
Coupling constants of proton A.
Coupling constants of proton B.
Desired closeness of agreement (in 
decimalJS) between the population of 
conformer calculated from proton A and 
that calculated from proton B.
Coupling constants of proton B.
Coupling constants of proton A.
Values for constants of eq 8 in 
Chapter 2.
Low and High 6 values for conformer 1. 
Low and high B values for conformer 2. 
Low and High 6 values for conformer 3. 




105 PRINT "THIS PROGRAM CALCULATES AVERAGE POPULATIONS FOR 
THREE CONFORMATIONS OF AN ABX SYSTEM"
110 DIM K$(15),K (15),FAT1(15),FAT2(15),FAT3(15),FBT1(15) ,
FBT2(15),FBT3(15)
120 READ K*<1),K*<2>,K*(3),K*<4),K*<5),K*<6),K*<7),K*<8),K$<9), 
K$(10),K*(11),K$(12),K*(13),K*(14),K*(15)
130 FOR Q=1 TO 15 
140 PRINT "INPUT 
150 INPUT K(Q)
160 NEXT Q





















370 DEF FB=A+B*COS(T+OTC)+C*CQS<2*T+TFC)+COS<T+OTC>*((S1+S2)* 
COS(T)+(S3+S4)#COS(T+TFC))
380 X=0







460 FOR T2=LT2 TO HT2
470 T=T2*RPD
480 X=X + 1
490 FAT2(X)=FA
500 FBT2 < X )=FB
510 NEXT T2
520 X=0











640 FOR T1=LT1 TO HT1 
650 Y=0 
660 X=X+1
670 FOR T2=LT2 TO HT2 
680 2=0 
690 Y=Y+1
700 FOR T3=LT3 TO HT3 
710 L=L+1 
720 2=2+1 






790 P3=<JA*JB2-JA*JB1-JA1*JB2-JB*JA2+JB*JA1+JB1#JA2> / (JA2*JB1- 
JA2*JB3+JA1*JB3+JA3*JB2-JA3*JB1-JA1*JB2)











910 PRINT "Pl= 'S’POPl! "Tl= "}T1
920 PRINT “P2= ";POP2 5”T2= "}T2
930 PRINT “P3= “JP0P3!“T3= "!T3











1040 PRINT "MEAN Pl= ";S U M P 1 / L ; S D P 1
1050 PRINT "MEAN P2= "»S U M P 2 / L J S D P 2
1060 PRINT "MEAN P3= "5S U M P 3 / L ; S D P 3
1070 PRINT




105 PRINT "THIS PROGRAM CALCULATES THETA FOR AN AX SYSTEM" 
110 DIM K*(6>,K<6>,D<360),INDEX<360>
120 READ K*<1> ,K*<2> ,K*<3> ,K9i<4) ,K$<5> ,KiS<6)
130 FOR Q=1 TO 6
140 PRINT "INPUT ";M5<Q);
150 INPUT K(Q)
160 NEXT Q














310 FOR 1=1 TO 360 
320 T=I#RPD




350 IF D <1)>CRIT THEN 380 
360 D (I) =INT (100X-D (I) + . 5) /100 
370 INDEX(I)=1 




420 FOR 1=1 TO 360
430 IF INDEX(I)=0 THEN 450
440 PRINT I,D (INDEX(I))




110 PRINT "THIS PROGRAM CALCULATES ANGULAR SOLUTIONS FOR 
SYSTEMS IN TERMS OF A HEAVY ATOM ANGLE"
ABX
120 DIM K$(17),K (15),JA1(180),JB1(180),JB2(180),JA2<180)
130 READ K*(l),K$(2>,K*(3),K*(4),K$(5>,K*(6),K$(7),K$(8), 
K*(10),K$<11),K*(12),K$(13),K$<14),K*(15)
K*(9)
140 FOR Q=1 TO 15
150 PRINT "INPUT "5K*(Q>;
160 INPUT K(Q>
170 NEXT Q












280 PRINT "DOES THETA = PHI FOR PROTON A OR B?"{
290 INPUT K*(16)
300 INPUT "DOES PHI-120 OR PHI+120 APPLY? INPUT + OR -M:K*(17)
310 IF K5M17> = " + “ THEN 430































620 FOR 1=1 TO ILIM
630 TA=(TA1L+I-1)#RPD
640 JA1<1>=A+B*C0S(TA>+C#C0S<2*TA)+C0S(TA>*((S1A + S4A) * 
COS < TA-OTC) + (S2A + S3A)#COS(TA+OTC))
650 TB=(TB1L+I-1)*RPD
660 JB1<I)=A+B#C0S(TB>+C*C0S<2*TB)+C0S(TB)*< (S1B+S4B)* 
COS < TB-OTC) + (S2B + S3B)ttCOS(TB + OTC))
670 NEXT I
680 FOR M=1 TO MLIM
690 'TA=(TA2L+M-1)*RPD






740 FOR 1=1 TO ILIM
750 FOR M=1 TO MLIM
760 P1A=(JA0-JA2(M))/(JA1(I)-JA2(M))
770 IF PIA<0 THEN 970 
780 IF P1A>1 THEN 970 
790 P1B=(JB0-JB2 <M))/(JB1(I)-JB2(M))
800 IF PIB<0 THEN 970 
810 IF P1B>1 THEN 970 
820 DIFF=ABS(P1A-P1B)





880 IF HEADER=0 THEN 910




930 PRINT "PHI1 "i"PHI2 "{"P1A "5"PIA-PIB"
940 PRINT








105 PRINT "THIS PROGRAM CALCULATES AVERAGE POPULATIONS




130 FOR Q=i TO 13
140 PRINT "INPUT "!K$(Q)(
150 INPUT K(Q)
160 NEXT Q

















340 DEF FA=A+B-XCOS (T) +C*C0S(2*T) +CO 
(S2+S3)#COS(T+OTC) )









420 NEXT T 1
430 X=0




470 FAT2(X > =FA 
480 FBT2(X )=FB 





540 FOR T1=LT1 TO HT1 
550 Y=0 
560 X=X+1
















730 SSQP2=SSQP2 + P0P2-'2
740 PRINT "Pl = "JPOP15"Tl= ";T1
750 PRINT "P2= " iPOP2»"T2= "5T2







830 PRINT "MEAN Pl= "J S U M P l V L ; 5SDP1
840 PRINT "MEAN P2= ";S U M P 2 / L S D P 2
850 PRINT
860 PRINT "NO. OF CALC=" *,L
870 INPUT "CHANGE PARAMETERS? ":Q*
880 IF 6f*="N" THEN 990 
890 FOR Q=1 TO 13
900 print q;k*<q>;tab(15);k(Q)
910 NEXT Q
920 INPUT "SELECT PARAMETER #":Y 
930 PRINT "INPUT "JK*(Y)5 
940 INPUT M 
950 K(Y)=M
960 INPUT "FINISHED?":Q$
970 IF Q*="Y" THEN 190 
980 GOTO 920 
990 END
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